Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2018

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File Number 001-37900


Everspin Technologies, Inc.

(Exact name of Registrant as specified in its Charter)


 

Delaware

    

26-2640654

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

5670 W. Chandler Boulevard, Suite 100

Chandler, Arizona 85226

(Address of principal executive offices including zip code)

 

Registrant’s telephone number, including area code: (480) 347-1111


Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES       NO  

 

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).    YES       NO  

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

  (Do not check if a small reporting company)

 

Small reporting company

 

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    YES       NO  

 

The number of shares of Registrant’s Common Stock outstanding as of August 1, 2018 was 16,904,112.

 

 


 

Table of Contents

Table of Contents

 

 

 

 

 

 

    

 

Page

 

 

PART I—FINANCIAL INFORMATION

 

Item 1.  

 

Financial Statements  

3

 

 

Condensed Balance Sheets as of June 30, 2018 (unaudited) and December 31, 2017

3

 

 

Condensed Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2018 and 2017 (unaudited)

4

 

 

Condensed Statements of Cash Flows for the six months ended June 30, 2018 and 2017 (unaudited)

5

 

 

Notes to Condensed Financial Statements (unaudited)

6

Item 2.  

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

22

Item 3.  

 

Quantitative and Qualitative Disclosures About Market Risk

35

Item 4.  

 

Controls and Procedures

36

 

 

 

 

 

 

PART II—OTHER INFORMATION

 

Item 1.  

 

Legal Proceedings

36

Item 1A.  

 

Risk Factors

36

Item 2.  

 

Unregistered Sales of Equity Securities and Use of Proceeds

57

Item 3.  

 

Defaults Upon Senior Securities

57

Item 4.  

 

Mine Safety Disclosures

57

Item 5.  

 

Other Information

57

Item 6.  

 

Exhibits

57

EXHIBIT INDEX  

58

SIGNATURES  

59

 

In this Quarterly Report on Form 10-Q, “we,” “our,” “us,” “Everspin Technologies,” and “the Company” refer to Everspin Technologies, Inc. The Everspin logo and other trade names, trademarks or service marks of Everspin Technologies are the property of Everspin Technologies, Inc. This report contains references to our trademarks and to trademarks belonging to other entities. Trade names, trademarks and service marks of other companies appearing in this report are the property of their respective holders. We do not intend our use or display of other companies’ trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

2


 

Table of Contents

PART I—FINANCIAL INFORMATIO N

Item 1. Financial Statement s

 

EVERSPIN TECHNOLOGIES, INC.

Condensed Balance Sheet s

(In thousands, except share and per share amounts)

 

 

 

 

 

 

 

 

 

 

June 30, 

 

December 31, 

 

 

2018

 

2017

 

 

(Unaudited)

 

(See Note 2)

Assets

 

 

  

 

 

  

Current assets:

 

 

  

 

 

  

Cash and cash equivalents

 

$

32,725

 

$

12,950

Accounts receivable, net

 

 

5,097

 

 

4,041

Inventory

 

 

9,621

 

 

9,837

Prepaid expenses and other current assets

 

 

1,225

 

 

590

Total current assets

 

 

48,668

 

 

27,418

Property and equipment, net

 

 

3,457

 

 

3,946

Other assets

 

 

209

 

 

73

Total assets

 

$

52,334

 

$

31,437

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

  

 

 

  

Current liabilities:

 

 

  

 

 

  

Accounts payable

 

$

2,883

 

$

2,920

Accrued liabilities

 

 

6,339

 

 

3,748

Deferred income on shipments to distributors

 

 

 —

 

 

1,720

Current portion of long-term debt

 

 

5,993

 

 

3,987

Total current liabilities

 

 

15,215

 

 

12,375

Long-term debt, net of current portion

 

 

5,366

 

 

8,178

Total liabilities

 

 

20,581

 

 

20,553

Commitments and contingencies

 

 

  

 

 

  

Stockholders’ equity:

 

 

  

 

 

  

Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of June 30, 2018 and December 31, 2017

 

 

 —

 

 

 —

Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 16,800,505 and 12,817,201 shares issued and outstanding as of June 30, 2018 and December 31, 2017

 

 

 2

 

 

 1

Additional paid-in capital

 

 

155,866

 

 

128,422

Accumulated deficit

 

 

(124,115)

 

 

(117,539)

Total stockholders’ equity

 

 

31,753

 

 

10,884

Total liabilities and stockholders’ equity

 

$

52,334

 

$

31,437

 

The accompanying notes are an integral part of these condensed financial statements.

3


 

Table of Contents

EVERSPIN TECHNOLOGIES, INC.

Condensed Statements of Operation s and Comprehensive Loss

(In thousands, except share and per share amounts)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

    

2018

    

2017

    

2018

    

2017

    

Product sales

 

$

9,449

 

$

7,200

 

$

18,814

 

$

13,848

 

Licensing, royalty, and other revenue

 

 

1,316

 

 

1,725

 

 

6,804

 

 

2,957

 

Total revenue

 

 

10,765

 

 

8,925

 

 

25,618

 

 

16,805

 

Cost of sales

 

 

5,459

 

 

3,133

 

 

10,357

 

 

6,796

 

Gross profit

 

 

5,306

 

 

5,792

 

 

15,261

 

 

10,009

 

Operating expenses:

 

 

  

 

 

  

 

 

  

 

 

  

 

Research and development

 

 

6,773

 

 

6,427

 

 

13,253

 

 

12,816

 

General and administrative

 

 

3,329

 

 

2,793

 

 

6,548

 

 

5,638

 

Sales and marketing

 

 

1,713

 

 

1,361

 

 

3,079

 

 

2,219

 

Total operating expenses

 

 

11,815

 

 

10,581

 

 

22,880

 

 

20,673

 

Loss from operations

 

 

(6,509)

 

 

(4,789)

 

 

(7,619)

 

 

(10,664)

 

Interest expense

 

 

(222)

 

 

(176)

 

 

(433)

 

 

(406)

 

Other income, net

 

 

132

 

 

24

 

 

176

 

 

43

 

Loss on extinguishment of debt

 

 

 —

 

 

(246)

 

 

 —

 

 

(246)

 

Net loss and comprehensive loss

 

$

(6,599)

 

$

(5,187)

 

$

(7,876)

 

$

(11,273)

 

Net loss per common share, basic and diluted

 

$

(0.40)

 

$

(0.42)

 

$

(0.50)

 

$

(0.91)

 

Weighted-average shares used to compute net loss per common share, basic and diluted

 

 

16,635,261

 

 

12,413,524

 

 

15,717,248

 

 

12,357,066

 

 

The accompanying notes are an integral part of these condensed financial statements.

4


 

Table of Contents

EVERSPIN TECHNOLOGIES, INC.

Condensed Statement of Cash Flow s

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

June 30, 

 

 

    

2018

    

2017

 

Cash flows from operating activities

 

 

  

 

 

  

 

Net loss

 

$

(7,876)

 

$

(11,273)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

  

 

 

  

 

Depreciation and amortization

 

 

729

 

 

510

 

Loss on disposal of property and equipment

 

 

19

 

 

 —

 

Stock-based compensation

 

 

1,342

 

 

839

 

Non-cash loss on extinguishment of debt

 

 

 —

 

 

185

 

Non-cash interest expense

 

 

200

 

 

119

 

Compensation expense related to vesting of common stock to GLOBALFOUNDRIES

 

 

462

 

 

716

 

Changes in operating assets and liabilities:

 

 

 

 

 

  

 

Accounts receivable

 

 

(1,391)

 

 

(524)

 

Inventory

 

 

170

 

 

(1,584)

 

Prepaid expenses and other current assets

 

 

(635)

 

 

48

 

Other assets

 

 

(136)

 

 

(11)

 

Accounts payable

 

 

51

 

 

(158)

 

Accrued liabilities

 

 

2,591

 

 

80

 

Deferred income on shipments to distributors

 

 

(39)

 

 

(237)

 

Net cash used in operating activities

 

 

(4,513)

 

 

(11,290)

 

Cash flows from investing activities

 

 

  

 

 

  

 

Purchases of property and equipment

 

 

(347)

 

 

(1,704)

 

Net cash used in investing activities

 

 

(347)

 

 

(1,704)

 

Cash flows from financing activities

 

 

  

 

 

  

 

Proceeds from the issuance of common stock, net of offering costs

 

 

24,609

 

 

 —

 

Proceeds from debt

 

 

 —

 

 

12,000

 

Payments on debt

 

 

(1,000)

 

 

(8,356)

 

Payments of debt issuance costs

 

 

 —

 

 

(49)

 

Payments on capital lease obligation

 

 

(6)

 

 

(7)

 

Proceeds from exercise of stock options and purchase of shares in employee stock purchase plan

 

 

1,032

 

 

855

 

Net cash provided by financing activities

 

 

24,635

 

 

4,443

 

Net increase (decrease) in cash and cash equivalents

 

 

19,775

 

 

(8,551)

 

Cash and cash equivalents at beginning of period

 

 

12,950

 

 

29,727

 

Cash and cash equivalents at end of period

 

$

32,725

 

$

21,176

 

Supplementary cash flow information:

 

 

 

 

 

  

 

Interest paid

 

$

233

 

$

288

 

Non-cash investing and financing activities:

 

 

  

 

 

  

 

Purchase of property and equipment in accounts payable

 

$

27

 

$

560

 

 

The accompanying notes are an integral part of these condensed financial statements.

5


 

Table of Contents

EVERSPIN TECHNOLOGIES, INC.

 

Notes to Unaudited Condensed Financial Statement s

 

1. Organization and Nature of Business

 

Everspin Technologies, Inc. (the Company) was incorporated in Delaware on May 16, 2008. The Company’s magnetoresistive (MRAM) solutions offer the persistence of non-volatile memory with the speed and endurance of random access memory (RAM) and enable the protection of mission critical data particularly in the event of power interruption or failure. The Company’s MRAM solutions allow its customers in the industrial, automotive and transportation, and enterprise storage markets to design high performance, power efficient and reliable systems without the need for bulky batteries or capacitors.

 

Ability to continue as a going concern  

 

The Company believes that its existing cash and cash equivalents as of June 30, 2018, coupled with its anticipated growth and sales levels will be sufficient to meet its anticipated cash requirements for at least the next twelve months from the financial statement issuance date. The Company’s future capital requirements will depend on many factors, including its growth rate, the timing and extent of its spending to support research and development activities, the timing and cost of establishing additional sales and marketing capabilities, and the introduction of new products. The Company may be required at some point in the future to seek additional equity or debt financing, to sustain operations beyond that point, and such additional financing may not be available on acceptable terms or at all. If the Company is unable to raise additional capital or generate sufficient cash from operations to adequately fund its operations, it will need to curtail planned activities to reduce costs. Doing so will likely harm its ability to execute on its business plan.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2017 has been derived from the audited financial statements at that date but does not include all of the information required by GAAP for complete financial statements. These unaudited interim condensed financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair statement of the Company’s financial information. The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018 or for any other interim period or for any other future year.

 

The accompanying condensed financial statements and related financial information should be read in conjunction with the audited financial statements and the related notes thereto for the year ended December 31, 2017, included in the Company’s Annual Report on Form 10-K filed with the SEC.

 

Use of Estimates

 

The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, fair value of assets and liabilities, inventory, income taxes, and stock-based compensation. Actual results could differ from those estimates and assumptions.

 

6


 

Table of Contents

Accounts receivable, net

 

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company generally does not require collateral or other security in support of accounts receivable. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables would be further adjusted. The Company also considers a number of factors in evaluating the sufficiency of its allowance for doubtful accounts, including the length of time receivables are past due, significant one-time events, creditworthiness of customers and historical experience. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. At June 30, 2018 and December 31, 2017, there was no allowance for doubtful accounts.

 

The Company also establishes an allowance for product returns. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of products when evaluating the adequacy of sales returns. As the returns are processed as credits on future purchases, the allowance is recorded against the balance of trade accounts receivable. In addition, the Company establishes an allowance for estimated price concessions related to its distributer agreements. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales. At June 30, 2018, the allowance for product returns and the allowance for price concessions were $238,000 and $362,000, respectively. At December 31, 2017, the allowance for product returns and the allowance for price concessions were $147,000 and $0, respectively.

 

Accounts receivable, net consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

June 30, 

 

December 31, 

 

 

2018

 

2017

Trade accounts receivable

 

$

5,408

 

$

4,188

Unbilled accounts receivable

 

 

289

 

 

 —

Allowance for accounts receivable

 

 

(600)

 

 

(147)

Accounts receivable, net

 

$

5,097

 

$

4,041

 

Concentration of Credit Risk

 

Financial instruments that potentially expose the Company to a concentration of credit risk consist principally of cash and cash equivalents that are held by a financial institution in the United States and accounts receivable. Amounts on deposit with a financial institution may at times exceed federally insured limits. The Company maintains its cash accounts with high credit quality financial institutions and, accordingly, minimal credit risk exists with respect to the financial institutions.

 

Significant customers are those which represent more than 10% of the Company’s total revenue or net accounts receivable balance at each respective balance sheet date. For the purposes of this disclosure, the Company defines “customer” as the entity that is purchasing the products or licenses directly from the Company, which includes the distributors of the Company’s products in addition to end customers that the Company sells to directly. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7


 

Table of Contents

 

 

Revenue

 

Revenue

 

Accounts Receivable, net

 

 

 

 

Three Months Ended

 

Six Months Ended

 

As of

 

As of

 

 

 

 

June 30, 

 

June 30, 

 

June 30, 

 

December 31, 

 

 

Customers

    

2018

    

2017

    

2018

    

2017

    

2018

    

2017

 

 

Customer A

 

*

 

*

 

20

%

*

 

*

 

*

 

 

Customer B

 

14

%

17

%

14

%

14

%  

*

    

*

 

 

Customer C

 

*

 

15

%

*

 

16

%  

*

    

*

 

 

Customer D

 

19

%

*

 

13

%

*

 

17

%

11

%

 

Customer E

 

*

 

*

 

*

 

11

%  

*

    

10

%

 

Customer F

 

*

 

*

 

*

 

*

%  

*

    

15

%

 


* Less than 10%

 

Fair Value of Financial Instruments

 

The Company discloses and recognizes the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). The guidance establishes three levels of the fair value hierarchy as follows:

 

Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.

 

Level 2—Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.

 

Level 3—Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

 

The carrying value of accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. As of June 30, 2018, based on Level 2 inputs and the borrowing rates available to the Company for loans with similar terms and consideration of the Company’s credit risk, the carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value. The Company’s financial instruments consist of Level 1 assets. Where quoted prices are available in an active market, securities are classified as Level 1. Level 1 assets consist of highly liquid money market funds that are included in cash equivalents.

 

The following tables sets forth the fair value of the Company’s financial assets measured at fair value on a recurring basis (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2018

 

    

Level 1

    

Level 2

    

Level 3

    

 

Total

Assets:

 

 

 

  

 

 

  

 

 

  

 

 

Money market funds

 

$

32,856

  

$

 —

  

$

 —

  

$

32,856

Total assets measured at fair value

 

$

32,856

  

$

 —

  

$

 —

  

$

32,856

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2017

 

    

Level 1

    

Level 2

    

Level 3

    

 

Total

Assets:

 

 

 

  

 

 

  

 

 

  

 

 

Money market funds

 

$

13,369

  

$

  

$

  

$

13,369

Total assets measured at fair value

 

$

13,369

  

$

 —

  

$

 —

  

$

13,369

 

8


 

Table of Contents

Revenue Recognition

 

The Company recognizes revenue when a customer obtains control of the promised products or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and price concessions, and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

Nature of Products and Services

 

The Company’s revenue is derived from the sale of MRAM-based products in discrete unit form, licenses of and royalties on its MRAM and magnetic sensor technology, the sale of backend foundry services and design services to third parties. Sales of products in discrete unit form are recognized at a point in time, revenue related to licensing agreements is recognized when the Company has delivered control of the technology, revenue related to royalty agreements is recognized in the period in which sales generated from products sold using the Company’s technology occurs, sales of backend foundry services are recognized over time, and design services to third parties are recognized either at a point in time or over time, depending on the nature of the services.

 

Product Revenue

 

For products sold in their discrete form, the Company either sells its products directly to original equipment manufacturers (OEMs), original design manufacturers (ODMs) and contract manufacturers (CMs), or through a network of distributors, who in turn sell to those customers. For sales directly to OEMs, ODMs and CMs, revenue is recognized when the OEM, ODM or CM obtains control of the product, which occurs at a point in time, generally upon shipment to the customer.

 

The Company sells the majority of its products to its distributors at a uniform list price. However, distributors may resell the Company’s products to end customers at a very broad range of individually negotiated price points. Distributors are provided with price concessions subsequent to the delivery of product to them and such amounts are dependent on the end customer and product sales price. The price concessions are based on a variety of factors, including customer, product, quantity, geography and competitive differentiation. Price protection rights grant distributors the right to a credit in the event of declines in the price of the Company’s products. Under these circumstances, the Company remits back to the distributor a portion of their original purchase price after the resale transaction is completed in the form of a credit against the distributors’ outstanding accounts receivable balance. The credits are on a per unit basis and are not given to the distributor until the distributor provides information regarding the sale to their end customer. The Company estimates these credits and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of an allowance for price concessions due to distributors. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales. Revenue on shipments to distributors is recorded when control of the products has been transferred to the distributor.

 

The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company estimates its product return liability by analyzing its historical returns, current economic trends and changes in customer demand and acceptance of products. The Company has received insignificant returns to date and believes that returns of its products will continue to be minimal. 

 

At the time of shipment to distributors, the Company records a trade receivable for the selling price as there is a legally enforceable obligation of the distributor to pay for the product delivered, an allowance is recorded for the estimated discount that will be provided to the distributor, and the net of these amounts is recorded as revenue on the statement of operations.

 

9


 

Table of Contents

License Revenue

 

For licenses of technology, recognition of revenue is dependent upon whether the Company has delivered rights to the technology, and whether there are future performance obligations under the contract. In some instances, the license agreements call for future events or activities to occur in order for milestones amounts to become due from the customer. The terms of such agreements include payment to the Company of one or more of the following: non-refundable upfront fees; and royalties on net sales of licensed products. Historically, these license agreements have not included other future performance obligations for the Company once the license has been transferred to the customer. 

 

The transaction price in each agreement is allocated to the identified performance obligations based on the standalone selling price (SSP) of each distinct performance obligation. Judgment is required to determine SSP. In instances where SSP is not directly observable, such as when a license or service is not sold separately, SSP is determined using information that may include market conditions and other observable inputs. 

 

Revenue from non-refundable up-front payments is recognized when the license is transferred to the customer and the Company has no other performance obligations.

 

Royalties

 

Revenue from sales-based royalties from licenses of the Company’s technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part).

 

Other Revenue

 

For certain revenue streams, the Company recognizes revenue based on the pattern of transfer of the services. The Company uses the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract as this method most faithfully depicts its performance.  The Company will record an unbilled receivable (within accounts receivable, net) for the portion of the work that has been completed but not invoiced at the end of each reporting period. 

 

Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. At the inception of each agreement that includes milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price by using the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. At the end of each subsequent reporting period, the Company re-evaluates the probability or achievement of each such milestone and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.

 

Net Loss per Common Share

 

Basic net loss per common share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period, less shares subject to repurchase, without consideration of potentially dilutive securities. Diluted net loss per common share is the same as basic net loss per common share since the effect of potentially dilutive securities is anti-dilutive.

 

Prior Period Reclassifications

 

Certain amounts in the prior period have been reclassified to conform with current period presentation. There was no impact on total revenue or net loss for the prior period.

 

10


 

Table of Contents

Recently Adopted Pronouncements

 

ASU No. 2014-09, Revenue from Contracts with Customers

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606). Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. The new standard permits adoption either by using (i) a full retrospective approach for all periods presented in the period of adoption or (ii) a modified retrospective approach with the cumulative effect of initially applying the new standard recognized at the date of initial application and providing certain additional disclosures. The new standard is effective for annual reporting periods beginning after December 15, 2017. The Company adopted this standard on January 1, 2018 using the modified retrospective method. The Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of its accumulated deficit. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods.

 

As a result of the adoption of the new standard, the Company changed its accounting policy for revenue recognition and the details of the significant changes and quantitative impact of the changes are disclosed below.

 

Distributor sales - Some of the Company's contracts with distributors provide the distributor with certain concessions and price protection credits. Under Topic 605, Revenue, these concessions and price protection credits were not fixed or determinable and, as a result, the associated revenue was deferred until delivery of the product to the end customer. At the time of shipment to distributors, the Company recorded a trade receivable for the selling price as there was a legally enforceable obligation of the distributor to pay for the product delivered, inventory was reduced by the carrying value of goods shipped, and the net of these amounts, the gross profit, was recorded as deferred income on shipments to distributors on the balance sheet. Under Topic 606, the Company recognizes revenue from sales to distributors upon delivery of the product to the distributor and estimates the amount of the concessions and price protection credits at the point of revenue recognition. Accordingly, the balance of the deferred income on shipments to distributors was eliminated as a cumulative effect adjustment of implementing Topic 606 as of January 1, 2018, net of the Company’s estimate of concessions and price protection credits for those contracts.

 

Performance obligations delivered over time –Topic 605 permitted straight-line recognition of revenue for performance obligations that were delivered over time. The new revenue standard requires an entity to recognize revenue based on the pattern of transfer of the services. Entities must use either an input method or an output method to measure progress toward complete satisfaction of a performance obligation. The Company determined that the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract most faithfully depicts its performance. Under Topic 606, the Company will record an unbilled receivable (within accounts receivable, net) for the portion of the service that has been completed but not invoiced at the end of each reporting period.

 

Milestone payments – Topic 605 permitted recognition using the milestone method, whereby revenue was recognized upon the completion of substantive milestones once the customers acknowledge the milestones have been met and the collection of the amounts is reasonably assured. The milestone method no longer exists under the new revenue standard. Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. The adoption of Topic 606 did not have an impact on milestone revenue recorded to date as the performance obligations related to such milestones were completed as of the adoption date.

 

Sales-based royalties – Topic 605 permitted recognition of royalties when reported to the Company, which generally coincided with the receipt of payment. Under the new revenue standard, revenue generated from sales-based royalties from licenses of technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part).

 

The change in revenue recognition upon adoption of Topic 606 resulted in a decrease in the accumulated deficit balance of $1.3 million on January 1, 2018.

11


 

Table of Contents

 

The following table summarizes the impact of adopting Topic 606 on select unaudited condensed balance sheet line items (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

    

Balances without

 

 

 

 

 

 

the adoption of

June 30, 2018

 

As reported

 

Adjustments

 

Topic 606

Accounts receivable, net

 

$

5,097

 

$

(524)

 

$

4,573

Inventory

 

 

9,621

 

 

47

 

 

9,668

Total current assets

 

 

48,668

 

 

(477)

 

 

48,191

Total assets

 

 

52,334

 

 

(477)

 

 

51,857

Deferred income on shipments to distributors

 

 

 —

 

 

2,151

 

 

2,151

Total current liabilities

 

 

15,215

 

 

2,151

 

 

17,366

Total liabilities

 

 

20,581

 

 

2,151

 

 

22,732

Accumulated deficit

 

 

(124,115)

 

 

(2,628)

 

 

(126,743)

Total liabilities and stockholders’ equity

 

 

52,334

 

 

(477)

 

 

51,857

 

The following table summarizes the impact of adopting Topic 606 on select unaudited condensed statement of operations line items (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances without

 

 

 

 

 

 

the adoption of

Three Months Ended June 30, 2018

 

As reported

 

Adjustments

 

Topic 606

Product sales

 

$

9,449

 

$

(586)

 

$

8,863

Licensing, royalty, and other revenue

 

 

1,316

 

 

(126)

 

 

1,190

Total revenue

 

 

10,765

 

 

(712)

 

 

10,053

Cost of sales

 

 

5,459

 

 

107

 

 

5,566

Gross profit

 

 

5,306

 

 

(819)

 

 

4,487

Loss from operations

 

 

(6,509)

 

 

(819)

 

 

(7,328)

Net loss and comprehensive loss

 

 

(6,599)

 

 

(819)

 

 

(7,418)

Net loss per common share, basic and diluted

 

 

(0.40)

 

 

(0.05)

 

 

(0.45)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances without

 

 

 

 

 

 

the adoption of

Six Months Ended June 30, 2018

 

As reported

 

Adjustments

 

Topic 606

Product sales

 

$

18,814

 

$

(1,418)

 

$

17,396

Licensing, royalty, and other revenue

 

 

6,804

 

 

(97)

 

 

6,707

Total revenue

 

 

25,618

 

 

(1,515)

 

 

24,103

Cost of sales

 

 

10,357

 

 

(187)

 

 

10,170

Gross profit

 

 

15,261

 

 

(1,328)

 

 

13,933

Loss from operations

 

 

(7,619)

 

 

(1,328)

 

 

(8,947)

Net loss and comprehensive loss

 

 

(7,876)

 

 

(1,328)

 

 

(9,204)

Net loss per common share, basic and diluted

 

 

(0.50)

 

 

(0.08)

 

 

(0.58)

 

The following table summarizes the impact of adopting Topic 606 on select unaudited condensed statement of cash flows line items (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances without

 

 

 

 

 

 

the adoption of

Six Months Ended June 30, 2018

 

As reported

 

Adjustments

 

Topic 606

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

Net loss

 

$

(7,876)

 

$

(1,328)

 

$

(9,204)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(1,391)

 

 

859

 

 

(532)

Inventory

 

 

170

 

 

(1)

 

 

169

Deferred income on shipments to distributors

 

 

(39)

 

 

470

 

 

431

 

12


 

Table of Contents

ASU No. 2017-09, Compensation-Stock Compensation

 

In May 2017, the FASB issued ASU No. 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting, which is intended to amend the scope of modification accounting for share-based payment arrangements. The amendments in the update provide guidance on types of changes to the terms or conditions of share-based payment awards that would require the Company to apply modification accounting under ASC 718, Compensation-Stock Compensation. This ASU is effective for annual reporting periods beginning after December 15, 2017, and early adoption was permitted. The Company adopted this standard on January 1, 2018, and the impact of its adoption on the Company’s financial statements was not material.

 

ASU No. 2016-15, Statement of Cash Flows

 

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows. The standard is effective for fiscal years and interim periods beginning after December 15, 2017. The standard should be applied retrospectively and early adoption was permitted, including adoption in an interim period. The Company adopted this standard on January 1, 2018, and the impact of its adoption on the Company’s financial statements was not material.

 

Recently Issued Pronouncements

 

In June 2018, the FASB issued ASU No. 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 is intended to reduce the cost and complexity and to improve financial reporting for nonemployee share-based payments. The ASU expands the scope of Topic 718, (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. The standard is effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606. The Company is currently evaluating the impact that the adoption of ASU 2018-07 will have on its financial statements and related disclosures.

 

 

 

 

3. Revenue

 

Adoption of ASU No. 2014-09

 

On January 1, 2018, the Company adopted ASU No. 2014-09 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605.

 

The Company sells the majority of its products to its distributors, but does recognize some revenue under licensing and royalty agreements. The following table presents the Company’s revenues disaggregated by sales channel, (in thousands):

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30, 2018

 

June 30, 2018

Distributor

 

$

8,386

 

$

16,531

Non-distributor

 

 

2,379

 

 

9,087

Total revenue

 

$

10,765

 

$

25,618

 

13


 

Table of Contents

All of the Company's performance obligations and associated revenue are generally transferred to customers at a point in time, with the exception of certain revenue streams which are performed over time commensurate with the delivery of service. The following table presents the Company’s revenues disaggregated by timing of recognition (in thousands):

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30, 2018

 

June 30, 2018

Point in time

 

$

9,644

 

$

24,116

Over time

 

 

1,121

 

 

1,502

Total revenue

 

$

10,765

 

$

25,618

 

The following table presents the Company’s revenues disaggregated by type (in thousands):

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30, 2018

 

June 30, 2018

Product sales

 

$

9,449

 

$

18,814

License fees

 

 

 —

 

 

5,000

Royalties

 

 

195

 

 

302

Other revenue

 

 

1,121

 

 

1,502

Total revenue

 

$

10,765

 

$

25,618

 

The Company recognizes revenue in three primary geographic regions: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific and Japan (APJ). The following table presents the Company’s revenues disaggregated by the geographic region to which the product is delivered or licensee is located (in thousands):

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30, 2018

 

June 30, 2018

North America

 

$

2,379

 

$

4,110

EMEA

 

 

2,096

 

 

5,147

APJ

 

 

6,290

 

 

16,361

Total revenue

 

$

10,765

 

$

25,618

 

 

 

4. Balance Sheet Components

 

Inventory

 

Inventory consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

June 30, 

 

December 31, 

 

 

2018

 

2017

Raw materials

 

$

92

 

$

682

Work-in-process

 

 

3,766

 

 

4,517

Finished goods

 

 

5,763

 

 

4,638

Total inventory

 

$

9,621

 

$

9,837

 

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

June 30, 

 

December 31,

 

    

2018

    

2017

Accrued payroll-related expenses

 

$

1,267

 

$

1,331

Accrued joint development agreement expenses

 

 

3,446

 

 

749

Accrued inventory

 

 

690

 

 

897

Deferred rent

 

 

322

 

 

230

Accrued sales commissions payable to sales representatives

 

 

133

 

 

75

Other

 

 

481

 

 

466

Total accrued liabilities

 

$

6,339

 

$

3,748

 

 

 

 

14


 

Table of Contents

 

 

5. Commitments and Contingencies

 

Operating Leases

 

During 2017, the Company entered into a lease for 27,974 square feet of office space for its corporate headquarters located in Chandler, Arizona. The lease expires in January 2022, however the Company has the option to renew the lease through August 2024. Rent expense is recognized on a straight-line basis over the term of the leases and, accordingly, the Company records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability.

 

In April 2018, the Company entered into a lease termination agreement that released the Company from any further obligations on its previous headquarters’ space in Chandler, Arizona. The remaining unamortized balance of deferred rent of $18,000 was written off and a lease termination fee of $43,000 was recognized as rent expense on the unaudited condensed statement of operations and comprehensive loss.

 

The Company leases office and fabrication space for its design facility located in Austin, Texas. The lease expires in January 2022.

 

The Company has another operating lease for its Arizona manufacturing facility, which includes office and fabrication space. This lease is cancellable upon 24 months’ notice by either of the parties. The lease expires in January 2020, however it can be further extended through January 2021 if an option to extend is initiated by the lessor.

 

 

 

6. Debt

 

2017 Credit Facility

 

On May 4, 2017, the Company entered into a Loan and Security Agreement with Silicon Valley Bank (2017 Credit Facility) for a $12.0 million term loan. The term loan provides for interest at a floating rate equal to the prime rate minus 0.75%. As of June 30, 2018, the interest rate was 4.25%. The term loan provides for a period of interest-only payments through April 30, 2018, followed by fixed principal and interest payments based on either a 24-month amortization schedule or a 36-month amortization schedule if the Company meets certain sales milestones. As of December 31, 2017, the Company determined it would not meet the sales milestones and as such the term loan is based on a 24-month amortization schedule. Borrowings under the 2017 Credit Facility mature in May 2020. The Company is required to comply with certain covenants under the 2017 Credit Facility, including requirements to maintain a minimum liquidity ratio, meet certain revenue targets, and restrictions on certain actions without the consent of the lender, such as the disposal and acquisition of its business or property, changes in business, and mergers or acquisitions. An end of term fee of 6% of the amount borrowed must be made when the loan is prepaid or repaid, whether at maturity or as a result of a prepayment or acceleration or otherwise. The additional payment is being accreted using the effective interest method.

 

Security for the 2017 Credit Facility includes all of the Company’s assets except for intellectual property. The 2017 Credit Facility contains customary covenants restricting the Company’s activities, including limitations on its ability to sell assets, engage in mergers and acquisitions, enter into transactions involving related parties, incur indebtedness or grant liens or negative pledges on its assets, make loans or make other investments. Under these covenants, the Company is prohibited from paying cash dividends with respect to its capital stock. The Company was in compliance with all covenants at June 30, 2018. The 2017 Credit Facility contains a material adverse effect clause which provides that an event of default will occur if, among other triggers, an event occurs that could reasonably be expected to result in a material adverse effect on the Company’s business, operations or condition, or on the Company’s ability to perform its obligations under the term loan. As of June 30, 2018, management does not believe that it is probable that the clause will be triggered within the next twelve months, and therefore the term loan is classified as long-term.

 

 

15


 

Table of Contents

The carrying value of the Company’s 2017 Credit Facility at June 30, 2018 was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

    

Current

    

Long-Term

    

 

 

 

 

Portion

 

Debt

 

Total

Debt, including end of term fee

 

$

6,000

 

$

5,720

 

$

11,720

Less:

 

 

 

 

 

 

 

 

 

Discount attributable to end of term fee and debt issuance costs

 

 

(17)

 

 

(369)

 

 

(386)

Net carrying value of debt

 

$

5,983

 

$

5,351

 

$

11,334

 

The carrying value of the Company’s 2017 Credit Facility at December 31, 2017 was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

    

Current

    

Long-Term

    

 

 

 

 

Portion

 

Debt

 

Total

Debt, including end of term fee

 

$

4,000

 

$

8,720

 

$

12,720

Less:

 

 

 

 

 

 

 

 

 

Discount attributable to end of term fee and debt issuance costs

 

 

(23)

 

 

(563)

 

 

(586)

Net carrying value of debt

 

$

3,977

 

$

8,157

 

$

12,134

 

Capital Lease Obligations

 

The Company leases certain equipment under a capital lease obligation expiring in October 2020. The balance of the capital lease obligation was $25,000 and $31,000 at June 30, 2018 and December 31, 2017, respectively.

 

Property and equipment under the capital lease amounted to $31,000 at June 30, 2018 and December 31, 2017. Accumulated depreciation and amortization on these assets was $7,000 and $2,000 at June 30, 2018 and December 31, 2017, respectively.

 

 

7 . Stockholders’ Equity

 

In February 2018, the Company completed a follow-on underwritten public offering of its common stock under its Registration Statement filed in November 2017 (File No. 333-221331), selling 3,772,447 shares of its common stock at an offering price of $7.00 per share for proceeds of $24.6 million, net of $1.8 million of underwriting discounts and commissions and other offering costs.

 

 

 

16


 

Table of Contents

8. Stock-Based Compensation

 

The following table summarizes the stock option activity for the six months ended June 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

 

 

 

 

 

Weighted-

 

Weighted-

 

 

 

 

 

 

 

 

 

Average

 

Average

 

 

 

 

 

Options

 

 

 

Exercise

 

Remaining

 

Aggregate

 

 

Available for

 

Number of

 

Price Per

 

Contractual

 

Intrinsic

 

    

Grant

    

Options

    

Share

    

Life (years)

    

Value

 

 

 

 

 

 

 

 

 

 

 

(In thousands)

Balance—December 31, 2017

 

83,929

 

1,593,195

 

$

8.88

 

6.6

 

$

1,997

Prior period adjustment

 

(1,026)

 

13,784

 

 

4.54

 

 

 

 

 

Options authorized

 

1,084,516

 

 —

 

 

 —

 

 

 

 

 

RSUs granted

 

(60,450)

 

 —

 

 

 —

 

 

 

 

 

RSUs cancelled/forfeited

 

1,900

 

 —

 

 

 —

 

 

 

 

 

Options granted

 

(310,715)

 

310,715

 

 

8.79

 

 

 

 

 

Options exercised

 

 —

 

(190,800)

 

 

4.69

 

 

 

$

815

Options cancelled/forfeited

 

28,834

 

(30,707)

 

 

7.97

 

 

 

 

 

Balance—June 30, 2018

 

826,988

 

1,696,187

 

$

7.28

 

7.2

 

$

3,204

Options exercisable—June 30, 2018

 

 

 

746,702

 

$

5.85

 

4.8

 

$

2,355

 

The total grant date fair value of options vested was $545,000 and $797,000 during the three months ended June 30, 2018 and 2017, respectively, and $922,000 and $904,000 during the six months ended June 30, 2018 and 2017, respectively.

 

The weighted-average grant date fair value of employee options granted during the three months ended June 30, 2018 and 2017 was $4.14 and $5.25 per share, respectively, and during the six months ended June 30, 2018 and 2017 was $4.56 and $4.67 per share, respectively.

 

2016 Employee Stock Purchase Plan

 

In January 2018, there was an increase of 128,172 shares reserved for issuance under the Company’s Employee Stock Purchase Plan (ESPP). The Company had 291,659 shares available for future issuance under the Company’s ESPP as of June 30, 2018. Employees purchased 20,057 shares for $137,000 during the three and six months ended June 30, 2018. Employees purchased 17,924 shares for $122,000 during the three and six months ended June 30, 2017.

 

Modification of Stock Awards

 

In February 2018, the Company modified the terms of 400,000 vested and unvested stock option awards granted to the Chief Executive Officer, by reducing their exercise price from $16.25 per share to $7.64 per share. There was no change to any of the other terms of the option awards. The modification resulted in an incremental value of $600,000 being allocated to the options, of which $63,000 was recognized to expense immediately based on options that were vested at the time of the modification. The remaining incremental value of $537,000 attributable to unvested options will be recognized over the remaining vesting term through September 2021.

 

17


 

Table of Contents

Restricted Stock Units

 

The following table summarizes Restricted Stock Units (RSUs) activity for the six months ended June 30, 2018:

 

 

 

 

 

 

 

 

 

RSUs Outstanding

 

 

 

 

Weighted-

 

 

 

 

Average

 

 

Number of

 

Grant Date

 

 

Restricted Stock

 

Fair Value Per

 

    

Units

    

Share

Balance—December 31, 2017

 

30,680

 

$

10.55

Granted

 

60,450

 

 

8.66

Cancelled/forfeited

 

(1,900)

 

 

8.39

Balance—June 30, 2018

 

89,230

 

$

9.32

 

The fair value of RSUs is determined on the date of grant based on the market price of the Company’s common stock on that date. As of June 30, 2018, there was $625,000 of unrecognized stock-based compensation expense related to RSUs to be recognized over a weighted-average period of 2.9 years.

 

Stock-based Compensation Expense

 

The Company recognized stock-based compensation expense from awards granted to employees and non-employees under its equity incentive plans and from its ESPP as follows, excluding amounts related to GLOBALFOUNDRIES, Inc. (GF) (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

    

2018

    

2017

    

2018

    

2017

    

Research and development

 

$

138

 

$

73

 

$

246

 

$

245

 

General and administrative

 

 

466

 

 

213

 

 

899

 

 

439

 

Sales and marketing

 

 

113

 

 

122

 

 

197

 

 

155

 

Total

 

$

717

 

$

408

 

$

1,342

 

$

839

 

 

As of June 30, 2018, there was $5.9 million of total unrecognized compensation expense related to unvested options which is expected to be recognized over a weighted-average period of 2.9 years.

 

Employee Stock-based Compensation

 

Stock-based compensation expense for employees was $688,000 and $319,000 for the three months ended June 30, 2018 and 2017, respectively, and $1.3 million and $740,000 for the six months ended June 30, 2018 and 2017, respectively.

 

The Company estimated the fair value of each option using the Black-Scholes option-pricing model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee stock options was estimated using the assumptions below. Each of these inputs is subjective and its determination generally requires significant judgment.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Option Plan

 

ESPP

 

 

 

 

Six Months Ended

 

Six Months Ended

 

 

 

 

June 30, 

 

June 30, 

 

 

 

    

2018

    

2017

    

2018

    

2017

 

 

Expected volatility

 

51.9-53.1

%  

47.2-59.3

%  

59.5- 87.8

%  

49.5

%

 

Risk-free interest rate

 

2.6-2.9

%  

2.0-2.1

%  

0.9-2.1

%  

0.5

%

 

Expected term (in years)

 

5.7-6.1

 

5.8-6.1

 

0.5-1.0

 

0.5

 

 

Dividend yield

 

 —

%  

 —

%  

 —

%  

 —

%

 

 

18


 

Table of Contents

Non-employee Stock-based Compensation

 

Stock-based compensation expense related to stock options granted to non-employees is recognized as the stock options vest. No stock options were granted to non-employees during the three months June 30, 2018. During the six months ended June 30, 2018, the Company granted stock options to non-employees to purchase 7,200 shares of common stock. No stock options were granted to non-employees during the three and six months June 30, 2017. As of June 30, 2018, options to purchase 45,072 shares of common stock were outstanding with a weighted-average exercise price of $9.15 per share. Stock-based compensation expense for non-employees was $29,000 and $89,000 for the three months ended June 30, 2018 and 2017, respectively, and $44,000 and $99,000 for the six months ended June 30, 2018 and 2017, respectively.

 

 

9. Joint Development Agreement

 

On October 17, 2014, the Company entered into a Joint Development Agreement (JDA) with GLOBALFOUNDRIES (GF), for the joint development of the Company’s Spin Transfer Torque MRAM (STT-MRAM) technology. The term of the agreement is the later of four years from the effective date or until the completion, termination or expiration of the last statement of work entered into pursuant to the JDA. The JDA also states that the specific terms and conditions for the production and supply of the developed STT-MRAM technology would be pursuant to a separate manufacturing agreement entered into between the parties.

 

Under the JDA, each party licenses its relevant intellectual property to the other party. For certain jointly developed works, the parties have agreed to follow an invention allocation procedure to determine ownership. In addition, GF possesses the exclusive right to manufacture the Company’s discrete and embedded STT-MRAM devices developed pursuant to the agreement until the earlier of three years after the qualification of the MRAM device for a particular technology node or four years after the completion of the relevant statement of work under which the device was developed. For the same exclusivity period associated with the relevant device, GF agreed not to license intellectual property developed in connection with the JDA to named competitors of the Company.

 

Generally, unless otherwise specified in the agreement or a statement of work, the Company and GF share project costs, which do not include personnel or production qualification costs, equally under the JDA. If GF manufactures, sells or transfers to customers wafers containing production quantified STT-MRAM devices that utilize certain design information, GF will be required to pay the Company a royalty. The term of the agreement is four years and is extended until the completion of any development work, if later.

 

The Company incurred project costs, recognized as research and development expense, of $2.3 million and $1.4 million for the three months ended June 30, 2018 and 2017 respectively, and $4.4 million and $3.2 million for the six months ended June 30, 2018 and 2017 respectively. The Company entered into Statement of Work 4B (SOW 4B) and an Amendment to SOW 4B, under the JDA with GF effective August 2016 and June 2018, respectively. The Company was eligible to receive milestone payments from SOW 4B and its Amendment for an aggregate of $1.6 million and $1.0 million, respectively. The Amendment was accounted for as a separate contract rather than a modification of SOW 4B, as the Company had completed its performance obligations under SOW 4B as of December 31, 2017. The Company recognized revenue from GF of $500,000 and $650,000 in the three months ended June 30, 2018 and 2017, respectively, and $500,000 and $1.2 million in the six months ended June 30, 2018 and 2017, respectively.

 

On October 21, 2014, GF participated, along with other investors, in the Company’s Series B redeemable convertible preferred stock financing and purchased 192,307 shares at $26.00 per share. Contemporaneously, the Company sold 461,538 shares of its common stock to GF at a discounted price of $0.00026 per share. The common shares vest upon the achievement of a goal as set forth in the Statement of Work #1 (the SOW) under the JDA. The unvested common shares are subject to repurchase by the Company, if the JDA is terminated for any reason, for a one-year period after such termination, at a price that is the lower of the original price paid by GF or the fair value of the Company’s common stock as of the date of repurchase. The Company has determined that the issuance of these shares of common stock to GF represents compensation for services to be provided under the JDA. Accordingly, the shares are accounted for similar to a stock award granted to a non-employee of the Company and are remeasured to their fair value as they vest. A total of 211,538 shares of common stock became vested on August 21, 2016, the designated Initial Measurement Date. The remaining shares vest on a monthly basis thereafter. Subsequent to the Initial Measurement Date

19


 

Table of Contents

through June 30, 2018, an additional 211,538 shares of common stock became vested. As of June 30, 2018, there were 38,462 shares unvested that were subject to repurchase.

 

The Company recognized non-cash compensation expense of $225,000 and $461,000 during the three months ended June 30, 2018 and 2017, respectively, and $462,000 and $716,000 during the six months ended June 30, 2018 and 2017, respectively, in research and development expense related to the vesting of the shares of common stock. The Company recognizes compensation expense based on the estimated fair value of the common stock at each reporting period, which was $8.92 and $7.50 per share as of June 30, 2018 and December 31, 2017, respectively.

 

 

10. Net Loss Per Common Share

 

The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

    

2018

    

2017

    

2018

    

2017

    

Numerator:

 

 

  

 

 

  

 

 

  

 

 

  

 

Net loss

 

$

(6,599)

 

$

(5,187)

 

$

(7,876)

 

$

(11,273)

 

Denominator:

 

 

  

 

 

  

 

 

  

 

 

  

 

Weighted-average common shares outstanding

 

 

16,689,677

 

 

12,583,325

 

 

15,786,043

 

 

12,541,245

 

Less: weighted-average unvested common shares subjected to repurchase

 

 

(54,416)

 

 

(169,801)

 

 

(68,795)

 

 

(184,179)

 

Weighted-average common shares outstanding used to calculate net loss per common share, basic and diluted

 

 

16,635,261

 

 

12,413,524

 

 

15,717,248

 

 

12,357,066

 

Net loss per common share, basic and diluted

 

$

(0.40)

 

$

(0.42)

 

$

(0.50)

 

$

(0.91)

 

 

The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per common share for the periods presented, because their inclusion would be anti-dilutive:

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

    

2018

    

2017

    

2018

    

2017

 

Options to purchase common stock

 

1,696,187

 

1,268,665

 

1,696,187

 

1,268,665

 

Restricted stock units

 

89,230

 

 —

 

89,230

 

 —

 

Common stock subject to repurchase

 

38,462

 

153,846

 

38,462

 

153,846

 

Common stock warrants

 

27,690

 

27,690

 

27,690

 

27,690

 

Total

 

1,851,569

 

1,450,201

 

1,851,569

 

1,450,201

 

 

 

 

20


 

Table of Contents

11. License Agreements

 

In March 2018, the Company entered into a global cross-license agreement with a customer pursuant to which the Company granted a worldwide, non-exclusive, non-transferable, irrevocable, royalty-bearing license under the Company’s patents to use, sell, import and export the Company’s products. Under the cross-license agreement, the Company received a non-refundable license fee and is entitled to quarterly royalty payments based upon low single digits of the average selling price of products covered under the license agreement. The license was transferred to the customer and the Company recognized the non-refundable license fee during the six months ended June 30, 2018. The cross-license agreement will remain in effect until the licensed patents have expired, been abandoned, or ruled invalid.

 

 

 

 

 

 

12. Subsequent Events

 

In July 2018, the Company entered into the First Amendment to its 2017 Credit Facility (the “Amended Credit Facility”). The Amended Credit Facility extends the period of interest-only payments through December 31, 2018, followed by fixed principal and interest payments based on a 24-month amortization schedule. If the Company achieves certain milestones, the loan will be based on a 36-month amortization schedule. The terms of the Amended Credit Facility include the return by Silicon Valley Bank of principal payments previously made by the Company. The Company is required to comply with certain covenants under the Amended Credit Facility, including requirements to maintain a minimum liquidity ratio, meet certain revenue targets, and restrictions on certain actions without the consent of the lender, such as the disposal and acquisition of its business or property, changes in business, and mergers or acquisitions. An end of term fee of 7% of the amount borrowed must be made when the loan is prepaid or repaid, whether at maturity or as a result of a prepayment or acceleration or otherwise.

 

In conjunction with the Amended Credit Facility, outstanding warrants held by SVB to purchase 9,229 shares of the Company’s common stock were cancelled. The Company subsequently issued a warrant to SVB for the purchase of 9,375 shares of the Company’s common stock at an exercise price of $8.91 per share. The warrant can be exercised at any time and expires five years after the date of issuance.

 

In August 2018, the Company amended its lease agreement for its Arizona manufacturing facility to extend the lease term through January 2021. The aggregate rent expense be recognized over the remaining term of the lease is $2.4 million.

 

 

 

 

 

 

 

 

21


 

Table of Contents

Item 2. Management’s Discussion and Analysi s of Financial Condition and Results of Operations.

 

You should read the following discussion and analysis of our financial condition and results of operations together with our condensed financial statements and related notes included in Part I, Item 1 of this report and with our audited financial statements and related notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2017.

 

Forward-Looking Statements

 

This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are identified by words such as “believe,” “will,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “could,” “potentially” or the negative of these terms or similar expressions. You should read these statements carefully because they discuss future expectations, contain projections of future results of operations or financial condition, or state other “forward-looking” information. These statements relate to our future plans, strategies, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in this report in Part II, Item 1A — “Risk Factors,” and elsewhere in this report. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. These statements, like all statements in this report, speak only as of their date, and we undertake no obligation to update or revise these statements in light of future developments. We caution investors that our business and financial performance are subject to substantial risks and uncertainties.

 

Overview

 

We are the leading provider of MRAM solutions. Our MRAM solutions offer the persistence of non-volatile memory, a type of memory that retains information even in the absence of power, with the speed and endurance of random access memory (RAM). This enables the protection of mission critical data particularly in the event of power interruption or failure. Our MRAM solutions allow our customers in the industrial, automotive, transportation, and enterprise storage markets to design high performance, power efficient and reliable systems without the need for bulky batteries or capacitors.

 

We derive our revenue from the sale of MRAM-based products in discrete unit form, the sale of services, licenses of and royalties on our MRAM and magnetic sensor technology, the sale of backend foundry services and design services to third parties.

 

We work directly with our distributors and customers to have our MRAM devices designed into and qualified for their products. Although we maintain direct sales, support, and development relationships with our customers, once our products are designed into a customer’s product, we sell a majority of our products to those customers through distributors. We generated 78% and 68% for the three months ended June 30, 2018 and 2017, respectively, and 65% and 73% for the six months ended June 30, 2018 and 2017, respectively, of our revenue from products sold through distributors.

 

Our sales team and representatives are organized into three primary regions: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific and Japan (APJ). We recognize revenue by geography based on the region in which our products are sold, and not to where the end products in which they are assembled are shipped. Our revenue by region for the periods indicated was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 

 

Six Months Ended June 30, 

 

 

2018

    

2017

    

2018

    

2017

North America

 

$

2,379

 

$

1,645

 

$

4,110

 

$

2,857

EMEA

 

 

2,096

 

 

2,023

 

 

5,147

 

 

3,395

APJ

 

 

6,290

 

 

5,257

 

 

16,361

 

 

10,553

 

 

$

10,765

 

$

8,925

 

$

25,618

 

$

16,805

 

22


 

Table of Contents

We leverage both internal and outsourced capabilities to manufacture our MRAM products. We purchase industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and complete the fabrication by inserting our magnetic-bit technology at our 200mm fabrication facility in Chandler, Arizona. We believe this allows us to streamline research and development, rapidly prototype new products, and bring new products to market quickly and cost effectively. This strategy significantly reduces the capital investment that would otherwise be required to operate manufacturing facilities of our own. We utilize leading semiconductor foundry GLOBALFOUNDRIES to support full turnkey high-volume production of our high density MRAM products on 300mm wafers at advanced process nodes.

 

During the three and six months ended June 30, 2018, we continued to invest in research and development to support the development and production of our Spin Transfer Torque MRAM (STT-MRAM) technology. We believe our continued investment will allow us to continue to develop and deploy products based on our STT-MRAM technology. Our research and development expenses were $6.8 million and $6.4 million for the three months ended June 30, 2018 and 2017, respectively, and $13.3 million and $12.8 million for the six months ended June 30, 2018 and 2017, respectively. We expect that our research and development expenses will increase in the future as we continue to develop our MRAM technology internally and through our joint development agreement with GLOBALFOUNDRIES.

 

We recorded revenue of $10.8 million and $8.9 million for the three months ended June 30, 2018 and 2017, respectively, and $25.6 million and $16.8 million for the six months ended June 30, 2018 and 2017, respectively; gross margin was 49.3% and 64.9% for the three months ended June, 2018 and 2017, respectively and 59.6% for the six months ended June 30, 2018 and 2017 ; and our net loss was $6.6 million and $5.2 million for the three months ended June 30, 2018 and 2017, respectively, a nd $7.9 million and $11.3 million for the six months ended June 30, 2018 and 2017, respectively . As of June 30, 2018, we had 96 employees, approximately half of whom are engaged in research and development.

 

Key Metrics

 

We monitor a variety of key financial metrics to help us evaluate trends, establish budgets, measure the effectiveness of our business strategies and assess operational efficiencies. These financial metrics include revenue, gross margin, operating expenses and operating income determined in accordance with GAAP. Additionally, we monitor and project cash flow to determine our sources and uses for working capital to fund our operations. We also monitor Adjusted EBITDA, a non-GAAP financial measure.  We define Adjusted EBITDA as net income or loss adjusted for interest expense, tax, depreciation and amortization, stock-based compensation expense, and compensation expense related to the vesting of common stock held by GLOBALFOUNDRIES resulting from our joint development agreement.

 

Our management and board of directors use Adjusted EBITDA to understand and evaluate our operating performance and trends, to prepare and approve our annual budget and to develop short-term and long-term operating and financing plans. Accordingly, we believe that Adjusted EBITDA provides useful information for investors in understanding and evaluating our operating results in the same manner as our management and our board of directors.

 

The following table presents a reconciliation of net loss, the most directly comparable GAAP measure, to Adjusted EBITDA for each of the periods indicated:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

    

2018

    

2017

    

2018

    

2017

    

Adjusted EBITDA reconciliation:

 

 

  

 

 

  

 

 

  

 

 

  

 

Net loss

 

$

(6,599)

 

$

(5,187)

 

$

(7,876)

 

$

(11,273)

 

Depreciation and amortization

 

 

356

 

 

278

 

 

729

 

 

510

 

Stock-based compensation expense

 

 

717

 

 

408

 

 

1,342

 

 

839

 

Compensation expense related to vesting of GLOBALFOUNDRIES common stock

 

 

225

 

 

461

 

 

462

 

 

716

 

Interest expense

 

 

222

 

 

176

 

 

433

 

 

406

 

Adjusted EBITDA

 

$

(5,079)

 

$

(3,864)

 

$

(4,910)

 

$

(8,802)

 

 

 

23


 

Table of Contents

Factors Affecting Our Results of Operations

 

Design wins. To continue to grow our revenue, we must continue to achieve design wins for our MRAM products. We consider a design win to occur when an original equipment manufacturer (OEM) or contract manufacturer notifies us that it has qualified one of our products as a component in a product or system for production. We are dependent on the adoption of our 256Mb and 1Gb MRAM products by our customers to secure design wins.  Because the life cycles for our customers’ products can last for many years, if these products have successful commercial introductions, we expect to continue to generate revenues over an extended period of time for each successful design win. Any delay in the development of our 1Gb MRAM product, or failure of our customers to adopt our 1Gb MRAM products, could inhibit revenue growth or cause declines, which would significantly harm our business and prevent us from becoming profitable. In the fourth quarter of 2017, we recorded revenue for our first sale of 40nm 256Mb STT-MRAM products and we are in process of ramping up production in 2018.

 

Customer acceptance of our technology and customer product success . For our customers to use our products, they may have to redesign certain components of their existing designs. We have established relationships with several storage controller and Field Programmable Gate Array (FPGA) companies as well as IP core companies, including Cadence, Synopsys, and Northwest Logic, to facilitate the integration of our MRAM solutions into our customers end products. Delays in our customers’ design cycles may have adverse effects on the demand, and therefore sales, of our products.

 

Customer concentration . A relatively small number of end customers have historically accounted for a significant percentage of our revenue. Revenue, including through distributors, from six of our customers collectively, accounted for approximately 47% and 60% of our total revenue in the three and six months ended June 30, 2018, respectively. Two of these customers accounted for in excess of 10% of our total revenue in the three months ended June 30, 2018. Three of these customers accounted for in excess of 10% of our total revenue in the six months ended June 30, 2018. Revenue, including through distributors, from five of our customers collectively, accounted for 38% and 35% of our total revenue in the three and six months ended June 30, 2017, respectively. None of these customers accounted for in excess of 10% of our total revenue in the three and six months ended June 30, 2017. It would be difficult to replace lost revenue resulting from the loss, reduction, cancellation or delay in purchase orders by any one of these customers. Consolidation among our customers may further concentrate our customer base and expose us to increased risks relating to increased customer concentration. In addition, any significant pricing pressure exerted by a significant customer could adversely affect our operating results.

 

Pricing, product cost and gross margins of our products. Our gross margin has been, and will continue to be, affected by a variety of factors, including the timing of changes in pricing, shipment volumes, new product introductions, changes in product mix, changes in our purchase price of fabricated wafers, assembly and test service expenses, manufacturing yields and inventory write downs, if any. In general, newly introduced products, and products with higher densities and performance, tend to be priced higher than older, more mature products. Average selling prices in the semiconductor industry typically decline as products mature. Consistent with this historical trend, we expect that the average selling prices of our products will decline as they mature. In the normal course of business, we seek to offset the effect of declining average selling prices on existing products by reducing manufacturing expenses and introducing newer, higher value-added products. If we are unable to maintain overall average selling prices or to offset any declines in average selling prices with savings on product costs, our gross margin will decline.

 

Gross margin impact of licensing revenue. Our licensing revenue, which we collect as licensing fees and royalty payments, generates significantly higher gross margin than product revenue. Due to the high gross margin profile of this revenue stream, fluctuations in licensing revenue may have a greater impact on gross margin than a corresponding change in the demand for our products. Therefore, as licensing revenue fluctuates, we may see significant variations in gross margin.

 

Technology, process, and product development investment. We invest heavily to develop our MRAM technology, including the core MRAM technology, the joint development agreement with GLOBALFOUNDRIES, and the design of new and innovative products based on MRAM, to provide solutions to our current and future customers. We anticipate that we will continue to invest in our research and development to achieve our technology and product roadmaps. Our product development is targeted to specific segments of the market where we believe the densities and performance of our products can provide the most benefit. We believe our close coordination with our customers regarding their future product requirements enhances the efficiency of our research and development expenditures.

24


 

Table of Contents

 

Financial Operations Overview

 

Revenue

 

We derive our revenue from the sale of our MRAM-based products in discrete unit form, the licensing of our MRAM and magnetic sensor technology and related royalties, the sale backend foundry services and design services to third parties. We recognize sales of products in discrete unit form at a point in time, we recognize revenue related to licensing agreements when we have delivered rights to the technology, we recognize revenue related to royalty agreements in the period in which sales generated from products sold using our technology occurs, and we recognize sales of backend foundry services and design services to third parties over time.

 

For some of our products, we provide price protection and product return rights. As such, for sales through distributors of our discrete MRAM products, at the time of revenue recognition, which occurs when control of the products has been transferred to the distributor, we estimate product returns and the expected price concessions that will be provided to the distributor, which is included in the transaction price. We estimate the credits to the distributors based on the historical rate of credits provided to distributors relative to sales or, for some customers the credit is based on a previously negotiated fixed rate. Our licensing revenue is largely dependent on a small number of transactions during a given year.

 

Cost of Sales and Gross Margin

 

Cost of sales primarily includes the cost of our products including costs to purchase wafers, costs paid for wafer fabrication, costs associated with the assembly and testing of our products, shipping costs and costs of our manufacturing personnel. Cost of sales also includes indirect costs, such as warranty, inventory valuation reserves and overhead costs.

 

Gross profit is revenue less cost of sales. Gross margin is gross profit expressed as a percentage of total revenue. We expect that our gross margin may fluctuate from period to period, primarily as a result of changes in average selling price, revenue mix among our products, product yields and manufacturing costs. In addition, we may reserve against the value at which we carry our inventory based upon the product’s life cycle and conditions in the markets in which we sell. Declines in average selling prices may be paired with improvements in our cost of sales, which may offset some of the gross margin reduction that could result from lower selling prices.

 

Operating Expenses

 

Our operating expenses consist of research and development, general and administrative and sales and marketing expenses. Personnel-related expenses, including salaries, benefits, bonuses and stock-based compensation, are among the most significant component of each of our operating expense categories.

 

Research and Development Expenses

 

Our research and development expenses consist primarily of personnel-related expenses for the design and development of our products and technologies, development wafers required to validate and characterize our technology, and expenses associated with our joint development agreement with GLOBALFOUNDRIES. Research and development expenses also include consulting services, circuit design costs, materials and laboratory supplies, fabrication and new packaging technology, and an allocation of related facilities and equipment costs. We recognize research and development expenses as they are incurred. We expect our research and development expenses to increase in connection with our joint development agreement with GLOBALFOUNDRIES.

 

General and Administrative Expenses

 

Our general and administrative expenses consist primarily of personnel expenses, allocated facilities costs, expenses for outside professional services, and expenses for personnel and consultants engaged in executive, finance, legal, information technology and administrative activities. We expect our general and administrative expenses to increase as we continue to hire personnel and expand our operations.

 

25


 

Table of Contents

Sales and Marketing Expenses

 

Our sales and marketing expenses consist primarily of compensation for our sales, marketing, and business development personnel, including bonuses and commissions for our sales representatives. We expect our sales and marketing expenses to increase as we hire additional sales personnel and representatives and increase our marketing activities.

 

Interest Expense

 

Interest expense consists of cash and non-cash components. The non-cash component consists of interest expense recognized from the amortization of debt discounts derived from the issuance of warrants and debt issuance costs capitalized on our balance sheets as a reduction of the debt balance. Interest expense is due to our borrowings under our loan agreements.

 

Other Income, Net

 

Other income, net consists primarily of the interest income earned on our cash equivalents and foreign currency exchange gains and losses. Our foreign currency exchange gains and losses relate to transactions and asset and liability balances denominated in currencies other than the U.S. dollar.

 

Loss on Extinguishment of Debt

 

In the second quarter of 2017, we repaid the outstanding balance of our revolving loan and term loan at which time we recognized the unamortized balance of the debt discount and a prepayment penalty for the term loan as a loss on extinguishment of debt.

 

 

26


 

Table of Contents

Results of Operations

 

The following table sets forth our results of operations for the periods indicated:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

June 30, 

 

June 30, 

 

 

    

2018

    

2017

    

2018

    

2017

    

2018

    

2017

    

2018

    

2017

 

 

 

(In thousands)

 

(As a percentage of revenue)

 

(In thousands)

 

(As a percentage of revenue)

 

Product sales

 

$

9,449

 

$

7,200

 

 

88

%

 

81

%

$

18,814

 

$

13,848

 

 

73

%

 

82

%

Licensing, royalty, and other revenue

 

 

1,316

 

 

1,725

 

 

12

 

 

19

 

 

6,804

 

 

2,957

 

 

27

 

 

18

 

Total revenue

 

 

10,765

 

 

8,925

 

 

100

 

 

100

 

 

25,618

 

 

16,805

 

 

100

 

 

100

 

Cost of sales

 

 

5,459

 

 

3,133

 

 

51

 

 

35

 

 

10,357

 

 

6,796

 

 

40

 

 

40

 

Gross profit

 

 

5,306

 

 

5,792

 

 

49

 

 

65

 

 

15,261

 

 

10,009

 

 

60

 

 

60

 

Operating expenses:

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

Research and development

 

 

6,773

 

 

6,427

 

 

63

 

 

72

 

 

13,253

 

 

12,816

 

 

52

 

 

76

 

General and administrative

 

 

3,329

 

 

2,793

 

 

31

 

 

31

 

 

6,548

 

 

5,638

 

 

26

 

 

34

 

Sales and marketing

 

 

1,713

 

 

1,361

 

 

15

 

 

15

 

 

3,079

 

 

2,219

 

 

12

 

 

13

 

Total operating expenses

 

 

11,815

 

 

10,581

 

 

109

 

 

119

 

 

22,880

 

 

20,673

 

 

90

 

 

123

 

Loss from operations

 

 

(6,509)

 

 

(4,789)

 

 

(60)

 

 

(54)

 

 

(7,619)

 

 

(10,664)

 

 

(30)

 

 

(63)

 

Interest expense

 

 

(222)

 

 

(176)

 

 

(2)

 

 

(2)

 

 

(433)

 

 

(406)

 

 

(2)

 

 

(2)

 

Other income, net

 

 

132

 

 

24

 

 

 1

 

 

 —

 

 

176

 

 

43

 

 

 1

 

 

 —

 

Loss on extinguishment of debt

 

 

 —

 

 

(246)

 

 

 —

 

 

(3)

 

 

 —

 

 

(246)

 

 

 —

 

 

(1)

 

Net loss

 

$

(6,599)

 

$

(5,187)

 

 

(61)

%

 

(59)

%

$

(7,876)

 

$

(11,273)

 

 

(31)

%

 

(66)

%

 

Comparison of the Three Months Ended June 30, 2018 and 2017

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Product sales

 

$

9,449

 

$

7,200

 

$

2,249

 

31.2

%

Licensing, royalty, and other revenue

 

 

1,316

 

 

1,725

 

 

(409)

 

(23.7)

%

Total revenue

 

$

10,765

 

$

8,925

 

$

1,840

 

20.6

%

 

Product sales increased by $2.2 million or 31.2%, from $7.2 million during the three months ended June 30, 2017, to $9.4 million during the three months ended June 30, 2018. The increase was primarily due to $2.5 million in increased sales volume and mix in our MRAM products offset by a $0.3 million decrease in sales of our legacy products as a result of a decrease in demand for our legacy products.

 

Licensing, royalty, and other revenue is a highly variable revenue item characterized by a small number of transactions annually with revenue based on size and terms of each transaction.  Licensing, royalty, and other revenue decreased by $0.4 million from $1.7 million during the three months ended June 30, 2017, to $1.3 million during the three months ended June 30, 2018. The decrease was primarily due to a $0.4 million decrease in sales of our backend foundry services.

27


 

Table of Contents

 

Cost of Sales and Gross Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

 

%

 

 

 

(Dollars in thousands)

 

Cost of sales

 

$

5,459

 

$

3,133

 

$

2,326

    

74.2

%

Gross margin

 

 

49.3

%  

 

64.9

%  

 

  

 

  

 

 

Cost of sales increased by $2.3 million or 74.2%, from $3.1 million during the three months ended June 30, 2017, to $5.5 million during the three months ended June 30, 2018. The increase was primarily due to increased sales volume, product mix, and lower yields on our MRAM products, partially offset by lower sales volume of backend foundry services and legacy products.

 

Gross margin decreased from 64.9% during the three months ended June 30, 2017, to 49.3% during the three months ended June 30, 2018. The decrease was primarily due to product mix and lower yields on our Toggle and MRAM products.

 

Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Research and development

 

$

6,773

 

$

6,427

 

$

346

 

5.4

%

Research and development as a % of revenue

 

 

63

%  

 

72

%  

 

 

 

 

 

 

Research and Development Expenses. Research and development expenses increased by $0.3 million or 5.4%, from $6.4 million during the three months ended June 30, 2017, to $6.8 million during the three months ended June 30, 2018. The increase was due to a $0.9 million increase in expenses incurred in our joint development agreement with GLOBALFOUNDRIES due to the use of more technologically advanced materials. The increase was partially offset by a decrease of $0.1 million in employee labor costs due to a decrease in headcount and bonuses, a decrease of $0.3 million in the amount attributable to the vesting of shares of common stock issued to GLOBALFOUNDRIES due to revaluing shares, and a decrease of $0.1 million in the allocation of supply costs to cost of goods sold due to an increase in production in 2018. Research and development expenses during the three months ended June 30, 2018 decreased as a percentage of revenue when compared with the corresponding period in 2017 primarily due to the increase in revenue from product sales being offset by the increase in research and development expenses.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

General and administrative

 

$

3,329

 

$

2,793

 

$

536

 

19.2

%

General and administrative as a % of revenue

 

 

31

%  

 

31

%  

 

 

 

 

 

 

 

General and Administrative Expenses. General and administrative spending increased by $0.5 million or 19.2%, from $2.8 million during the three months ended June 30, 2017, to $3.3 million during the three months ended June 30, 2018. The increase was primarily due to a $0.6 million increase in employee and contract labor costs due to an increase in headcount, bonuses and stock-based compensation expense. The increase was partially offset by a decrease of $0.1 million in professional services due to costs incurred in 2017 related to becoming a recent public company. General and administrative expense for the three months ended June 30, 2018 remained unchanged as a percentage of revenue when compared with the corresponding period in 2017.

 

28


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Sales and marketing

 

$

1,713

 

$

1,361

 

$

352

 

25.9

%

Sales and marketing as a % of revenue

 

 

16

%  

 

15

%  

 

 

 

 

 

 

Sales and Marketing Expenses. Sales and marketing expenses increased by $0.4 million or 25.9%, from $1.4 million during the three months ended June 30, 2017, to $1.7 million during the three months ended June 30, 2018. The increase was primarily due to a $0.4 million increase in employee and contract labor costs as a result of higher headcount and an increase in salaries, commissions, bonuses and stock-based compensation expense. Sales and marketing expense for the three months ended June 30, 2018 slightly increased as a percentage of revenue when compared with the corresponding period in 2017 primarily due to the increase in revenue from product sales not fully offsetting the increase in sales and marketing expense.

 

Interest Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Interest expense

 

$

222

 

$

176

 

$

46

 

26.1

%

 

Interest expense remained relatively flat during the three months ended June 30, 2017 compared to the three months ended June 30, 2018. The small increase was primarily due to higher interest expense on our 2017 Credit Facility with Silicon Valley Bank, compared to our prior facility with Ares Venture Finance, due to an increase in the prime rate.

 

Other Income, Net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

Other income, net

 

$

132

 

$

24

 

$

108

 

450.0

%

 

Other income, net was $0.1 million during the three months ended June 30, 2018 compared to $24,000 during the three months ended June 30, 2017. The increase was primarily related to an increase in interest income earned on our cash balances as a result of the increase in our cash balances from the follow-on public offering in February 2018.

 

Loss on Extinguishment of Debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

June 30, 

 

Change

 

    

2018

    

2017

    

Amount

    

%

 

 

(Dollars in thousands)

Loss on extinguishment of debt

 

$

 —

 

$

246

 

$

(246)

 

*


* Not meaningful

 

Loss on extinguishment of debt was $0.2 million during the three months ended June 30, 2017 due to the payoff of our prior facility with Ares Venture Finance. There was no such loss during the three months ended June 30, 2018.

 

29


 

Table of Contents

Comparison of the Six Months Ended June 30, 2018 and 2017

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Product sales

 

$

18,814

 

$

13,848

 

$

4,966

 

35.9

%

Licensing, royalty, and other revenue

 

 

6,804

 

 

2,957

 

 

3,847

 

*

%

Total revenue

 

$

25,618

 

$

16,805

 

$

8,813

 

52.4

%


* Not meaningful

 

Product sales increased by $5.0 million or 35.9%, from $13.9 million during the six months ended June 30, 2017, to $18.8 million during the six months ended June 30, 2018. The increase was primarily due to $5.9 million in increased sales volume and mix in our MRAM products offset by a $0.9 million decrease in sales of our legacy products as a result of a decrease in demand of our legacy products.

 

Licensing, royalty, and other revenue is a highly variable revenue item characterized by a small number of transactions annually with revenue based on size and terms of each transaction. Licensing, royalty, and other revenue increased by $3.8 million from $3.0 million during the six months ended June 30, 2017, to $6.8 million during the six months ended June 30, 2018. The increase was primarily due to a non-refundable license fee related to a cross-license agreement entered into with a customer in March 2018, partially offset by a $0.7 million decrease in milestone payments earned for research and development activity performed on behalf of GLOBALFOUNDRIES and a $0.6 million decrease in sales of our backend foundry services.

 

Cost of Sales and Gross Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Cost of sales

 

$

10,357

 

$

6,796

 

$

3,561

 

52.4

%

Gross margin

 

 

59.6

%  

 

59.6

%  

 

  

 

 

 

 

Cost of sales increased by $3.6 million or 52.4%, from $6.8 million during the six months ended June 30, 2017, to $10.4 million during the six months ended June 30, 2018. The increase was primarily due to increased sales volume and lower yields on our MRAM products, partially offset by lower sales volume of backend foundry services and legacy products.

 

Gross margin remained flat at 59.6% during the six months ended June 30, 2018 and 2017. There were lower yields on our MRAM products that were partially offset by a onetime licensing event in the first quarter of 2018.

 

Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Research and development

 

$

13,253

 

$

12,816

 

$

437

 

3.4

%

Research and development as a % of revenue

 

 

52

%  

 

76

%  

 

 

 

 

 

 

Research and Development Expenses. Research and development expenses increased by $0.4 million or 3.4%, from $12.8 million during the six months ended June 30, 2017, to $13.3 million during the six months ended June 30, 2018. The increase was due to a $1.1 million increase in expenses incurred in our joint development agreement with GLOBALFOUNDRIES due to the use of more technologically advanced materials and a $0.3 million increase in software expenses due to the purchase of software to improve simulations. The increases were partially offset by a decrease of $0.5 million in employee labor costs due to a decrease in headcount and bonuses, a $0.3 million decrease in  

30


 

Table of Contents

the amount attributable to the vesting of shares of common stock issued to GLOBALFOUNDRIES due to revaluing shares, and a $0.2 million decrease in the allocation of supply costs to cost of goods sold due to an increase in production in 2018 . Research and development expense during the three months ended June 30, 2018 decreased as a percentage of revenue when compared with the corresponding period in 2017 primarily due to the increase in revenue from product sales and to the non-refundable license fee.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

General and administrative

 

$

6,548

 

$

5,638

 

$

910

 

16.1

%

General and administrative as a % of revenue

 

 

26

%  

 

34

%  

 

 

 

 

 

 

General and Administrative Expenses. General and administrative spending increased by $0.9 million or 16.1%, from $5.6 million during the six months ended June 30, 2017, to $6.5 million during the six months ended June 30, 2018. The increase was primarily due a $1.2 million increase in employee and contract labor costs due to an increase in headcount, of which $0.1 million was due to increased stock-based compensation expense and the repricing of certain stock options in the six months ended June 30, 2018. The increase was partially offset by a decrease of $0.3 million in professional services due to costs incurred in 2017 related to becoming a recent public company. General and administrative expense for the three months ended June 30, 2018 decreased as a percentage of revenue when compared with the corresponding period in 2017 primarily due to the increase in revenue from product sales and the non-refundable license fee.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Sales and marketing

 

$

3,079

 

$

2,219

 

$

860

 

38.8

%

Sales and marketing as a % of revenue

 

 

12

%  

 

13

%  

 

 

 

 

 

 

Sales and Marketing Expenses. Sales and marketing expenses increased by $0.9 million or 38.8%, from $2.2 million during the six months ended June 30, 2017, to $3.1 million during the six months ended June 30, 2018. The increase was primarily due to a $0.6 million increase in employee and contract labor costs as a result of higher headcount and an increase in salaries, commissions, bonuses and stock-based compensation expense, a $0.1 million increase in commissions to sales representatives and a $0.1 million increase in expenditures on marketing materials.

 

Interest Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

 

Interest expense

 

$

433

 

$

406

 

$

27

 

6.7

%

 

Interest expense remained relatively flat during the six months ended June 30, 2017 compared to the six months ended June 30, 2018. The small increase was primarily due to higher interest expense on our 2017 Credit Facility with Silicon Valley Bank, compared to our prior facility with Ares Venture Finance, due to an increase in the prime rate.

 

Other Income, Net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

 

June 30, 

 

Change

 

 

    

2018

    

2017

    

Amount

    

%

 

 

 

(Dollars in thousands)

Other income, net

 

$

176

 

$

43

 

$

133

 

309.3

%

 

Other income, net was $0.2 million during the six months ended June 30, 2018 compared to $43,000 during the six months ended June 30, 2017. The increase was primarily related to an increase in interest income earned on our cash balances as a result of the increase in our cash balances from the follow-on public offering in February 2018.

 

31


 

Table of Contents

Loss on Extinguishment of Debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

June 30, 

 

Change

 

    

2018

    

2017

    

Amount

    

%

 

 

(Dollars in thousands)

Loss on extinguishment of debt

 

$

 —

 

$

246

 

$

(246)

 

*


* Not meaningful

 

Loss on extinguishment of debt was $0.2 million during the six months ended June 30, 2017 due to the payoff of our prior facility with Ares Venture Finance. There was no such loss during the six months ended June 30, 2018.

 

Liquidity and Capital Resources

 

We have generated significant losses since our inception and had an accumulated deficit of $124.1 million as of June 30, 2018, compared to $117.5 million as of December 31, 2017. As of June 30, 2018, we had $32.7 million of cash and cash equivalents, compared to $13.0 million as of December 31, 2017.

 

In May 2017, we executed a Loan and Security Agreement with Silicon Valley Bank for a $12.0 million term loan. The term of the loan is three years, which would be extended by one year if we achieve a revenue target of $4.0 million for our Spin Transfer Torque product. The loan bears interest at a floating rate equal to the prime rate minus 0.75% and is payable monthly. The outstanding balance of the loan is to be repaid monthly beginning on May 1, 2018 over the remaining two-year term of the loan. The loan is secured by a first priority perfected security interest in our assets excluding any intellectual property.

 

In February 2018, we completed a follow-on underwritten public offering of our common stock under our Registration Statement filed in November 2017 (File No. 333-221331), selling 3,772,447 shares of our common stock at an offering price of $7.00 per share for proceeds of $24.6 million, net of $1.8 million of underwriting discounts and commissions and other offering costs.

 

We believe that our existing cash and cash equivalents as of June 30, 2018, coupled with our anticipated growth and sales levels   will be sufficient to meet our anticipated cash requirements for at least the next twelve months. Our future capital requirements will depend on many factors, including our growth rate, the timing and extent of our spending to support research and development activities, the timing and cost of establishing additional sales and marketing capabilities, and the introduction of new products. If we need to raise additional capital to fund our operations, we may be required to seek additional equity or debt financing, and such additional financing may not be available to us on acceptable terms or at all. If we are unable to raise additional capital or generate sufficient cash from operations to adequately fund our operations, we will need to curtail planned activities to reduce costs and extend the time period over which our current resources will be able to fund operations. Doing so will likely harm our ability to execute on our business plan.

 

Cash Flows

 

The following table summarizes our cash flows for the periods indicated (in thousands):

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

June 30, 

 

    

2018

    

2017

 

 

(In thousands)

Cash used in operating activities

 

$

(4,513)

 

$

(11,290)

Cash used in investing activities

 

 

(347)

 

 

(1,704)

Cash provided by financing activities

 

 

24,635

 

 

4,443

 

Cash Flows From Operating Activities

 

During the six months ended June 30, 2018, cash used in operating activities was $4.5 million, which consisted of a net loss of $7.9 million, adjusted by non-cash charges of $2.8 million and a change of $0.6 million in our net operating assets and liabilities. The non-cash charges primarily consisted of stock-based compensation of $1.3 million,

32


 

Table of Contents

depreciation and amortization of $0.7 million, compensation expense related to vesting of common stock issued to GLOBALFOUNDRIES under our joint development agreement of $0.5 million, and interest expense related to the amortization of debt issuance costs of $0.2 million. The change in our net operating assets and liabilities was primarily due to an increase in accounts receivable of $1.4 million due to timing of cash receipts for outstanding balances and an increase of $0.8 million in prepaid expenses and other current assets and other assets due to the timing of payments. These changes were partially offset by an increase of $2.6 million in accounts payable and accrued liabilities due to the timing of payments and an increase in inventory purchases in connection with the joint development agreement with GLOBALFOUNDRIES, and a decrease of $0.2 million in inventory due to increased sales.

 

During the six months ended June 30, 2017, cash used in operating activities was $11.3 million, which consisted of a net loss of $11.3 million, adjusted by non-cash charges of $2.4 million and a change of $2.4 million in our net operating assets and liabilities. The non-cash charges primarily consisted of stock-based compensation of $0.8 million, compensation expense related to vesting of common stock issued to GLOBALFOUNDRIES under our joint development agreement of $0.7 million, depreciation and amortization of $0.5 million, loss on extinguishment of debt of $0.2 million, and interest expense related to the amortization of debt issuance costs of $0.1 million. The change in our net operating assets and liabilities was primarily due to an increase in inventory of $1.6 million to meet demands of future sales and growing backlog, an increase of $0.5 million in accounts receivable due to timing of cash receipts for outstanding balances, a decrease of $0.2 million in deferred income on shipments to distributors, and a decrease in accounts payable and accrued liabilities of $0.1 million due to the timing of payments.

 

Cash Flows From Investing Activities

 

Cash used in investing activities during six months ended June 30, 2018, was $0.3 million for the purchase of manufacturing and computer equipment.

 

Cash used in investing activities during the six months ended June 30, 2017, was $1.7 million for the purchase of manufacturing equipment and capitalized costs related to the move to our new office and laboratory space in Chandler, Arizona.

 

Cash Flows From Financing Activities

 

During the six months ended June 30, 2018, cash provided by financing activities was $24.6 million consisting of net proceeds from the issuance of common stock of $24.6 million, and $1.0 million from stock option exercises and purchases of shares in our employee stock purchase plan, offset in part by payments of long-term debt of $1.0 million.

 

During the six months ended June 30, 2017, cash provided by financing activities was $4.4 million consisting of proceeds of $12.0 million in borrowings, and $0.9 million from stock option exercises and purchases of shares in our employee stock purchase plan, offset in part by payments of long term debt of $8.4 million.

 

Contractual Obligations

 

There were no material changes in our contractual obligations from December 31, 2017.

 

Off-Balance Sheet Arrangements

 

We have not entered into any off-balance sheet arrangements and do not have any holdings in variable interest entities.

 

Critical Accounting Policies and Significant Judgments and Estimates

 

Our condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. The preparation of these condensed financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the

33


 

Table of Contents

carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Revenue Recognition

 

On January 1, 2018, we adopted Auditing Standards Update, or ASU, No. 2014-09, Revenue from Contracts with Customers (Topic 606) using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605, Revenue.

 

We recognize revenue when a customer obtains control of the promised products or services, in an amount that reflects the consideration which we expect to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and price concessions, and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

Nature of Products and Services

 

Our revenue is derived from the sale of MRAM-based products in discrete unit form, licenses of and royalties on our MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. Sales of products in discrete unit form are recognized at a point in time, revenue related to licensing agreements is recognized when we have delivered control of the technology, revenue related to royalty agreements is recognized in the period in which sales generated from products sold using our technology occurs, and sales of backend foundry services are recognized over time, and design services to third parties are recognized either at a point in time or over time, depending on the nature of the services.

 

Product Revenue

 

For products sold in their discrete form, we either sell our products directly to OEMs, original design manufacturers (ODMs), contract manufacturers (CMs), or through a network of distributors, who in turn sell to those customers. For sales directly to OEMs, ODMs and CMs, revenue is recognized when the OEM, ODM or CM obtains control of the product, which occurs at a point in time, generally upon shipment to the customer.

 

We sell a majority of our products to our distributors at a uniform list price. However, distributors may resell our products to end customers at a very broad range of individually negotiated price points. Distributors are provided with price concessions subsequent to the delivery of product to them and such amounts are dependent on the end customer and product sales price. The price concessions are based on a variety of factors, including customer, product, quantity, geography and competitive differentiation. Price protection rights grant distributors the right to a credit in the event of declines in the price of our products. Under these circumstances, we remit back to the distributor a portion of their original purchase price after the resale transaction is completed in the form of a credit against the distributors’ outstanding accounts receivable balance. The credits are on a per unit basis and are not given to the distributor until the distributor provides information regarding the sale to their end customer. We estimate these credits and record such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of an allowance for price concessions for amounts due to distributors. We estimate credits to distributors based on the historical rate of credits provided to distributors relative to sales. Revenue on shipments to distributors is recorded when control of the products has been transferred to the distributor.

 

We estimate the amount of our product sales that may be returned by our customers and record this estimate as a reduction of revenue in the period the related product revenue is recognized. We estimate our product return liability by analyzing our historical returns, current economic trends and changes in customer demand and acceptance of products. We have received insignificant returns to date and believe that returns of our products will continue to be minimal. 

 

At the time of shipment to distributors, we record a trade receivable for the selling price as there is a legally enforceable obligation of the distributor to pay for the product delivered, an allowance is recorded for the estimated discount that will be provided to the distributor, and the net of these amounts is recorded as revenue on the statement of operations.

 

34


 

Table of Contents

License Revenue

 

For licenses of technology, recognition of revenue is dependent upon whether we have delivered rights to the technology, and whether there are future performance obligations under the contract. In some instances, the license agreements call for future events or activities to occur in order for milestones amounts to become due from the customer. The terms of such agreements include payment to us of one or more of the following: non-refundable upfront fees; and royalties on net sales of licensed products. Historically, these license agreements have not included other future performance obligations once the license has been transferred to the customer. 

 

The transaction price in each agreement is allocated to the identified performance obligations based on the standalone selling price (SSP) of each distinct performance obligation. Judgment is required to determine SSP. In instances where SSP is not directly observable, such as when a license or service is not sold separately, SSP is determined using information that may include market conditions and other observable inputs. 

 

Revenue from non-refundable up-front payments is recognized when the license is transferred to the customer and the we have no other performance obligations.

 

Royalties

 

Revenue from sales-based royalties from licenses of our technology is recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part).

 

Other Revenue

 

For certain revenue streams, we recognize revenue based on the pattern of transfer of the services. We use the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract as this method most faithfully depicts its performance.  We record an unbilled receivable (within accounts receivable, net) for the portion of the work that has been completed but not invoiced at the end of each reporting period

 

Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. At the inception of each agreement that includes milestone payments, we evaluate whether the milestones are considered probable of being reached and estimate the amount to be included in the transaction price by using the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. At the end of each subsequent reporting period, we re-evaluate the probability or achievement of each such milestone and any related constraint, and if necessary, adjust our estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.

 

There have been no other changes to our critical accounting policies and estimates described in the Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Securities and Exchange Commission (SEC) on March 15, 2018, that have had a material impact on our condensed financial statements and related notes.

 

Item 3. Quantitative and Qualitativ e Disclosures about Market Risk

 

We are exposed to market risks in the ordinary course of our business, including the effects of interest rate changes and foreign currency fluctuations. Information relating to quantitative and qualitative disclosures about these markets risks is described below.

 

Interest Rate Risk  

 

We are primarily exposed to interest rate risk from variable rate borrowings under our 2017 Credit Facility, and to a lesser extent, from our cash position. We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure. We have not been exposed to, nor do we anticipate being exposed to, material risks due to changes in interest rates. A hypothetical 10% increase in our borrowing rates would not have a material impact on interest expense on our principal balances as of June 30, 2018 and

35


 

Table of Contents

December 31, 2017. A hypothetical 10% change in interest rates would not have a material impact on interest income on our cash and cash equivalent balances as of June 30, 2018 and December 31, 2017.

 

Foreign Currency Risk  

 

Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates. Substantially all of our revenue is denominated in United States dollars. Our expenses are generally denominated in United States dollars; however, we do incur expenses in the currencies of our subcontracted manufacturing suppliers, which are located in Europe and in Asia. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. The effect of a hypothetical 10% change in foreign currency exchanges rates applicable to our business would not have a material impact on our historical financial statements.

 

We have not hedged exposures denominated in foreign currencies or used any other derivative financial instruments. Although we transact the substantial majority of our business in U.S. dollars, future fluctuations in the value of the U.S. dollar may affect the competitiveness of our products and thus may impact our results of operations and cash flows.

 

Item 4. Controls and Procedure s

 

Evaluation of disclosure controls and procedures.

 

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, have evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) prior to the filing of this quarterly report. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this quarterly report, our disclosure controls and procedures were effective at the reasonable assurance level.

 

Changes in internal control over financial reporting.

 

There were no changes in our internal control over financial reporting during the quarter ended June 30, 2018, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent limitation on the effectiveness of internal control.

 

The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute assurances. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial reporting.

 

PART II – OTHER INFORMATIO N

 

ITEM 1. Legal Proceeding s

 

We are not party to any material legal proceedings at this time. From time to time, we may become involved in various legal proceedings that arise in the ordinary course of our business.

 

ITEM 1A. Risk Factor s

 

The following are important factors that could cause actual results or events to differ materially from those contained in any forward-looking statements made by us or on our behalf. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we deem immaterial

36


 

Table of Contents

also may impair our business operations. If any of the following risks or such other risks actually occurs, our business could be harmed.

 

Risk Factors Related to Our Business and Our Industry

 

We have a history of losses which may continue in the future, and we cannot be certain that we will achieve or sustain profitability.

 

We have incurred net losses since our inception. We incurred net losses of $21.1 million and $7.9 million for the year ended December 31, 2017 and the six months ended June 30, 2018, respectively. As of June 30, 2018, we had an accumulated deficit of $124.1 million. We expect to incur significant expenses related to the continued development and expansion of our business, including in connection with our efforts to develop and improve upon our products and technology, maintain and enhance our research and development and sales and marketing activities and hire additional personnel. While our products offer unique benefits over other industry memory technologies, our per-bit cost to product our product is currently higher than competing technologies. As a result, our ability to capture market share and generate sufficient revenue to transition to profitability and generate consistent positive cash flows is uncertain. We do not know whether our revenue will grow rapidly enough to absorb these costs, and our limited operating history makes it difficult to assess the extent of these expenses, or their impact on our results of operations.

 

Further, our revenue may not increase or may decline for a number of possible reasons, many of which are outside our control, including a decline in demand for our products, increased competition, business conditions that adversely affect the semiconductor memory industry, including reduced demand for products in the end markets that we serve, or our failure to capitalize on growth opportunities. If we fail to generate sufficient revenue to support our operations, we may not be able to achieve or sustain profitability.

 

Our limited operating history makes it difficult to evaluate our current business and future prospects.

 

We have been in existence as a stand-alone company since 2008, when Freescale Semiconductor, Inc. (subsequently acquired by NXP Semiconductor) spun-out its MRAM business as Everspin. We have been shipping magnetoresistive random access memory (MRAM) products since our incorporation in 2008, and we have experienced a high rate of growth for our products. However, we may not be able to sustain the growth rate for sales of these products and our revenue could decline. We are just starting the manufacture of Spin Transfer Torque MRAM (STT-MRAM) products. Adoption of these products is important to the future growth of our business, but revenue associated with these products has not been material to date.

 

Our limited operating history and limited experience selling products, combined with the rapidly evolving and competitive nature of our market, makes it difficult to evaluate our current business and future prospects. In addition, we have limited insight into emerging trends that may adversely affect our business, financial condition, results of operations and prospects. We have encountered and will continue to encounter risks and difficulties frequently experienced by growing companies in rapidly changing industries, including unpredictable and volatile revenue and increased expenses as we continue to grow our business. The viability and demand for our products may be affected by many factors outside of our control, such as the factors affecting the growth of the industrial, automotive and transportation, and enterprise storage industries and changes in macroeconomic conditions. If we do not manage these risks and overcome these difficulties successfully, our business will suffer.

 

We may be unable to match production with customer demand for a variety of reasons including our inability to accurately forecast customer demand or the capacity constraints of our suppliers, which could adversely affect our operating results.

 

We make planning and spending decisions, including determining production levels, production schedules, component procurement commitments, personnel needs and other resource requirements, based on our estimates of product demand and customer requirements. Our products are typically purchased pursuant to individual purchase orders. While our customers may provide us with their demand forecasts, they are not contractually committed to buy any quantity of products beyond purchase orders. Furthermore, many of our customers may increase, decrease, cancel or delay purchase orders already in place without significant penalty. The short-term nature of commitments by our customers and the possibility of unexpected changes in demand for their products reduce our ability to accurately estimate future customer requirements. On occasion, customers may require rapid increases in production, which can strain our resources, necessitate more onerous procurement commitments and reduce our gross margin. If we

37


 

Table of Contents

overestimate customer demand, we may purchase products that we may not be able to sell, which could result in decreases in our prices or write-downs of unsold inventory. Conversely, if we underestimate customer demand or if sufficient manufacturing capacity is unavailable, we could lose sales opportunities and could lose market share or damage our customer relationships. We manufacture MRAM products at our 200mm facility we lease in Chandler, Arizona and use a single foundry, GLOBALFOUNDRIES Singapore Pte. Ltd., for production of higher density products on advanced technology nodes, which may not have sufficient capacity to meet customer demand. The rapid pace of innovation in our industry could also render significant portions of our inventory obsolete. Excess or obsolete inventory levels could result in unexpected expenses or write-downs of inventory values that could adversely affect our business, operating results and financial condition.

We may require additional capital to fund our business, which may not be available to us on favorable terms or at all.

We believe that our existing cash and cash equivalents as of June 30, 2018, coupled with our anticipated growth and sales levels will be sufficient to meet our anticipated cash requirements for at least the next 12 months. Our future capital requirements will depend on many factors, including our growth rate, the timing and extent of our spending to support research and development activities, the timing and cost of establishing additional sales and marketing capabilities, and the introduction of new products. We may be required to seek additional equity or debt financing, and we cannot assure you that any such additional financing will be available to us on acceptable terms or at all. If we are unable to raise additional capital or generate sufficient cash from operations to adequately fund our operations, we will need to curtail planned activities to reduce costs. Doing so will likely harm our ability to execute on our business plan.

If we raise additional funds through issuances of equity, convertible debt securities or other securities convertible into equity, our existing stockholders could suffer significant dilution in their percentage ownership of our company, and any new equity securities we issue could have rights, preferences and privileges senior to those of holders of our common stock. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to continue to grow or support our business and to respond to business challenges could be significantly limited.

As we expand into new potential markets, we expect to face intense competition, including from our customers and potential customers, and may not be able to compete effectively, which could harm our business.

We expect that our new and future MRAM products will be applicable to markets in which we are not currently operating. Selling into such new markets, could put us into direct competition with our current or potential customers or other competitors with substantially more resources and experience than us. The markets in which we operate and may operate in the future are extremely competitive and are characterized by rapid technological change, continuous evolving customer requirements and declining average selling prices. We may not be able to compete successfully against current or potential competitors, which include our current or potential customers as they seek to internally develop solutions competitive with ours or as we develop products potentially competitive with their existing products. If we do not compete successfully, our market share and revenue may decline. We compete with large semiconductor manufacturers and designers and others, and our current and potential competitors have longer operating histories, significantly greater resources and name recognition and a larger base of customers than we do. This may allow them to respond more quickly than we can to new or emerging technologies or changes in customer requirements. In addition, these competitors may have greater credibility with our existing and potential customers. Some of our current and potential customers with their own internally developed solutions may choose not to purchase products from third-party suppliers like us.

We rely on third parties to distribute, manufacture, package, assemble and test our products, which exposes us to a number of risks, including reduced control over manufacturing and delivery timing and potential exposure to price fluctuations, which could result in a loss of revenue or reduced profitability.

 

Although we operate an integrated magnetic fabrication line located in Chandler, Arizona, we purchase wafers from third parties and outsource the manufacturing, packaging, assembly and testing of our products to third-party foundries and assembly and testing service providers. We use a single foundry, GLOBALFOUNDRIES Singapore Pte. Ltd., for production of higher density products on advanced technology nodes. Our primary product package and test operations are located in China, Taiwan and other Asian countries. We also use standard CMOS wafers from third-party foundries, which we process at our Chandler, Arizona, facility.

 

38


 

Table of Contents

Relying on third-party distribution, manufacturing, assembly, packaging and testing presents a number of risks, including but not limited to:

 

    our interests could diverge from those of our foundries, or we may not be able to agree with them on ongoing development, manufacturing and operational activities, or on the amount, timing, or nature of further investments in our joint development;

 

    capacity and materials shortages during periods of high demand;

 

    reduced control over delivery schedules, inventories and quality;

 

    the unavailability of, or potential delays in obtaining access to, key process technologies;

 

    the inability to achieve required production or test capacity and acceptable yields on a timely basis;

 

    misappropriation of our intellectual property;

 

    the third party’s ability to perform its obligations due to bankruptcy or other financial constraints;

 

    exclusive representatives for certain customer engagements;

 

    limited warranties on wafers or products supplied to us; and

 

      potential increases in prices.

 

We currently do not have long-term supply contracts with our third-party contract manufacturers for our MRAM products, including NXP, United Microelectronics Corporation, Taiwan Semiconductor Manufacturing Company, Limited (TSMC), United Test and Assembly Center (UTAC), Global Testing Corporation (GTC), ChipMos, OSE Taiwan, and Amkor, and we typically negotiate pricing on a per-purchase order basis and in some cases on an annual basis. Therefore, they are not obligated to perform services or supply components to us for any specific period, in any specific quantities, or at any specific price, except as may be provided in a particular purchase order. During periods of high demand and tight inventories, our third-party foundries and packaging, assembly and testing contractors may allocate capacity to the production of other companies products while reducing deliveries to us, or significantly raise their prices. In particular, they may allocate capacity to other customers that are larger and better financed than us or that have long-term agreements, decreasing the capacity available to us. Shortages of capacity available to us may be caused by the actions of their other, large customers that may be difficult to predict, such as major product launches.

 

Our manufacturing agreement with GLOBALFOUNDRIES includes a customary forecast and ordering mechanism for the supply of certain of our wafers, and we are obligated to order and pay for, and GLOBALFOUNDRIES is obligated to supply, wafers consistent with the binding portion of our forecast. However, our manufacturing arrangement is also subject to both a minimum and maximum order quantity that while we believe currently addresses our projected foundry capacity needs, may not address our maximum foundry capacity requirements in the future. We may also be obligated to pay for unused capacity if our demand decreases in the future, or if our estimates prove inaccurate. GLOBALFOUNDRIES also has the ability to discontinue its manufacture of any of our wafers upon due notice and completion of the notice period. This could cause us to have to find another foundry to manufacture those wafers or redesign our core technology and would mean that we may not have products to sell until such time. Any time spent engaging a new manufacturer or redesigning our core technology could be costly and time consuming and may allow potential competitors to take opportunities in the market place. Moreover, if we are unable to find another foundry to manufacture our products or if we have to redesign our core technology, this could cause material harm to our business and operating results.

 

If we need other foundries or packaging, assembly and testing contractors, or if we are unable to obtain timely and adequate deliveries from our providers, we might not be able to cost-effectively and quickly retain other vendors to satisfy our requirements. Because the lead-time needed to establish a relationship with a new third-party supplier could be several quarters, there is no readily available alternative source of supply for any specific component. In addition, the time and expense to qualify a new foundry could result in additional expense, diversion of resources or lost sales, any of which would negatively impact our financial results.

39


 

Table of Contents

 

If any of our current or future foundries or packaging, assembly and testing subcontractors significantly increases the costs of wafers or other materials or services, interrupts or reduces our supply, including for reasons outside of their control, or if any of our relationships with our suppliers is terminated, our operating results could be adversely affected. Such occurrences could also damage our customer relationships, result in lost revenue, cause a loss in market share or damage our reputation.

 

Our joint development agreement and strategic relationships involve numerous risks.

 

We have entered into strategic relationships to manufacture products and develop new manufacturing process technologies and products. These relationships include our joint development agreement with GLOBALFOUNDRIES to develop advanced MTJ technology and STT-MRAM. These relationships are subject to various risks that could adversely affect the value of our investments and our results of operations. These risks include the following:

 

    our interests could diverge from those of our foundries, or we may not be able to agree with them on ongoing development, manufacturing and operational activities, or on the amount, timing, or nature of further investments in our joint development;

 

    we may experience difficulties in transferring technology to a foundry;

 

    we may experience difficulties and delays in getting to and/or ramping production at foundries;

 

    our control over the operations of foundries is limited;

 

    due to financial constraints, our joint development collaborators may be unable to meet their commitments to us and may pose credit risks for our transactions with them;

 

    due to differing business models or long-term business goals, our collaborators may decide not to join us in funding capital investment, which may result in higher levels of cash expenditures by us;

 

    our cash flows may be inadequate to fund increased capital requirements;

 

    we may experience difficulties or delays in collecting amounts due to us from our collaborators;

 

    the terms of our arrangements may turn out to be unfavorable;

 

    we are migrating toward a fabless model as 300mm production becomes required and this increases risks related to less control over our critical production processes; and

 

    changes in tax, legal, or regulatory requirements may necessitate changes in our agreements.

 

In addition, under the terms of our joint development agreement with GLOBALFOUNDRIES, we are responsible for half of the costs incurred by GLOBALFOUNDRIES, and we are not able to control the expenses incurred by GLOBALFOUNDRIES.  If GLOBALFOUNDRIES were to incur expenses greater than we expect, our expenses would increase by more than we expect. Further, GLOBALFOUNDRIES may terminate the joint development agreement with us if we materially breach a term of the agreement, such as, but not limited to, by our failing to pay any undisputed sum which has been outstanding for 45 or more days from the date of invoice, and fail to remedy the breach within 60 days after receiving notice from GLOBALFOUNDRIES. If GLOBALFOUNDRIES terminates the joint development agreement, our ability to continue to develop our MRAM technology will be significantly impaired.

 

If our strategic relationships are unsuccessful, our business, results of operations, or financial condition may be materially adversely affected.

 

40


 

Table of Contents

The market for semiconductor memory products is characterized by declines in average selling prices, which we expect to continue, and which could negatively affect our revenue and margins.

 

Our customers for some of our products may see the average selling price of competitive products decrease year-over-year and we expect this trend to continue. When such pricing declines occur, we may not be able to mitigate the effects by selling more or higher margin units, or by reducing our manufacturing costs. In such circumstances, our operating results could be materially and adversely affected. Our stand-alone and embedded MRAM products have experienced declining average selling prices over their life cycle. The rate of decline may be affected by a number of factors, including relative supply and demand, the level of competition, production costs and technological changes. As a result of the decreasing average selling prices of our products following their launch, our ability to increase or maintain our margins depends on our ability to introduce new or enhanced products with higher average selling prices and to reduce our per-unit cost of sales and our operating costs. We may not be able to reduce our costs as rapidly as companies that operate their own manufacturing, assembly and testing facilities, and our costs may even increase because we rely in part on third parties to manufacture, assemble and test our products, which could also reduce our gross margins. In addition, our new or enhanced products may not be as successful or enjoy as high margins as we expect. If we are unable to offset any reductions in average selling prices by introducing new products with higher average selling prices or reducing our costs, our revenue and margins will be negatively affected and may decrease.

 

The semiconductor memory market is highly cyclical and has experienced severe downturns in the past, generally as a result of wide fluctuations in supply and demand, constant and rapid technological change, continuous new product introductions and price erosion. During downturns, periods of intense competition, or the presence of oversupply in the industry, the selling prices for our products may decline at a high rate over relatively short time periods as compared to historical rates of decline. We are unable to predict selling prices for any future periods and may experience unanticipated, sharp declines in selling prices for our products.

 

Unfavorable economic and market conditions, domestically and internationally, may adversely affect our business, financial condition, results of operations and cash flows.

 

We have significant customer sales both in the U.S. and internationally. We also rely on domestic and international suppliers, manufacturing partners and distributors. We are therefore susceptible to adverse U.S. and international economic and market conditions. If any of our manufacturing partners, customers, distributors or suppliers experience serious financial difficulties or cease operations, our business will be adversely affected. In addition, the adverse impact of an unfavorable economy may adversely impact customer spending, which may adversely impact demand for our products.

 

We must continuously develop new and enhanced products, and if we are unable to successfully market our new and enhanced products for which we incur significant expenses to develop, our results of operations and financial condition will be materially adversely affected.

 

To compete effectively in our markets, we must continually design, develop and introduce new and improved technology and products with improved features in a cost-effective manner in response to changing technologies and market demand. This requires us to devote substantial financial and other resources to research and development. We are developing new technology and products, which we expect to be one of the drivers of our revenue growth in the future. However, as it is taking us longer than we expected to develop our 1Gb STT-MRAM product, we may not succeed in developing and marketing this and other new and enhanced products. We also face the risk that customers may not value or be willing to bear the cost of incorporating our new and enhanced products into their products, particularly if they believe their customers are satisfied with current solutions. Regardless of the improved features or superior performance of our new and enhanced products, customers may be unwilling to adopt our solutions due to design or pricing constraints, or because they do not want to rely on a single or limited supply source. Because of the extensive time and resources that we invest in developing new and enhanced products, if we are unable to sell customers our new products, our revenue could decline and our business, financial condition, results of operations and cash flows would be negatively affected. For example, we generated limited revenue from sales of our STT-MRAM products to date. While we expect revenue from our STT-MRAM products to increase, if we are unable to generate more customer adoption of our 256Mb product and scale MRAM to gigabit densities to address applications currently served by DRAM, we may not be able to materially increase our revenue. If we are unable to successfully develop and market our new and enhanced products that we have incurred significant expenses developing, our results of operations and financial condition will be materially and adversely affected.

41


 

Table of Contents

 

Our success and future revenue depend on our ability to secure design wins and on our customers’ ability to successfully sell the products that incorporate our solutions. Securing design wins is a lengthy, expensive and competitive process, and may not result in actual orders and sales, which could cause our revenue to decline.

 

We sell to customers that incorporate MRAM into their products. A design win occurs after a customer has tested our product, verified that it meets the customer’s requirements and qualified our solutions for their products. We believe we are dependent on the adoption of our 256Mb and 1Gb MRAM products by our customers to secure design wins. In the fourth quarter of 2017, we recorded revenue for our first sale of 40nm 256Mb STT-MRAM products and we are in process of ramping up production in 2018. To date we have not sold any of our 1Gb MRAM products. Our customers may need several months to years to test, evaluate and adopt our product and additional time to begin volume production of the product that incorporates our solution. Due to this generally lengthy design cycle, we may experience significant delays from the time we increase our operating expenses and make investments in our products to the time that we generate revenue from sales of these products. Moreover, even if a customer selects our solution, we cannot guarantee that this will result in any sales of our products, as the customer may ultimately change or cancel its product plans, or efforts by our customer to market and sell its product may not be successful. We may not generate any revenue from design wins after incurring the associated costs, which would cause our business and operating results to suffer. Any further delay in the development of our 1Gb MRAM products, or failure of our customers to adopt our 256Mb and 1Gb MRAM products, could inhibit revenue growth or cause declines, which would significantly harm our business and prevent us from becoming profitable.

 

If a current or prospective customer designs a competitor’s solution into its product, it becomes significantly more difficult for us to sell our solutions to that customer because changing suppliers involves significant time, cost, effort and risk for the customer even if our solutions are superior to other solutions and remain compatible with their product design. Our ability to compete successfully depends on customers viewing us as a stable and reliable supplier to mission critical customer applications when we have less production capacity and less financial resources compared to most of our larger competitors. If current or prospective customers do not include our solutions in their products and we fail to achieve a sufficient number of design wins, our results of operations and business may be harmed.

 

We rely on our relationships with OEMs and original design manufacturers (ODMs) to enhance our solutions and market position, and our failure to continue to develop or maintain such relationships in the future would harm our ability to remain competitive.

 

We develop our products for leading OEMs and ODMs that serve a variety of end markets and are developing devices for automotive, transportation, industrial and storage applications. For each application, manufacturers create products that incorporate specialized semiconductor technology, which makers of memory products use as the basis for their products. These manufacturers set the specifications for many of the key components to be used on each generation of their products and, in the case of memory components, generally qualify only a few vendors to provide memory components for their products. As each new generation of their products is released, vendors are validated in a similar fashion. We must work closely with OEMs and ODMs to ensure our products become qualified for use in their products. As a result, maintaining close relationships with leading OEMs and ODMs that are developing devices for automotive, transportation, industrial and storage applications is crucial to the long-term success of our business. We could lose these relationships for a variety of reasons, including our failure to qualify as a vendor, our failure to demonstrate the value of our new solutions, declines in product quality, or if OEMs or ODMs seek to work with vendors with broader product suites, greater production capacity or greater financial resources. If our relationships with key industry participants were to deteriorate or if our solutions were not qualified by our customers, our market position and revenue could be materially and adversely affected.

 

The loss of one or several of our customers or reduced orders or pricing from existing customers may have a significant adverse effect on our operations and financial results.

 

We have derived and expect to continue to derive a significant portion of our revenues from a small group of customers during any particular period due in part to the concentration of market share in the semiconductor industry. Our four largest end customers together accounted for 41% of our total revenue for the six months ended June 30, 2018, and two of these customers accounted for more than 10% of our revenue during the period. Our four largest end customers together accounted for 28% of our total revenue for the year ended December 31, 2017, but none of these customers individually accounted for more than 10% of our total revenue during the period. The loss of a significant

42


 

Table of Contents

customer, a business combination among our customers, a reduction in orders or decrease in price from a significant customer or disruption in any of our commercial or distributor arrangements may result in a significant decline in our revenues and could have a material adverse effect on our business, liquidity, results of operations, financial condition and cash flows.

 

Our results of operations can fluctuate from period to period, which could cause our share price to fluctuate.

 

Our results of operations have fluctuated in the past and may fluctuate from period to period in the future due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations include the following factors, as well as other factors described elsewhere in this report:

 

    the receipt, reduction, delay or cancellation of orders by large customers;

 

    the gain or loss of significant customers or distributors;

 

    the timing and success of our launch of new or enhanced products and those of our competitors;

 

    market acceptance of our products and our customers’ products;

 

    the level of growth or decline in the industrial, automotive and transportation, enterprise storage and other markets;

 

    the timing and extent of research and development and sales and marketing expenditures;

 

    the amount and timing of operating expenses related to the maintenance and expansion of our business, operations and infrastructure;

 

    changes in our product mix;

 

    our ability to reduce the manufacturing costs of our products;

 

    competitive pressures resulting in lower than expected average selling prices;

 

    fluctuations in sales by and inventory levels of OEMs and ODMs that incorporate our memory products in their products;

 

    cyclical and seasonal fluctuations in our markets;

 

    fluctuations in the manufacturing yields of our third-party manufacturers;

 

    quality issues that arise from manufacturing issues at our third-party manufacturers;

 

    events that impact the availability of production capacity at our third-party subcontractors and other interruptions in the supply chain including due to geopolitical events, natural disasters, materials shortages, bankruptcy or other causes;

 

    supply constraints for and changes in the cost of the other components incorporated into our customers’ products;

 

    the timing of expenses related to the acquisition of technologies or businesses;

 

    product rates of return or price concessions in excess of those expected or forecasted;

 

    costs associated with the repair and replacement of defective products;

 

    unexpected inventory write-downs or write-offs;

43


 

Table of Contents

 

    costs associated with litigation over intellectual property rights and other litigation;

 

    changes in accounting standards, such as revenue recognition, which we were required to adopt beginning in 2018;

 

    changes in tax laws, such as the Tax Cuts and Jobs Act of 2017 recently enacted;

 

    the length and unpredictability of the purchasing and budgeting cycles of our customers;

 

    loss of key personnel or the inability to attract qualified engineers; and

 

    geopolitical events, such as war, threat of war or terrorist actions, or the occurrence of natural disasters.

 

The semiconductor memory industry is highly cyclical and our markets may experience significant cyclical fluctuations in demand as a result of changing economic conditions, budgeting and buying patterns of customers and other factors. As a result of these and other factors affecting demand for our products and our results of operations in any given period, the results of any prior quarterly or annual periods should not be relied upon as indicative of our future revenue or operating performance. Fluctuations in our revenue and operating results could also cause our stock price to decline.

 

If sales of our customers’ products decline or if their products do not achieve market acceptance, our business and operating results could be adversely affected.

 

Our revenue depends on our customers ability to commercialize their products successfully. The markets for our customers products are extremely competitive and are characterized by rapid technological change. Competition in our customers markets is based on a variety of factors including price, performance, product quality, marketing and distribution capability, customer support, name recognition and financial strength. As a result of rapid technological change, the markets for our customers products are characterized by frequent product introductions, short product life cycles, fluctuating demand and increasing product capabilities. As a result, our customers products may not achieve market success or may become obsolete. We cannot assure you that our customers will dedicate the resources necessary to promote and commercialize their products, successfully execute their business strategies for such products, or be able to manufacture such products in quantities sufficient to meet demand or cost-effectively manufacture products at a high volume. Our customers do not have contracts with us that require them to manufacture, distribute or sell any products. Moreover, our customers may develop internally, or in collaboration with our competitors, technology that they may utilize instead of the technology available to them through us. Our customers failure to achieve market success for their products, including as a result of general declines in our customers markets or industries, could negatively affect their willingness to utilize our products, which may result in a decrease in our revenue and negatively affect our business and operating results.

 

Our revenue also depends on the timely introduction, quality and market acceptance of our customers products that incorporate our solutions. Our customers products are often very complex and subject to design complexities that may result in design flaws, as well as potential defects, errors and bugs. We incur significant design and development costs in connection with designing our solutions for customers products. If our customers discover design flaws, defects, errors or bugs in their products, or if they experience changing market requirements, failed evaluations or field trials, or issues with other vendors, they may delay, change or cancel a project. If we have already incurred significant development costs, we may not be able to recoup those costs, which in turn would adversely affect our business and financial results.

 

We face competition and expect competition to increase in the future. If we fail to compete effectively, our revenue growth and results of operations will be materially and adversely affected.

 

The global semiconductor market in general, and the semiconductor memory market in particular, are highly competitive. We expect competition to increase and intensify as other semiconductor companies enter our markets, many of which have greater financial and other resources with which to pursue technology development, product design, manufacturing, marketing and sales and distribution of their products. Increased competition could result in price pressure, reduced profitability and loss of market share, any of which could materially and adversely affect our business, revenue and operating results. Currently, our competitors range from large, international companies offering a wide

44


 

Table of Contents

range of traditional memory technologies to companies specializing in other alternative, specialized emerging memory technologies. Our primary memory competitors include Cypress, Fujitsu, Integrated Silicon Solution, Macronix, Microchip, Micron, Renesas, Samsung, and Toshiba. The main competition for sensor products includes AMR, Crocus, GMR and Hall Effect. These technologies directly compete with our products and are supplied by ALPS Electric, Asahi Kasei Microdevices, Fairchild, Invensys (now Schneider), Kionix and Micronas. In addition, as the MRAM market opportunity grows, we expect new entrants such as Avalanche Technologies may enter this market and existing competitors, including leading semiconductor companies, may make significant investments to compete more effectively against our products. These competitors could develop technologies or architectures that make our products or technologies obsolete.

 

Our ability to compete successfully depends on factors both within and outside of our control, including:

 

    the functionality and performance of our products and those of our competitors;

 

    our relationships with our customers and other industry participants;

 

    prices of our products and prices of our competitors’ products;

 

    our ability to develop innovative products;

 

    our competitors’ greater resources to make acquisitions;

 

    our ability to obtain adequate capital to finance operations;

 

    our ability to retain high-level talent, including our management team and engineers; and

 

    the actions of our competitors, including merger and acquisition activity, launches of new products and other actions that could change the competitive landscape.

 

Competition could result in pricing pressure, reduced revenue and loss of market share, any of which could materially and adversely affect our business, results of operations and prospects. In the event of a market downturn, competition in the markets in which we operate may intensify as our customers reduce their purchase orders. Our competitors that are significantly larger and have greater financial, technical, marketing, distribution, customer support and other resources or more established market recognition than us may be better positioned to accept lower prices and withstand adverse economic or market conditions.

 

Our customers require our products and our third-party contractors to undergo a lengthy and expensive qualification process. If we are unsuccessful or delayed in qualifying any of our products with a customer, our business and operating results would suffer.  

 

Prior to selecting and purchasing our products, our customers typically require that our products undergo extensive qualification processes, which involve testing of our products in the customers systems, as well as testing for reliability. This qualification process may continue for several months or years. However, obtaining the requisite qualifications for a memory product does not assure any sales of the product. Even after successful qualification and sales of a product to a customer, a subsequent revision in our third-party contractors manufacturing process or our selection of a new contract manufacturer may require a new qualification process, which may result in delays and excess or obsolete inventory. After our products are qualified and selected, it can and often does take several months or years before the customer commences volume production of systems that incorporate our products. Despite these uncertainties, we devote substantial resources, including design, engineering, sales, marketing and management efforts, to qualify our products with customers in anticipation of sales. If we are unsuccessful or delayed in qualifying any of our products with a customer, sales of those products may be precluded or delayed, which may impede our growth and harm our business.

 

Our costs may increase substantially if we or our third-party manufacturing contractors do not achieve satisfactory product yields or quality.

 

The fabrication process is extremely complicated and small changes in design, specifications or materials can result in material decreases in product yields or even the suspension of production. From time to time, we and/or the third-party

45


 

Table of Contents

foundries that we contract to manufacture our products may experience manufacturing defects and reduced manufacturing yields. In some cases, we and/or our third-party foundries may not be able to detect these defects early in the fabrication process or determine the cause of such defects in a timely manner. There may be a higher risk of product yield issues in newer STT-MRAM products.

 

Generally, in pricing our products, we assume that manufacturing yields will continue to improve, even as the complexity of our products increases. Once our products are initially qualified either internally or with our third-party foundries, minimum acceptable yields are established. We are responsible for the costs of the units if the actual yield is above the minimum set with our third-party foundries. If actual yields are below the minimum we are not required to purchase the units. Typically, minimum acceptable yields for our new products are generally lower at first and gradually improve as we achieve full production, but yield issues can occur even in mature processes due to break downs in mechanical systems, equipment failures or calibration errors. Unacceptably low product yields or other product manufacturing problems could substantially increase overall production time and costs and adversely impact our operating results. Product yield losses will increase our costs and reduce our gross margin. In addition to significantly harming our results of operations and cash flow, poor yields may delay shipment of our products and harm our relationships with existing and potential customers.

 

The complexity of our products may lead to defects, which could negatively impact our reputation with customers and result in liability.

 

Products as complex as ours may contain defects when first introduced to customers or as new versions are released. Delivery of products with production defects or reliability, quality or compatibility problems could significantly delay or hinder market acceptance of the products or result in a costly recall and could damage our reputation and adversely affect our ability to retain existing customers and attract new customers. Defects could cause problems with the functionality of our products, resulting in interruptions, delays or cessation of sales of these products to our customers. We may also be required to make significant expenditures of capital and resources to resolve such problems. We cannot assure you that problems will not be found in new products, both before and after commencement of commercial production, despite testing by us, our suppliers or our customers. Any such problems could result in:

 

    delays in development, manufacture and roll-out of new products;

 

    additional development costs;

 

    loss of, or delays in, market acceptance;

 

    diversion of technical and other resources from our other development efforts;

 

    claims for damages by our customers or others against us; and

 

    loss of credibility with our current and prospective customers.

 

Any such event could have a material adverse effect on our business, financial condition and results of operations.

 

We may experience difficulties in transitioning to new wafer fabrication process technologies or in achieving higher levels of design integration, which may result in reduced manufacturing yields, delays in product deliveries and increased expenses.

 

We aim to use the most advanced manufacturing process technology appropriate for our solutions that is available from our third-party foundries. As a result, we periodically evaluate the benefits of migrating our solutions to other technologies to improve performance and reduce costs. These ongoing efforts require us from time to time to modify the manufacturing processes for our products and to redesign some products, which in turn may result in delays in product deliveries. We may face difficulties, delays and increased expense as we transition our products to new processes, and potentially to new foundries. We will depend on our third-party foundries as we transition to new processes. We cannot assure you that our third-party foundries will be able to effectively manage such transitions or that we will be able to maintain our relationship with our third-party foundries or develop relationships with new third-party foundries. If we or any of our third-party foundries experience significant delays in transitioning to new processes or fail to efficiently

46


 

Table of Contents

implement transitions, we could experience reduced manufacturing yields, delays in product deliveries and increased expenses, any of which could harm our relationships with our customers and our operating results.

 

As smaller line width geometry manufacturing processes become more prevalent, we intend to move our future products to increasingly smaller geometries to integrate greater levels of storage capacity and/or functionality into our products. This transition will require us and our third-party foundries to migrate to new designs and manufacturing processes for smaller geometry products. We may not be able to achieve smaller geometries with higher levels of design integration or to deliver new integrated products on a timely basis. We periodically evaluate the benefits, on a product-by-product basis, of migrating to smaller geometry process technologies to increase product value. We are dependent on our relationships with our third-party foundries to transition to smaller geometry processes successfully. We cannot assure you that our third-party foundries will be able to effectively manage any such transition. If we or our third-party foundries experience significant delays in any such transition or fail to implement a transition, our business, financial condition and results of operations could be materially harmed.

 

Changes to industry standards and technical requirements relevant to our products and markets could adversely affect our business, results of operations and prospects.

 

Our products are only a part of larger electronic systems. All products incorporated into these systems must comply with various industry standards and technical requirements created by regulatory bodies or industry participants to operate efficiently together. Industry standards and technical requirements in our markets are evolving and may change significantly over time. For our products, the industry standards are developed by the Joint Electron Device Engineering Council, an industry trade organization. In addition, large industry-leading semiconductor and electronics companies play a significant role in developing standards and technical requirements for the product ecosystems within which our products can be used. Our customers also may design certain specifications and other technical requirements specific to their products and solutions. These technical requirements may change as the customer introduces new or enhanced products and solutions.

 

Our ability to compete in the future will depend on our ability to identify and comply with evolving industry standards and technical requirements. The emergence of new industry standards and technical requirements could render our products incompatible with products developed by other suppliers or make it difficult for our products to meet the requirements of certain of our customers in automotive, transportation, industrial, storage and other markets. As a result, we could be required to invest significant time and effort and to incur significant expense to redesign our products to ensure compliance with relevant standards and requirements. If our products are not in compliance with prevailing industry standards and technical requirements for a significant period of time, we could miss opportunities to achieve crucial design wins, our revenue may decline and we may incur significant expenses to redesign our products to meet the relevant standards, which could adversely affect our business, results of operations and prospects.

 

Failure to protect our intellectual property could substantially harm our business.

 

Our success and ability to compete depend in part upon our ability to protect our intellectual property. We rely on a combination of intellectual property rights, including patents, mask work protection, copyrights, trademarks, trade secrets and know-how, in the United States and other jurisdictions. The steps we take to protect our intellectual property rights may not be adequate, particularly in foreign jurisdictions such as China. Any patents we hold may not adequately protect our intellectual property rights or our products against competitors, and third parties may challenge the scope, validity or enforceability of our issued patents, which third parties may have significantly more financial resources with which to litigate their claims than we have to defend against them. In addition, other parties may independently develop similar or competing technologies designed around any patents or patent applications that we hold. Some of our products and technologies are not covered by any patent or patent application, as we do not believe patent protection of these products and technologies is critical to our business strategy at this time. A failure to timely seek patent protection on products or technologies generally precludes us from seeking future patent protection on these products or technologies.

 

In addition to patents, we also rely on contractual protections with our customers, suppliers, distributors, employees and consultants, and we implement security measures designed to protect our trade secrets and know-how. However, we cannot assure you that these contractual protections and security measures will not be breached, that we will have adequate remedies for any such breach or that our customers, suppliers, distributors, employees or consultants will not assert rights to intellectual property or damages arising out of such contracts.

 

47


 

Table of Contents

We may initiate claims against third parties to protect our intellectual property rights if we are unable to resolve matters satisfactorily through negotiation. Litigation brought to protect and enforce our intellectual property rights could be costly, time-consuming and distracting to management. It could also result in the impairment or loss of portions of our intellectual property, as an adverse decision could limit our ability to assert our intellectual property rights, limit the value of our technology or otherwise negatively impact our business, financial condition and results of operations. Additionally, any enforcement of our patents or other intellectual property may provoke third parties to assert counterclaims against us. Our failure to secure, protect and enforce our intellectual property rights could materially harm our business.

 

We may face claims of intellectual property infringement, which could be time-consuming, costly to defend or settle, result in the loss of significant rights, harm our relationships with our customers and distributors, or otherwise materially adversely affect our business, financial condition and results of operations.

 

The semiconductor memory industry is characterized by companies that hold patents and other intellectual property rights and that vigorously pursue, protect and enforce intellectual property rights. These companies include patent holding companies or other adverse patent owners who have no relevant product revenue and against whom our own patents may provide little or no deterrence. From time to time, third parties may assert against us and our customers patent and other intellectual property rights to technologies that are important to our business. We have in the past, and may in the future, face such claims.

 

Claims that our products, processes or technology infringe third-party intellectual property rights, regardless of their merit or resolution, could be costly to defend or settle and could divert the efforts and attention of our management and technical personnel. We may also be obligated to indemnify our customers or business partners in connection with any such litigation, which could result in increased costs. Infringement claims also could harm our relationships with our customers or distributors and might deter future customers from doing business with us. If any such proceedings result in an adverse outcome, we could be required to:

 

    cease the manufacture, use or sale of the infringing products, processes or technology;

 

    pay substantial damages for infringement;

 

    expend significant resources to develop non-infringing products, processes or technology, which may not be successful;

 

    license technology from the third-party claiming infringement, which license may not be available on commercially reasonable terms, or at all;

 

    cross-license our technology to a competitor to resolve an infringement claim, which could weaken our ability to compete with that competitor; or

 

    pay substantial damages to our customers to discontinue their use of or to replace infringing technology sold to them with non-infringing technology, if available.

 

Any of the foregoing results could have a material adverse effect on our business, financial condition and results of operations. Furthermore, our exposure to the foregoing risks may also be increased if we acquire other companies or technologies. For example, we may have a lower level of visibility into the development process with respect to intellectual property or the care taken to safeguard against infringement risks with respect to the acquired company or technology. In addition, third parties may make infringement and similar or related claims after we have acquired technology that had not been asserted prior to the acquisition.

 

We make significant investments in new technologies and products that may not achieve technological feasibility or profitability or that may limit our revenue growth.

 

We have made and will continue to make significant investments in research and development of new technologies and products, including new and more technically advanced versions of our MRAM technology.

 

48


 

Table of Contents

Investments in new technologies are speculative and technological feasibility may not be achieved. Commercial success depends on many factors including demand for innovative technology, availability of materials and equipment, selling price the market is willing to bear, competition and effective licensing or product sales. We may not achieve significant revenue from new product investments for a number of years, if at all. Moreover, new technologies and products may not be profitable, and even if they are profitable, operating margins for new products and businesses may not be as high as the margins we have experienced historically or originally anticipated. Our inability to capitalize on or realize substantial revenue from our significant investments in research and development could harm our operating results and distract management, harming our business.

 

Our success depends on our ability to attract and retain key employees, and our failure to do so could harm our ability to grow our business and execute our business strategies.

 

Our success depends on our ability to attract and retain our key employees, including our management team and experienced engineers. Competition for personnel in the semiconductor memory technology field, and in the MRAM space in particular, is intense, and the availability of suitable and qualified candidates is limited. We compete to attract and retain qualified research and development personnel with other semiconductor companies, universities and research institutions. Given our experience as an early entrant in the MRAM space, our employees are frequently contacted by MRAM startups and MRAM groups within larger companies seeking to employ them. The members of our management and key employees are at-will employees and although we issued refresh equity awards to our personnel in connection with our initial public offering, and repriced options in mid-December 2016 to reflect our then current stock price, there can be no assurance that these awards will be effective to retain our key employees. If we lose the services of any key senior management member or employee, we may not be able to locate suitable or qualified replacements, and may incur additional expenses to recruit and train new personnel, which could severely impact our business and prospects. The loss of the services of one or more of our key employees, especially our key engineers, or our inability to attract and retain qualified engineers, could harm our business, financial condition and results of operations.

 

We may not be able to effectively manage our growth, and we may need to incur significant expenditures to address the additional operational and control requirements of our growth, either of which could harm our business and operating results.

 

As we continue to expand our business, we expect our headcount and overall size of our operations to grow significantly. To effectively manage our growth, we must continue to expand our operational, engineering and financial systems, procedures and controls and to improve our accounting and other internal management systems, such as our new ERP system that we have recently implemented. This may require substantial managerial and financial resources, and our efforts in this regard may not be successful. Our current systems, procedures and controls may not be adequate to support our future operations. If we fail to adequately manage our growth, or to improve our operational, financial and management information systems, or fail to effectively motivate or manage our new and future employees, the quality of our products and the management of our operations could suffer, which could adversely affect our operating results.

 

We may engage in acquisitions of, or investments in, other companies, each of which may divert our management’s attention, result in additional dilution to stockholders or use resources that are necessary to operate our business.

 

We may in the future seek to acquire or invest in businesses, products or technologies that we believe could complement or expand our business, enhance our technical capabilities or otherwise offer growth opportunities. However, our term loan and revolving credit facility prohibits our ability to merge with or acquire any other entity. Even if we were allowed to pursue such acquisitions or investments, they could create risks for us, including:

 

    difficulties in assimilating acquired personnel, operations and technologies or realizing synergies expected in connection with an acquisition, particularly with acquisitions of companies with large and widespread operations, complex products or that operate in markets in which we historically have had limited experience;

 

    unanticipated costs or liabilities, including possible litigation, associated with the acquisition;

 

    incurrence of acquisition-related costs;

 

    diversion of management’s attention from other business concerns;

 

49


 

Table of Contents

    use of resources that are needed in other parts of our business; and

 

    use of substantial portions of our available cash to consummate an acquisition.

 

A significant portion of the purchase price of companies we acquire may be allocated to acquired goodwill, which must be assessed for impairment at least annually. If such acquisitions do not yield expected returns, we may be required to take charges to our earnings based on this impairment assessment process, which could harm our results of operations.

 

We may be unable to complete acquisitions at all or on commercially reasonable terms, which could limit our future growth. Acquisitions could also result in dilutive issuances of equity securities or the incurrence of additional debt, which could adversely affect our operating results and result in a decline in our stock price and further restrict our ability to pursue business opportunities, including potential acquisitions. In addition, if an acquired business fails to meet our expectations, our operating results may suffer.

 

We maintain operations outside of the United States and intend to expand our international operations, which exposes us to significant risks.

 

We have limited operations in Europe and Asia. We intend to expand our operations internationally. The success of our business depends, in large part, on our ability to operate successfully from geographically disparate locations and to further expand our international operations and sales. Operating in international markets requires significant resources and management attention and subjects us to regulatory, economic and political risks that are different from those we face in the United States. We cannot be sure that further international expansion will be successful. In addition, we face risks in doing business internationally that could expose us to reduced demand for our products, lower prices for our products or other adverse effects on our operating results. Among the risks we believe are most likely to affect us are:

 

    difficulties, inefficiencies and costs associated with staffing and managing foreign operations;

 

    longer and more difficult customer qualification and credit checks;

 

    greater difficulty collecting accounts receivable and longer payment cycles;

 

    the need for various local approvals to operate in some countries;

 

    difficulties in entering some foreign markets without larger-scale local operations;

 

    compliance with local laws and regulations;

 

    unexpected changes in regulatory requirements, including the elimination of tax holidays;

 

    reduced protection for intellectual property rights in some countries;

 

    adverse tax consequences as a result of repatriating cash generated from foreign operations to the United States;

 

    adverse tax consequences, including potential additional tax exposure if we are deemed to have established a permanent establishment outside of the United States;

 

    the effectiveness of our policies and procedures designed to ensure compliance with the Foreign Corrupt Practices Act of 1977 and similar regulations;

 

    fluctuations in currency exchange rates, which could increase the prices of our products to customers outside of the United States, increase the expenses of our international operations by reducing the purchasing power of the U.S. dollar and expose us to foreign currency exchange rate risk if, in the future, we denominate our international sales in currencies other than the U.S. dollar;

 

    new and different sources of competition; and

 

50


 

Table of Contents

    political and economic instability, and terrorism.

 

Our failure to manage any of these risks successfully could harm our operations and reduce our revenue.

 

To comply with environmental laws and regulations, we may need to modify our activities or incur substantial costs, and if we fail to comply with environmental regulations we could be subject to substantial fines or be required to have our suppliers alter their processes.

 

The semiconductor memory industry is subject to a variety of international, federal, state and local governmental regulations directed at preventing or mitigating environmental harm, as well as to the storage, discharge, handling, generation, disposal and labeling of toxic or other hazardous substances. Failure to comply with environmental regulations could subject us to civil or criminal sanctions and property damage or personal injury claims. Compliance with current or future environmental laws and regulations could restrict our ability to expand our business or require us to modify processes or incur other substantial expenses which could harm our business. In response to environmental concerns, some customers and government agencies impose requirements for the elimination of hazardous substances, such as lead (which is widely used in soldering connections in the process of semiconductor packaging and assembly), from electronic equipment. For example, the European Union adopted its Restriction on Hazardous Substance Directive which prohibits, with specified exceptions, the sale in the EU market of new electrical and electronic equipment containing more than agreed levels of lead or other hazardous materials and China has enacted similar regulations. Environmental laws and regulations such as these could become more stringent over time, causing a need to redesign technologies, imposing greater compliance costs and increasing risks and penalties associated with violations, which could seriously harm our business.

 

Some of the facilities of our suppliers are located near known earthquake fault zones, and the occurrence of an earthquake or other catastrophic disaster could damage our facilities, which could cause us to curtail our operations.  

 

Some of our foundries and suppliers facilities in Asia are located near known earthquake fault zones and, therefore, are vulnerable to damage from earthquakes. We are also vulnerable to damage from other types of disasters, such as power loss, fire, floods and similar events. If any such disaster were to occur, our ability to operate our business could be seriously impaired. In addition, we may not have adequate insurance to cover our losses resulting from disasters or other similar significant business interruptions. Any significant losses that are not recoverable under our insurance policies could seriously impair our business and financial condition.

 

Provisions of our credit facility may restrict our ability to pursue our business strategies.

 

Borrowings under our existing credit facility are secured by substantially all of our assets, except for intellectual property. Our term loan facility prohibits our ability to, among other things:

 

    dispose of or sell assets;

 

    consolidate or merge with other entities;

 

    incur additional indebtedness;

 

    create liens on our assets;

 

    pay dividends;

 

    make investments;

 

    enter into transactions with affiliates; and

 

    redeem subordinated indebtedness.

 

These restrictions are subject to certain exceptions. In addition, our existing credit facility requires that we meet certain operating covenants, such as maintaining insurance on the collateral and meeting certain financial covenants, such as a minimum liquidity ratio. The operating restrictions and covenants in the term loan facility, as well as any future

51


 

Table of Contents

financing agreements that we may enter into, may restrict our ability to finance our operations, engage in business activities or expand or fully pursue our business strategies. Our ability to comply with these covenants may be affected by events beyond our control, and we may not be able to meet those covenants. A breach of any of these covenants could result in a default under the credit facility, which could cause all of the outstanding indebtedness thereunder to either become immediately due and payable or increase by five percent of the interest rate charged during the period of the unremedied breach.

 

Our ability to use net operating losses to offset future taxable income may be subject to certain limitations.

 

In general, under Section 382 of the U.S. Internal Revenue Code of 1986, as amended, or the Code, a corporation that undergoes an ownership change is subject to limitations on its ability to utilize its pre-change net operating losses, or NOLs, to offset future taxable income, and tax credits to offset tax. As of December 31, 2017, we had federal net operating loss carryforwards of approximately $100.1 million which will begin to expire in 2028 if not utilized, and state net operating loss carryforwards of approximately $39.3 million which will begin to expire in 2023 if not utilized. The federal NOLs generated prior to 2018 will continue to be governed by the NOL tax rules as they existed prior to the adoption of the new Tax Act, which means that generally they will expire 20 years after they were generated if not used prior thereto. The federal NOLs generated prior to 2018 will continue to be governed by the NOL tax rules as they existed prior to the adoption of the new Tax Act, which means that generally they will expire 20 years after they were generated if not used prior thereto.  We may experience an ownership change in the future, and our ability to utilize our NOLs and tax credits could be further limited by Section 382 of the Code. Future changes in our stock ownership, many of which are outside of our control, could result in an ownership change under Section 382 of the Code. Our net operating losses and tax credits could also be impaired under state laws. As a result, we might not be able to utilize a material portion of our state NOLs and tax credits.

 

The recently enacted tax reform bill could adversely affect our business and financial condition.

 

On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act (2017 Tax Act), which significantly amends the Internal Revenue Code of 1986. The 2017 Tax Act, among other things, reduces the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, limits the tax deduction for interest expense to 30% of adjusted earnings, eliminates net operating loss carrybacks, imposes a one-time tax on offshore earnings at reduced rates regardless of whether they are repatriated, allows immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifies or repeals many business deductions and credits. The rate reduction took effect on January 1, 2018.

 

If we fail to retain finance personnel and strengthen our financial reporting systems and infrastructure, we may not be able to timely and accurately report our financial results or comply with the requirements of being a public company, including compliance with the Sarbanes-Oxley Act and SEC reporting requirements.

 

We have hired additional accounting and finance staff members to augment our current staff and to improve the effectiveness of our closing and financial reporting processes. Any inability to retain such personnel would have an adverse impact on our ability to accurately and timely prepare our financial statements. We may be unable to locate and hire qualified professionals with requisite technical and public company experience when and as needed. In addition, new employees will require time and training to learn our business and operating processes and procedures. If our finance and accounting organization is unable for any reason to respond adequately to the demands of being a public company, the quality and timeliness of our financial reporting may suffer, which could result in the identification of material weaknesses in our internal controls. Any consequences resulting from inaccuracies or delays in our reported financial statements could cause the trading price of our common stock to decline and could harm our business, operating results and financial condition.

 

Interruptions in our information technology systems could adversely affect our business.

 

We rely on the efficient and uninterrupted operation of complex information technology systems and networks to operate our business. Any significant disruption to our systems or networks, including, but not limited to, new system implementations, computer viruses, security breaches, facility issues, natural disasters, terrorism, war, telecommunication failures or energy blackouts, could have a material adverse impact on our operations, sales and financial results. Such disruption could result in a loss of our intellectual property or the release of sensitive competitive information or supplier, customer or employee personal data. Any loss of such information could harm our competitive

52


 

Table of Contents

position, result in a loss of customer confidence, and cause us to incur significant costs to remedy the damages caused by any such disruptions or security breaches. Additionally, any failure to properly manage the collection, handling, transfer or disposal of personal data of employees and customers may result in regulatory penalties, enforcement actions, remediation obligations, litigation, fines and other sanctions.

 

We may experience attacks on our data, attempts to breach our security and attempts to introduce malicious software into our IT systems. If attacks are successful, we may be unaware of the incident, its magnitude, or its effects until significant harm is done. Any such attack or disruption could result in additional costs related to rebuilding of our internal systems, defending litigation, responding to regulatory actions, or paying damages. Such attacks or disruptions could have a material adverse impact on our business, operations and financial results.

 

Third-party service providers, such as wafer foundries, assembly and test contractors, distributors and other vendors have access to certain portions of our and our customers sensitive data. In the event that these service providers do not properly safeguard the data that they hold, security breaches and loss of data could result. Any such loss of data by our third-party service providers could negatively impact our business, operations and financial results, as well as our relationship with our customers.

 

If we experience material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to accurately report our financial condition or results of operations which may adversely affect investor confidence in us and, as a result, the value of our common stock.

 

As a result of being a public company, we are required, under Section 404 of the Sarbanes-Oxley Act to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. This assessment includes disclosure of any material weaknesses identified by our management in our internal control over financial reporting. A material weakness is a deficiency or combination of deficiencies in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual and interim financial statements will not be detected or prevented on a timely basis. In connection with the audit of our financial statements as of and for the years ended December 31, 2016 and 2015, we identified material weaknesses in our internal control over financial reporting, as defined in the standards established by the Public Company Accounting Oversight Board of the United States. Although we enhanced our internal controls, processes and related documentation necessary to remediate our material weakness and to perform the evaluation needed to comply with Section 404, and have concluded that we do not currently have any material weaknesses, there can be no assurances that we will not have any material weaknesses in the future.

When we cease to be an “emerging growth company” under the federal securities laws, our auditors will be required to express an opinion on the effectiveness of our internal controls. If we are unable to confirm that our internal control over financial reporting is effective, or if our auditors are unable to express an opinion on the effectiveness of our internal controls, we could lose investor confidence in the accuracy and completeness of our financial reports, which could cause the price of our common stock to decline.

The issuance of new accounting standards or future interpretations of existing accounting standards could adversely affect our operating results.

 

We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America, or GAAP. A change in those principles could have a significant effect on our reported results and might affect our reporting of transactions completed before a change is announced. GAAP is issued and subject to interpretation by the Financial Accounting Standards Board, the SEC and various other bodies formed to promulgate and interpret accounting principles. A change in these principles or interpretations could have a significant effect on our reported financial results, and could affect the reporting of transactions completed before the announcement of a change. For example, beginning with our first quarter of 2018, we will adopt the new revenue recognition standard, which will change the way we recognize revenue. We do not expect the adoption of the standard to have a material impact on our quarterly and/or annual statement of operations, however the exact impact will be dependent on facts and circumstances that could vary from quarter to quarter. The issuance of new accounting standards or future interpretations of existing accounting standards, or changes in our business practices or estimates, could result in future changes in our revenue recognition or other accounting policies that could have a material adverse effect on our results of operations.

 

53


 

Table of Contents

Regulations related to “conflict minerals” may force us to incur additional expenses, may make our supply chain more complex and may result in damage to our reputation with customers.

 

Pursuant to the Dodd-Frank Act, the SEC has adopted requirements for companies that use certain minerals and metals, known as conflict minerals, in their products, whether or not these products are manufactured by third parties. These requirements will require companies to perform diligence and disclose and report whether or not such minerals originate from the Democratic Republic of Congo and adjoining countries. The implementation of these requirements could adversely affect the sourcing, availability and pricing of minerals used in the manufacture of our products, and affect our costs and relationships with customers, distributors and suppliers as we must obtain additional information from them to ensure our compliance with the disclosure requirement. In addition, we will incur additional costs to comply with the disclosure requirements, including costs related to determining the source of any of the relevant minerals and metals used in our products. Since our supply chain is complex, we may not be able to sufficiently verify the origins for these minerals and metals used in our products through the due diligence procedures that we implement, which may harm our reputation. In such event, we may also face difficulties in satisfying customers who require that all of the components of our products are certified as conflict mineral free and these customers may discontinue, or materially reduce, purchases of our products, which could result in a material adverse effect on our results of operations and our financial condition may be adversely affected.

 

Risks Related to Our Common Stock

 

An active trading market may not be sustained.

 

Prior to the initial public offering of our common stock in October 2016, there was no public market for our common stock. Although our stock is currently traded on the Nasdaq Stock Market, an active trading market may not be sustained. The lack of an active market may impair the value of your shares and your ability to sell your shares at the time you wish to sell them. An inactive market may also impair our ability to both raise capital by selling shares and acquire other complementary products, technologies or businesses by using our shares as consideration.

 

We expect that the price of our common stock will fluctuate substantially.

 

The market price of our common stock is likely to be highly volatile and may fluctuate substantially due to many factors, including:

 

    the introduction of new products or product enhancements by us or others in our industry;

 

    disputes or other developments with respect to our or others’ intellectual property rights;

 

    product liability claims or other litigation;

 

    quarterly variations in our results of operations or those of others in our industry;

 

    sales of large blocks of our common stock, including sales by our executive officers and directors;

 

    changes in earnings estimates or recommendations by securities analysts; and

    general market conditions and other factors, including factors unrelated to our operating performance or the operating performance of our competitors.

 

In recent years, the stock markets generally have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may significantly affect the market price of our common stock, regardless of our actual operating performance. These fluctuations may be even more pronounced in the trading market for our common stock.

 

In addition, in the past, class action litigation has often been instituted against companies whose securities have experienced periods of volatility in market price, or for other reasons. Securities litigation brought against us following volatility in our stock price or otherwise, regardless of the merit or ultimate results of such litigation, could result in substantial costs, which would hurt our financial condition and operating results and divert management s attention and resources from our business.

54


 

Table of Contents

 

These and other factors may make the price of our stock volatile and subject to unexpected fluctuation.

 

Securities analysts may not publish favorable research or reports about our business or may publish no information at all, which could cause our stock price or trading volume to decline.

 

The trading market for our common stock will be influenced to some extent by the research and reports that industry or financial analysts publish about us and our business. We do not control these analysts. As a newly public company, we may be slow to attract research coverage and the analysts who publish information about our common stock will have had relatively little experience with our company or industry, which could affect their ability to accurately forecast our results and could make it more likely that we fail to meet their estimates. In the event we obtain securities or industry analyst coverage, if any of the analysts who cover us provide inaccurate or unfavorable research or issue an adverse opinion regarding our stock price, our stock price could decline. If one or more of these analysts cease coverage of our company or fail to publish reports covering us regularly, we could lose visibility in the market, which in turn could cause our stock price or trading volume to decline.

 

We are an “emerging growth company” and we cannot be certain if the reduced disclosure requirements applicable to “emerging growth companies” will make our common stock less attractive to investors.

 

We are an emerging growth company, as defined in the JOBS Act, and we may take advantage of certain exemptions and relief from various reporting requirements that are applicable to other public companies that are not emerging growth companies. In particular, while we are an emerging growth company (1) we will not be required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, (2) we will be exempt from any rules that may be adopted by the Public Company Accounting Oversight Board requiring mandatory audit firm rotations or a supplement to the auditor s report on financial statements, (3) we will be subject to reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and (4) we will not be required to hold nonbinding advisory votes on executive compensation or stockholder approval of any golden parachute payments not previously approved.

 

We may remain an emerging growth company until as late as December 31, 2021, the fiscal year-end following the fifth anniversary of the completion of our initial public offering, though we may cease to be an emerging growth company earlier under certain circumstances, including (1) if the market value of our common stock that is held by nonaffiliates exceeds $700 million as of any June 30, in which case we would cease to be an emerging growth company as of the following December 31, or (2) if our gross revenue exceeds $1.07 billion in any fiscal year.

 

Investors may find our common stock less attractive if we rely on the exemptions and relief granted by the JOBS Act. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may decline or become more volatile.

 

Sales of a substantial number of shares of our common stock in the public market by our existing stockholders could cause our stock price to fall.  

 

Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that sales may have on the prevailing market price of our common stock.

 

Our directors, officers and principal stockholders have significant voting power and may take actions that may not be in the best interests of our other stockholders.

 

Our officers, directors and principal stockholders each holding more than 5% of our common stock, collectively, control a significant percentage of our outstanding common stock. As a result, these stockholders, if they act together, will be able to control the management and affairs of our company and most matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may have the effect of delaying or preventing a change of control and might adversely affect the market price of our common stock. This concentration of ownership may not be in the best interests of our other stockholders.

 

55


 

Table of Contents

Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.

 

We are subject to the periodic reporting requirements of the Exchange Act. We have designed our disclosure controls and procedures to provide reasonable assurance that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

 

These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected.

 

Provisions in our corporate charter documents and under Delaware law could make an acquisition of us more difficult and may prevent attempts by our stockholders to replace or remove our current management.

 

Provisions in our amended and restated certificate of incorporation and our amended and restated bylaws may discourage, delay or prevent a merger, acquisition or other change in control of us that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors. Because our board of directors is responsible for appointing the members of our management team, these provisions could in turn affect any attempt by our stockholders to replace current members of our management team. Among others, these provisions include that:

 

    our board of directors has the right to expand the size of our board of directors and to elect directors to fill a vacancy created by the expansion of the board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;

 

    our stockholders may not act by written consent or call special stockholders’ meetings; as a result, a holder, or holders, controlling a majority of our capital stock would not be able to take certain actions other than at annual stockholders’ meetings or special stockholders’ meetings called by the board of directors, the chairman of the board, the chief executive officer or the president;

 

    our certificate of incorporation prohibits cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;

 

    the affirmative vote of holders of at least 66-2/3% of the voting power of all of the then outstanding shares of voting stock, voting as a single class, will be required (a) to amend certain provisions of our certificate of incorporation, including provisions relating to the size of the board, removal of directors, special meetings, actions by written consent and cumulative voting and (b) to amend or repeal our bylaws, although our bylaws may be amended by a simple majority vote of our board of directors;

 

    stockholders must provide advance notice and additional disclosures to nominate individuals for election to the board of directors or to propose matters that can be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror’s own slate of directors or otherwise attempting to obtain control of our company; and

 

    our board of directors may issue, without stockholder approval, shares of undesignated preferred stock; the ability to issue undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to acquire us.

 

Moreover, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which prohibits a person who owns in excess of 15% of our outstanding voting

56


 

Table of Contents

stock from merging or combining with us for a period of three years after the date of the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner.  

 

Item 2. Recent Sales of Unregistered Securitie s and Use of Proceeds

 

Recent Sales of Unregistered Securities

 

On July 6, 2018, we issued a warrant to Silicon Valley Bank to purchase 9,375 shares of our common stock at an exercise price of $8.91 per share. The warrant can be exercised at any time and expires five years after the date of issuance. The warrant was issued in connection with an amendment to our Loan and Security Agreement with Silicon Valley Bank. The warrant was issued in reliance on Section 4(2) of the Securities Act of 1933, as amended, in that it was issued to a single accredited investor. 

 

Item 3. Defaults Upon Senior Securities .

 

None.

 

Item 4. Mine Safety Disclosures .

 

Not applicable.

 

Item 5. Other Information .

 

None.

 

 

Item 6. Exhibit s

 

57


 

Table of Contents

EXHIBIT INDE X

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Incorporation By Reference

 

 

Exhibit
Number

    

Description

    

Form

    

SEC File No.

    

Exhibit/
Reference

    

Filing Date

 

 

 

 

 

 

 

 

 

 

 

3.1

 

Amended and Restated Certificate of Incorporation.

 

8-K

 

001-37900

 

3.1

 

10/13/2016

 

 

 

 

 

 

 

 

 

 

 

3.2

 

Bylaws.

 

S-1

 

333-213569

 

3.6

 

9/09/2016

 

 

 

 

 

 

 

 

 

 

 

4.1

 

Form of Common Stock Certificate of the Company.

 

S-1

 

333-213569

 

4.1

 

9/09/2016

 

 

 

 

 

 

 

 

 

 

 

4.2*

 

Warrant to Purchase Common Stock, dated as of July 6, 2018, between the Company and Silicon Valley Bank

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.3

 

Reference is made to Exhibits 3.1 and 3.2.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.1

 

Everspin Technologies, Inc. Amended and Restated 2016 Equity Incentive Plan

 

8-K

 

001-37900

 

10.1

 

5/22/2018

 

 

 

 

 

 

 

 

 

 

 

10.2*

 

First Amendment to Loan and Security Agreement, dated as of July 6, 2018, between the Company and Silicon Valley Bank

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.3*

 

Separation Agreement, dated June 6, 2018 between Everspin Technologies, Inc. and Patrick Patla

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.4*

 

Lease Termination Agreement, dated as of April 12, 2018, by and between Everspin Technologies, Inc. and Jutland 4141 Investments, Ltd.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31.1*

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31.2*

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32.1**

 

Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.INS*

 

XBRL Instance Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.SCH*

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.CAL*

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.DEF*

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.LAB*

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.PRE*

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 


*     Filed herewith.

**   Furnished herewith.

 

58


 

SIGNATURE S

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

 

Everspin Technologies, Inc.

 

 

Date: August 8, 2018

By:

/s/ Kevin Conley

 

 

Kevin Conley

 

 

President and Chief Executive Officer

 

 

(Principal Executive Officer ) and Director

 

 

 

 

Everspin Technologies, Inc.

 

 

Date: August 8, 2018

By:

/s/ Jeffrey Winzeler

 

 

Jeffrey Winzeler

 

 

Chief Financial Officer

 

 

(Principal Financial and Accounting Officer)

 

59


Exhibit 4.2

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ ACT ”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.

WARRANT TO PURCHASE COMMON STOCK

Company:                   EVERSPIN TECHNOLOGIES, INC., a Delaware corporation

Number of Shares:    9,375 shares of Common Stock

Warrant Price:          8.91 1

Issue Date:                 July 06, 2018

Expiration Date:       July 06, 2023                 See also Section 5.1(b).

Credit Facility:         This Warrant to Purchase Common Stock (“ Warrant ”) is issued in connection with that certain Loan and Security Agreement dated as of May 4, 2017, between Silicon Valley Bank and the Company (the “ Loan Agreement ”).

THIS WARRANT CERTIFIES THAT, for good and valuable consideration, SILICON VALLEY BANK (together with any successor or permitted assignee or transferee of this Warrant or of any shares issued upon exercise hereof, “ Holder ”) is entitled to purchase the number of fully paid and non-assessable shares (the “ Shares ”) of the above-stated common stock (the “ Common Stock ”) of the above-named company (the “ Company ”) at the above-stated Warrant Price, all as set forth above and as adjusted pursuant to Section 2 of this Warrant, subject to the provisions and upon the terms and conditions set forth in this Warrant. Reference is made to Section 5.4 of this Warrant whereby Silicon Valley Bank shall transfer this Warrant to its parent company, SVB Financial Group.

SECTION 1.  EXERCISE .

1.1        Method of Exercise .  Holder may at any time and from time to time exercise this Warrant, in whole or in part, by delivering to the Company the original of this Warrant together with a duly executed Notice of Exercise in substantially the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to a cashless exercise set forth in Section 1.2, a check, wire transfer of same-day funds (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate Warrant Price for the Shares being purchased.


1          The average closing price for the previous five (5) consecutive days of trading.


 

1.2        Cashless Exercise .  On any exercise of this Warrant, in lieu of payment of the aggregate Warrant Price in the manner as specified in Section 1.1 above, but otherwise in accordance with the requirements of Section 1.1, Holder may elect to receive Shares equal to the value of this Warrant, or portion hereof as to which this Warrant is being exercised.  Thereupon, the Company shall issue to the Holder such number of fully paid and non-assessable Shares as are computed using the following formula:

 

 

 

 

 

 

 

 

    

X =

Y(A-B)/A

 

 

 

 

 

where:

 

X =

the number of Shares to be issued to the Holder;

 

 

 

 

 

 

 

 

Y =

the number of Shares with respect to which this Warrant is being exercised (inclusive of the Shares surrendered to the Company in payment of the aggregate Warrant Price);

 

 

 

 

 

 

 

 

A =

the Fair Market Value (as determined pursuant to Section 1.3 below) of one Share; and

 

 

 

 

 

 

 

 

B =

the Warrant Price.

 

1.3        Fair Market Value .  If the Company’s Common Stock is then traded or quoted on a nationally recognized securities exchange, inter-dealer quotation system or over-the-counter market (a “ Trading Market ”), the fair market value of a Share shall be the closing price or last sale price of a share of Common Stock reported for the Business Day immediately before the date on which Holder delivers this Warrant together with its Notice of Exercise to the Company.  If the Company’s Common Stock is not traded in a Trading Market, the Board of Directors of the Company shall determine the fair market value of a Share in its reasonable good faith judgment.

1.4        Delivery of Certificate and New Warrant .  Within a reasonable time after Holder exercises this Warrant in the manner set forth in Section 1.1 or 1.2 above, the Company shall deliver to Holder a certificate representing the Shares issued to Holder upon such exercise and, if this Warrant has not been fully exercised and has not expired, a new warrant of like tenor representing the Shares not so acquired.

1.5        Replacement of Warrant .  On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form, substance and amount to the Company or, in the case of mutilation, on surrender of this Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of this Warrant, a new warrant of like tenor and amount.

1.6        Treatment of Warrant Upon Acquisition of Company .

(a)         Acquisition .  For the purpose of this Warrant, “ Acquisition ” means any transaction or series of related transactions involving:  (i) the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company; (ii) any merger or consolidation of the Company into or with another person or entity (other than a merger or consolidation effected


 

exclusively to change the Company’s domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity as such immediately prior to such merger, consolidation or reorganization, own less than a majority of the Company’s (or the surviving or successor entity’s) outstanding voting power immediately after such merger, consolidation or reorganization; or (iii) any sale or other transfer by the stockholders of the Company of shares representing at least a majority of the Company’s then-total outstanding combined voting power.

(b)         Treatment of Warrant at Acquisition .  In the event of an Acquisition in which the consideration to be received by the Company’s stockholders consists solely of cash, solely of Marketable Securities or a combination of cash and Marketable Securities (a “ Cash/Public Acquisition ”), and the fair market value of one Share as determined in accordance with Section 1.3 above would be greater than the Warrant Price in effect on such date immediately prior to such Cash/Public Acquisition, and Holder has not exercised this Warrant pursuant to Section 1.1 above as to all Shares, then this Warrant shall automatically be deemed to be Cashless Exercised pursuant to Section 1.2 above as to all Shares effective immediately prior to and contingent upon the consummation of a Cash/Public Acquisition.  In connection with such Cashless Exercise, Holder shall be deemed to have restated each of the representations and warranties in Section 4 of the Warrant as the date thereof and the Company shall promptly notify the Holder of the number of Shares (or such other securities) issued upon exercise.  In the event of a Cash/Public Acquisition where the fair market value of one Share as determined in accordance with Section 1.3 above would be less than the Warrant Price in effect immediately prior to such Cash/Public Acquisition, then this Warrant will expire immediately prior to the consummation of such Cash/Public Acquisition.

(c)        Upon the closing of any Acquisition other than a Cash/Public Acquisition defined above, the acquiring, surviving or successor entity shall assume the obligations of this Warrant, and this Warrant shall thereafter be exercisable for the same securities and/or other property as would have been paid for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on and as of the closing of such Acquisition, subject to further adjustment from time to time in accordance with the provisions of this Warrant.

(d)        As used in this Warrant, “ Marketable Securities ” means securities meeting all of the following requirements:  (i) the issuer thereof is then subject to the reporting requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), and is then current in its filing of all required reports and other information under the Act and the Exchange Act; (ii) the class and series of shares or other security of the issuer that would be received by Holder in connection with the Acquisition were Holder to exercise this Warrant on or prior to the closing thereof is then traded in Trading Market; and (iii) following the closing of such Acquisition, Holder would not be restricted from publicly re-selling all of the issuer’s shares and/or other securities that would be received by Holder in such Acquisition were Holder to exercise or convert this Warrant in full on or prior to the closing of such Acquisition, except to the extent that any such restriction (x) arises solely under federal or state securities laws, rules or regulations, and (y) does not extend beyond six (6) months from the closing of such Acquisition.


 

SECTION 2.  ADJUSTMENTS TO THE SHARES AND WARRANT PRICE .

2.1        Stock Dividends, Splits, Etc.  If the Company declares or pays a dividend or distribution on the outstanding shares of the Common Stock payable in securities or property (other than cash), then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without additional cost to Holder, the total number and kind of securities and property which Holder would have received had Holder owned the Shares of record as of the date the dividend or distribution occurred.  If the Company subdivides the outstanding shares of the Common Stock by reclassification or otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased.  If the outstanding shares of the Common Stock are combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately decreased.

2.2        Reclassification, Exchange, Combinations or Substitution .  Upon any event whereby all of the outstanding shares of the Common Stock are reclassified, exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from and after the consummation of such event, this Warrant will be exercisable for the number, class and series of Company securities that Holder would have received had the Shares been outstanding on and as of the consummation of such event, and subject to further adjustment thereafter from time to time in accordance with the provisions of this Warrant.  The provisions of this Section 2.2 shall similarly apply to successive reclassifications, exchanges, combinations substitutions, replacements or other similar events.

2.3        Intentionally Omitted .

2.4        Intentionally Omitted .

2.5        No Fractional Share .  No fractional Share shall be issuable upon exercise of this Warrant and the number of Shares to be issued shall be rounded down to the nearest whole Share.  If a fractional Share interest arises upon any exercise of the Warrant, the Company shall eliminate such fractional Share interest by paying Holder in cash the amount computed by multiplying the fractional interest by (i) the fair market value (as determined in accordance with Section 1.3 above) of a full Share, less (ii) the then-effective Warrant Price.

2.6        Notice/Certificate as to Adjustments .  Upon each adjustment of the Warrant Price, Common Stock and/or number of Shares, the Company, at the Company’s expense, shall notify Holder in writing within a reasonable time setting forth the adjustments to the Warrant Price, class and/or number of Shares and facts upon which such adjustment is based.  The Company shall, upon written request from Holder, furnish Holder with a certificate of its Chief Financial Officer, including computations of such adjustment and the Warrant Price, class and number of Shares in effect upon the date of such adjustment.


 

SECTION 3.  REPRESENTATIONS AND COVENANTS OF THE COMPANY .

3.1        Representations and Warranties .  The Company represents and warrants to, and agrees with, the Holder as follows:

(a)        The initial Warrant Price referenced on the first page of this Warrant is not greater than the price per share at which shares of Company Common Stock or options to purchase shares of Company Common Stock were issued immediately prior to the Issue Date hereof.

(b)        All Shares which may be issued upon the exercise of this Warrant, shall, upon issuance, be duly authorized, validly issued, fully paid and non-assessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state securities laws.  The Company covenants that it shall at all times cause to be reserved and kept available out of its authorized and unissued capital stock such number of securities as will be sufficient to permit the exercise in full of this Warrant.

(c)        The Company’s capitalization table attached hereto as Schedule 1 is true and complete, in all material respects, as of the Issue Date.

3.2        Notice of Certain Events .  If the Company proposes at any time to:

(a)        declare any dividend or distribution upon the outstanding shares of the Company’s stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend;

(b)        offer for subscription or sale pro rata to the holders of the outstanding shares any additional shares of any class or series of the Company’s stock (other than pursuant to contractual pre-emptive rights);

(c)        effect any reclassification, exchange, combination, substitution, reorganization or recapitalization of the outstanding shares of the Common Stock; or

(d)        effect an Acquisition or to liquidate, dissolve or wind up.

then, in connection with each such event, the Company shall give Holder:

(1)        in the case of the matters referred to in (a) and (b) above, at least seven (7) Business Days prior written notice of the earlier to occur of the effective date thereof or the date on which a record will be taken for such dividend, distribution, or subscription rights (and specifying the date on which the holders of outstanding shares of the Common Stock will be entitled thereto) or for determining rights to vote, if any, and

(2)        in the case of the matters referred to in (c) and (d) above at least seven (7) Business Days prior written notice of the date when the same will take place (and specifying the date on which the holders of outstanding shares of the Class will be entitled to exchange their shares for the securities or other property deliverable upon the occurrence of such event and such reasonable information as


 

Holder may reasonably require regarding the treatment of this Warrant in connection with such event giving rise to the notice).

Company will also provide information requested by Holder that is reasonably necessary to enable Holder to comply with Holder’s accounting or reporting requirements.

SECTION 4.  REPRESENTATIONS, WARRANTIES OF THE HOLDER .

The Holder represents and warrants to the Company as follows:

4.1        Purchase for Own Account .  This Warrant and the Shares to be acquired upon exercise of this Warrant by Holder are being acquired for investment for Holder’s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Act.  Holder also represents that it has not been formed for the specific purpose of acquiring this Warrant or the Shares.

4.2        Disclosure of Information .  Holder is aware of the Company’s business affairs and financial condition and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and its underlying securities.  Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access.

4.3        Investment Experience .  Holder understands that the purchase of this Warrant and its underlying securities involves substantial risk.  Holder has experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk of such Holder’s investment in this Warrant and its underlying securities and has such knowledge and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities and/or has a preexisting personal or business relationship with the Company and certain of its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial circumstances of such persons.

4.4        Accredited Investor Status .  Holder is an “accredited investor” within the meaning of Regulation D promulgated under the Act.

4.5        The Act .  Holder understands that this Warrant and the Shares issuable upon exercise hereof have not been registered under the Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent as expressed herein.  Holder understands that this Warrant and the Shares issued upon any exercise hereof must be held indefinitely unless subsequently registered under the Act and qualified under applicable state securities laws, or unless exemption from such registration and qualification are otherwise available.  Holder is aware of the provisions of Rule 144 promulgated under the Act.


 

4.6        Market Stand-off Agreement .  The Holder agrees that the Shares shall be subject to the Market Standoff provisions in Section 2.11 of the Investor Rights Agreement or similar agreement.

4.7        No Voting Rights .  Holder, as a Holder of this Warrant, will not have any voting rights until the exercise of this Warrant.

SECTION 5.  MISCELLANEOUS .

5.1        Term and Automatic Conversion Upon Expiration .

(a)         Term .  Subject to the provisions of Section 1.6 above, this Warrant is exercisable in whole or in part at any time and from time to time on or before 6:00 PM, Pacific time, on the Expiration Date and shall be void thereafter.

(b)         Automatic Cashless Exercise upon Expiration .  In the event that, upon the Expiration Date, the fair market value of one Share (or other security issuable upon the exercise hereof) as determined in accordance with Section 1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall automatically be deemed on and as of such date to be exercised pursuant to Section 1.2 above as to all Shares (or such other securities) for which it shall not previously have been exercised, and the Company shall, within a reasonable time, deliver a certificate representing the Shares (or such other securities) issued upon such exercise to Holder.

5.2        Legends .  The Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) shall be imprinted with a legend in substantially the following form:

THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ ACT ”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT TO PURCHASE COMMON STOCK ISSUED BY THE ISSUER TO SILICON VALLEY BANK DATED JUNE [__], 2018, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.

5.3        Compliance with Securities Laws on Transfer .  This Warrant and the Shares issuable upon exercise of this Warrant (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part except in compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the Company).  The Company shall not require Holder to provide an opinion of counsel if the transfer is to SVB Financial Group (Silicon Valley Bank’s parent company) or any other affiliate of Holder, provided that any such transferee is an “accredited investor” as defined in Regulation D promulgated under the Act.


 

Additionally, the Company shall also not require an opinion of counsel if there is no material question as to the availability of Rule 144 promulgated under the Act.

5.4        Transfer Procedure .  After receipt by Silicon Valley Bank of the executed Warrant, Silicon Valley Bank will transfer all of this Warrant to its parent company, SVB Financial Group.  By its acceptance of this Warrant, SVB Financial Group hereby makes to the Company each of the representations and warranties set forth in Section 4 hereof and agrees to be bound by all of the terms and conditions of this Warrant as if the original Holder hereof.  Subject to the provisions of Section 5.3 and upon providing the Company with written notice, SVB Financial Group and any subsequent Holder may transfer all or part of this Warrant or the Shares issuable upon exercise of this Warrant (or the securities issuable directly or indirectly, upon conversion of the Shares, if any) to any transferee , provided, however, in connection with any such transfer, SVB Financial Group or any subsequent Holder will give the Company notice of the portion of the Warrant being transferred with the name, address and taxpayer identification number of the transferee and Holder will surrender this Warrant to the Company for reissuance to the transferee(s) (and Holder if applicable); and provided further, that any subsequent transferee other than SVB Financial Group shall agree in writing with the Company to be bound by all of the terms and conditions of this Warrant.

5.5        Notices .  All notices and other communications hereunder from the Company to the Holder, or vice versa, shall be deemed delivered and effective (i) when given personally, (ii)on the third (3 rd ) Business Day after being mailed by first-class registered or certified mail, postage prepaid, (iii) upon actual receipt if given by facsimile or electronic mail and such receipt is confirmed in writing by the recipient, or (iv) on the first Business Day following delivery to a reliable overnight courier service, courier fee prepaid, in any case at such address as may have been furnished to the Company or Holder, as the case may be, in writing by the Company or such Holder from time to time in accordance with the provisions of this Section 5.5.  All notices to Holder shall be addressed as follows until the Company receives notice of a change of address in connection with a transfer or otherwise:

SVB Financial Group

Attn:  Treasury Department

3003 Tasman Drive, HC 215

Santa Clara, CA 95054

Telephone: (408) 654-7400

Facsimile: (408) 988-8317

Email address:  derivatives@svb.com


 

Notice to the Company shall be addressed as follows until Holder receives notice of a change in address:

Everspin Technologies, Inc.

Attn:  Jeff Winzeler, CFO

1347 North Alma School Road, Suite 220

Chandler, Arizona 85224

Email: jeff.winzeler@everspin.com

5.6        Waiver .  This Warrant and any term hereof may be changed, waived, discharged or terminated (either generally or in a particular instance and either retroactively or prospectively) only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought.

5.7        Attorney’s Fees .  In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees.

5.8        Counterparts; Facsimile/Electronic Signatures .  This Warrant may be executed in counterparts, all of which together shall constitute one and the same agreement.  Any signature page delivered electronically or by facsimile shall be binding to the same extent as an original signature page with regards to any agreement subject to the terms hereof or any amendment thereto.

5.9        Governing Law .  This Warrant shall be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles regarding conflicts of law.

5.10      Headings .  The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision of this Warrant.

5.11      Business Days .  “ Business Day ” is any day that is not a Saturday, Sunday or a day on which Silicon Valley Bank is closed.

[Remainder of page left blank intentionally]

[Signature page follows]


 

IN WITNESS WHEREOF, the parties have caused this Warrant to be executed by their duly authorized representatives effective as of the Issue Date written above.

 

“HOLDER”

    

“COMPANY”

 

SILICON VALLEY BANK

 

EVERSPIN TECHNOLOGIES, INC.

By:

/s/ Chris Goodwin

 

/s/ Jeff Winzeler

Name:

Chris Goodwin

 

Jeff Winzeler

Title

VP

 

Chief Financial Officer

 


 

 

APPENDIX 1

NOTICE OF EXERCISE

1.         The undersigned Holder hereby exercises its right to purchase ___________ shares of the Common Stock of __________________ (the “ Company ”) in accordance with the attached Warrant To Purchase Common Stock, and tenders payment of the aggregate Warrant Price for such shares as follows:

[    ]      check in the amount of $________ payable to order of the Company enclosed herewith

[    ]      Wire transfer of immediately available funds to the Company’s account

[    ]      Cashless Exercise pursuant to Section 1.2 of the Warrant

[    ]      Other [Describe] __________________________________________

2.         Please issue a certificate or certificates representing the Shares in the name specified below:

___________________________________________

Holder’s Name

___________________________________________

___________________________________________

(Address)

3.         By its execution below and for the benefit of the Company, Holder hereby restates each of the representations and warranties in Section 4 of the Warrant to Purchase Common Stock as of the date hereof.

 

    

HOLDER:

 

 

 

 

 

 

 

 

 

 

 

By:

 

 

 

 

 

 

 

Name:

 

 

 

 

 

 

 

Title:

 

 

 

 

 

 

 

(Date):

 

 


Exhibit 10.2

FIRST AMENDMENT TO

LOAN AND SECURITY AGREEMENT

THIS FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “ Amendment ”) is entered into this 6 th day of July, 2018, by and between SILICON VALLEY BANK, a California corporation (“ Bank ”), and EVERSPIN TECHNOLOGIES, INC., a Delaware corporation (“ Borrower ”).

RECITALS

A.  Bank and Borrower have entered into that certain Loan and Security Agreement dated as of May 4, 2017 (as the same may from time to time be amended, modified, supplemented or restated, the “ Loan Agreement ”).

B.   Bank has extended credit to Borrower for the purposes permitted in the Loan Agreement.

C.   Borrower has requested that Bank amend the Loan Agreement to make certain revisions to the Loan Agreement as more fully set forth herein.

D.  Bank has agreed to amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

1.         Definitions.  Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement.

2.         Amendments to Loan Agreement.

2.1       Section 2.1.1  ( Term Loan Advance ). Section 2.1.1(c) of the Loan Agreement is hereby deleted in its entirety and replaced with the following:

(c)         Prepayment .

(i)          Voluntary Prepayment .  Borrower shall have the option to prepay all or any portion of the Term Loan Advances advanced by Bank under this Agreement, provided Borrower (A) delivers written notice to Bank of its election to prepay the Term Loan Advances at least ten (10) days prior to such prepayment, and (B) pays, on the date of such prepayment (1) all accrued and unpaid interest with respect to such Term Loan Advances being prepaid through the date the prepayment is made, plus (2) all unpaid


 

principal with respect to such Term Loan Advances being prepaid, plus (3) the Final Payment, plus (4) the Prepayment Fee, plus (5) all other sums, if any, that shall have become due and payable hereunder in connection with the Term Loan Advances, including interest at the Default Rate with respect to any past due amounts.

(ii)        Mandatory Prepayment Upon an Acceleration .  If the Term Loan Advance is accelerated following the occurrence of an Event of Default or otherwise, Borrower shall immediately pay to Bank an amount equal to the sum of (A) all accrued and unpaid interest with respect to the Term Loan Advance through the date the prepayment is made, plus (B) all outstanding principal with respect to the Term Loan Advance, plus (C) the Final Payment, plus (D) the Prepayment Fee, plus (E) all other sums, if any, that shall have become due and payable hereunder in connection with the Term Loan Advance.

2.2       Section 2.3  ( Fees ).  Section 2.3(e) is hereby inserted in the Loan Agreement immediately following Section 2.3(d) of the Loan Agreement:

(e)         Prepayment Fee .  The Prepayment Fee, when due hereunder.

2.3       Section 6.2  ( Financial Statements, Reports, Certificates ).  Section 6.2(i) is hereby inserted in the Loan Agreement immediately following Section 6.2(h) of the Loan Agreement:

(i)          Beneficial Ownership Information .  Borrower shall provide Bank with prompt written notice of any changes to the beneficial ownership information set out in the Beneficial Ownership Information Disclosure Form.  Borrower understands and acknowledges that Bank relies on such true, accurate and up-to-date beneficial ownership information to meet Bank’s regulatory obligations to obtain, verify and record information about the beneficial owners of its legal entity customers.

2.4       Section 6.7  ( Financial Covenants ).  Section 6.7 of the Loan Agreement is hereby deleted in its entirety and replaced with the following:

6.7       Financial Covenants .  Maintain at all times, subject to periodic reporting as of the last day of each month, unless otherwise noted, on a consolidated basis with respect to Borrower and its Subsidiaries:

(a)         Liquidity Ratio .  As of the last day of each month, a Liquidity Ratio of not less than (i) 1.25:1.00 for each month prior to Borrower achieving the Extension Milestone, and (ii) 1.50:1.00 for each month after Borrower achieves the Extension Milestone.

(b)         Performance to Plan .  As of the last day of each month, Borrower’s TFS Revenue for such month calculated on a cumulative fiscal year to date basis, shall be equal to or greater than the amount set forth for such month on Schedule 1 of the Compliance Certificate.


 

Commencing with the month ending January 31, 2020, the Performance to Plan financial covenant set forth in this Section shall be calculated based on the annual financial projections approved by Borrower’s  Board of Directors and delivered and accepted by Bank for the 2020 fiscal year (the “ 2020 Performance to Plan Financial Covenant ”).  Borrower and Bank shall negotiate in good faith to reach an agreement on such 2020 Performance to Plan Financial Covenant and, upon reaching such agreement, will execute and deliver to Bank an amendment to this Agreement which provides the terms for the 2020 Performance to Plan Financial Covenant no later than February 28, 2020.

2.5       Section 6.10 (Access to Collateral; Books and Records) .  The last paragraph of Section 6.10 of the Loan Agreement is hereby deleted in its entirety and replaced with the following:

“In the event Borrower and Bank schedule an audit more than eight (8) days in advance, and Borrower cancels or seeks to or reschedules the audit with less than eight (8) days written notice to Bank, then (without limiting any of Bank’s rights or remedies) Borrower shall pay Bank a fee of Two Thousand Dollars ($2,000) plus any out-of-pocket expenses incurred by Bank to compensate Bank for the anticipated costs and expenses of the cancellation or rescheduling.”

2.6       Section 12.2  ( Successors and Assigns ).  Section 12.2 of the Loan Agreement is hereby deleted in its entirety and replaced with the following:

12.2     Successors and Assigns .  This Agreement binds and is for the benefit of the successors and permitted assigns of each party.  Borrower may not assign this Agreement or any rights or obligations under it without Bank’s prior written consent (which may be granted or withheld in Bank’s discretion).  Bank has the right, without the consent of or notice to Borrower, to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, Bank’s obligations, rights, and benefits under this Agreement and the other Loan Documents (other than the Warrant, as to which assignment, transfer and other such actions are governed by the terms thereof).

2.7       Section 13  ( Definitions ).

(a)        The following terms and their respective definitions set forth in Section 13.1 of the Loan Agreement are hereby deleted in their entirety and replaced with the following:

Applicable Number ” means (a) twenty-four (24) if Borrower does not achieve the Extension Milestone, and (b) thirty-six (36) if Borrower achieves the Extension Milestone.

Final Payment Percentage ” is, for each Term Loan Advance, equal to seven percent (7.00%).

Interest-Only Period ” is the period of time from the Effective Date through December 31, 2018.


 

Loan Documents ” are, collectively, this Agreement and any schedules, exhibits, certificates, notices, and any other documents related to this Agreement, any Bank Services Agreement, the Warrant, any subordination agreement, any note, or notes or guaranties executed by Borrower or any guarantor, and any other present or future agreement by Borrower and/or any guarantor with or for the benefit of Bank in connection with this Agreement or Bank Services, all as amended, restated, or otherwise modified.

Obligations ” are Borrower’s obligations to pay when due any debts, principal, interest, fees, Bank Expenses, the Final Payment, the Prepayment Fee, and other amounts Borrower owes Bank now or later, whether under this Agreement, the other Loan Documents, or otherwise, including, without limitation, all obligations relating to letters of credit (including reimbursement obligations for drawn and undrawn letters of credit), cash management services, and foreign exchange contracts, if any, and including interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower assigned to Bank, and to perform Borrower’s duties under the Loan Documents.

TFS Revenue ” is the aggregate net revenue (gross revenue minus discounts and returns) received by Borrower from (a) the sale of Borrower’s Sensor, Toggle, and Foundry products, (b) any licensing of Borrower’s products, and (c) any non-recurring engineering services revenue received by Borrower.  Evidence of such net revenue shall be received and approved by Bank in Bank’s sole and absolute discretion.

(b)        The following new defined terms are hereby inserted alphabetically in Section 13.1 of the Loan Agreement:

Beneficial Ownership Information Disclosure Form ” means the form attached hereto as Exhibit E .

EBIDA ” shall mean (a) Net Income, plus (b) Interest Expense, plus (c) to the extent deducted in the calculation of Net Income, depreciation expense and amortization expense.

Extension Milestone ” is the date on which Bank receives and approves evidence satisfactory to Bank, in Bank’s sole and absolute discretion, on or before the Conversion Date, that for the fiscal year ended December 31, 2018, (i) Borrower has received gross revenue of at least Fifty-Four Million Eight Hundred Ninety-Three Thousand Eight Hundred Dollars ($54,893,800), and (ii) Borrower has achieved an EBIDA loss of no greater than Seven Million Three Hundred Sixty-Seven Thousand Eighty-Eight Dollars ($7,367,088).

First Amendment Effective Date ” is July 6, 2018.

Interest Expense ” means for any fiscal period, interest expense (whether cash or non-cash) determined in accordance with GAAP for the relevant period ending on such date, including, in any event, interest expense with respect to any Credit Extension and other Indebtedness of Borrower, including, without limitation or duplication, all commissions, discounts, or related amortization and other fees and charges with respect to letters of credit and bankers’ acceptance financing and the net costs associated with interest


 

rate swap, cap, and similar arrangements, and the interest portion of any deferred payment obligation (including leases of all types).

Net Income ” means, as calculated on a consolidated basis for Borrower and its Subsidiaries for any period as at any date of determination, the net profit (or loss), after provision for taxes, of Borrower and its Subsidiaries for such period taken as a single accounting period.

Prepayment Fee ” shall be an additional fee, payable to Bank, with respect to the Term Loan Advances, in an amount equal to (a) Two Hundred Forty Thousand Dollars ($240,000) if the prepayment is made on or before the date that is twelve (12) months after the First Amendment Effective Date, and (b) One Hundred Twenty Thousand Dollars ($120,000) if the prepayment is made after the date that is twelve (12) months after the First Amendment Effective Date and on or before the Term Loan Maturity Date.

Warrant ” is that certain Warrant to Purchase Common Stock dated as of the First Amendment Effective Date between Borrower and Bank, as amended, modified, supplemented and/or restated from time to time.

(c)        The defined terms “ Non Spin-Torque Product ”,  “ Spin-Torque Milestone ”, and “ Spin-Torque Product ”, set forth in Section 13.1 of the Loan Agreement and all references thereto in the Loan Agreement are deleted in their entirety.

2.8       Compliance Certificate .  From and after the date hereof, Exhibit B of the Loan Agreement is replaced in its entirety with Exhibit B attached hereto and all references in the Loan Agreement to the Compliance Certificate shall be deemed to refer to Exhibit B attached hereto.

2.9       Exhibit E (Beneficial Ownership Information Disclosure Form) .  The Loan Agreement is hereby amended by adding the Beneficial Ownership Information Disclosure Form attached hereto as Exhibit E as Exhibit E to the Loan Agreement. From and after the date hereof, all references in the Loan Agreement to the Beneficial Ownership Information Disclosure Form shall be deemed to refer to the Beneficial Ownership Information Disclosure Form attached hereto as Exhibit  E .

3.         Original Warrant . Bank and Borrower hereby agree that, as of the date hereof, that each of (i) Warrant to Purchase Stock issued by Borrower to Bank on November 14, 2010, and (ii) Warrant to Purchase Stock issued by Borrower to Bank on February 14, is hereby cancelled and will be returned to Borrower promptly hereafter.

4.         Limitation of Amendments.

4.1        The amendments and waiver set forth in Sections 2 through 4, above, are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Bank may now have or may have in the future under or in connection with any Loan Document.


 

4.2        This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed and shall remain in full force and effect.

5.         Representations and Warranties.  To induce Bank to enter into this Amendment, Borrower hereby represents and warrants to Bank as follows:

5.1        Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;

5.2        Borrower has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as amended by this Amendment;

5.3        The organizational documents of Borrower delivered to Bank on the Effective Date remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect;

5.4        The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, have been duly authorized;

5.5        The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual restriction with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower;

5.6        The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except as already has been obtained or made; and

5.7        This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.

6.         Integration .  This Amendment and the Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements.  All prior


 

agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of this Amendment and the Loan Documents merge into this Amendment and the Loan Documents.

7.         Counterparts.  This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument.

8.         Effectiveness .  This Amendment shall be deemed effective upon (a) the due execution and delivery to Bank of this Amendment by each party hereto, (b) the due execution and delivery to Bank of a Warrant to Purchase Common Stock dated on or about the date hereof by each party thereto, and (c)Borrower’s payment of Bank’s legal fees and expenses incurred in connection with this Amendment.

[Signature page follows.]


 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above.

 

BANK

    

BORROWER

 

 

 

 

 

SILICON VALLEY BANK

 

EVERSPIN TECHNOLOGIES, INC.

 

 

 

 

By:

/s/ Chris Goodwin

 

/s/ Jeff Winzeler

Name:

Chris Goodwin

 

Jeff Winzeler

Title

VP

 

Chief Financial Officer

 


 

EXHIBIT B

COMPLIANCE CERTIFICATE

 

 

 

TO:

SILICON VALLEY BANK

Date:

 

 

 

 

 

FROM:

EVERSPIN TECHNOLOGIES, INC.

 

 

 

The undersigned authorized officer of EVERSPIN TECHNOLOGIES, INC., a Delaware corporation, (“ Borrower ”) certifies that under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (the “ Agreement ”):

(1) Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below; (2) there are no Events of Default; (3) all representations and warranties in the Agreement are true and correct in all material respects on this date except as noted below; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date; (4) Borrower, and each of its Subsidiaries, has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section 5.8 of the Agreement; and (5) no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Bank.

Attached are the required documents supporting the certification.  The undersigned certifies that these are prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes.  The undersigned acknowledges that no borrowings may be requested at any time or date of determination that Borrower is not in compliance with any of the terms of the Agreement, and that compliance is determined not just at the date this certificate is delivered.  Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.

Please indicate compliance status by circling Yes/No under “Complies” column.

 

 

 

Reporting Covenants

Required

Complies

Monthly financial statements with Compliance Certificate

Monthly within 30 days

Yes    No

Annual financial statement (CPA Audited)

FYE within 150 days

Yes    No

Board Projections

Earlier of (i) 15 days after board approval or (ii) February 28th of each calendar year

Yes    No

 


 

 

 

 

10‑Q, 10‑K and 8-K

Within 5 days after filing with SEC

Yes    No

Board Projections

FYE within 30 days

Yes    No

 

Financial Covenant

Required

Actual

Complies

Maintain on a Monthly Basis:

 

 

 

Liquidity Ratio

See Schedule 1

____ to 1.00

Yes    No

 

 

 

 

TFS Revenue

See Schedule 1

$_____

Yes    No

 

The following financial covenant analysis and information set forth in Schedule 1 attached hereto are true and accurate as of the date of this Certificate.

Other Matters

 

 

 

Have there been any amendments of or other changes to the capitalization table of Borrower and to the Operating Documents of Borrower or any of its Subsidiaries?  If yes, provide copies of any such amendments or changes with this Compliance Certificate.

Yes

No

 

The following are the exceptions with respect to the certification above:  (If no exceptions exist, state “No exceptions to note.”)

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

EVERSPIN TECHNOLOGIES, INC.

    

BANK USE ONLY

 

 

 

 

 

 

By:

 

 

Received by:

 

Name:

 

 

 

AUTHORIZED SIGNER

Title:

 

 

Date:

 

 

 

 

 

 

 

Verified:

 

 

 

 

AUTHORIZED SIGNER

 

 

 

 

 

 

Date:

 

 

 

 

 

 

 

Compliance Status:   Yes        No

 


 

Schedule 1 to Compliance Certificate

Financial Covenants of Borrower

In the event of a conflict between this Schedule and the Loan Agreement, the terms of the Loan Agreement shall govern.

Dated:  ____________________

I.          Liquidity Ratio (Section 6.7(a))

Required:         As of the last day of each month, a Liquidity Ratio of not less than (i) 1.25:1.00 for each month prior to Borrower achieving the Extension Milestone, and (ii) 1.50:1.00 for each month after Borrower achieves the Extension Milestone.

Actual:

A.

Unrestricted cash and Cash Equivalents maintained at Bank

$________

B.

Net accounts receivable

$________

C.

Liquidity (line A, plus line B)

$________

D.

Outstanding Obligations

$________

E.

Liquidity Ratio (line C, divided by line D)

______

 

Is line E equal or greater than the required ratio?

________  No, not in compliance

________  Yes, in compliance

 


 

II.          Performance to Plan (Section 6.7(b))

Required TFS Revenue of Borrower for such month (calculated on a cumulative fiscal year to date basis):

Month Ending

Minimum TFS Revenue

April 30, 2018

$11,052,000

May 31, 2018

$14,485,000

June 30, 2018

$18,889,000

July 31, 2018

$20,933,000

August 31, 2018

$24,492,000

September 30, 2018

$29,069,000

October 31, 2018

$31,355,000

November 30, 2018

$35,355,000

December 31, 2018

$40,498,000

January 31, 2019

$2,493,000

February 28, 2019

$6,979,000

March 31, 2019

$12,459,000

April 30, 2019

$15,049,000

May 31, 2019

$19,724,000

June 30, 2019

$25,439,000

July 31, 2019

$28,399,000

August 31, 2019

$33,739,000

September 30, 2019

$40,264,000

October 31, 2019

$43,840,000

November 30, 2019

$50,277,000

December 31, 2019

$58,144,000

 


 

Actual:

A.

Actual TFS Revenue of Borrower for such month (calculated on a cumulative year to date basis):

$ ___________

 

Is line A equal to or greater than as required above?

No, not in compliance

Yes, in compliance

 


 

EXHIBIT E

Beneficial Ownership Information Disclosure Form

1.   Does any individual ,   directly or indirectly (for example, if applicable, through such individual’s equity interests in the Borrower’s parent entity), through any contract, arrangement, understanding, relationship or otherwise, own 25% or more of the equity interests of Borrower:

Yes                No       

 

 

If yes, complete the following information:

 

 

Name

 

Date of

 

Residential

 

For US

 

For Non-US

 

Percentage

 

 

 

 

birth

 

address

 

Persons,

 

Persons: Type

 

of

 

 

 

 

 

 

 

 

Social

 

of ID, ID

 

ownership

 

 

 

 

 

 

 

 

Security

 

number,

 

(if indirect

 

 

 

 

 

 

 

 

Number:

 

country of

 

ownership,

 

 

 

 

 

 

 

 

(non-US

 

issuance,

 

explain

 

 

 

 

 

 

 

 

persons

 

expiration date

 

structure)

 

 

 

 

 

 

 

 

should

 

 

 

 

 

 

 

 

 

 

 

 

provide SSN

 

 

 

 

 

    

 

    

 

    

 

    

if available)

    

 

    

 

1

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

2.   Identify one individual with significant responsibility for managing Borrower, i.e., an executive officer or senior manager (e.g., Chief Executive Officer, President, Vice President, Chief Financial Officer, Treasurer, Chief Operating Officer, Managing Member or General Partner) or any other individual who regularly performs similar functions.  If appropriate, an individual listed in Section 1 above may also be listed here.


 

 

 

 

    

Name

    

Date of

    

Residential

    

For US Persons,

    

For Non-US

 

 

 

 

birth

 

address

 

Social Security

 

Persons: Type of

 

 

 

 

 

 

 

 

Number:

 

ID, ID number,

 

 

 

 

 

 

 

 

(non-US persons

 

country of

 

 

 

 

 

 

 

 

should provide SSN

 

issuance,

 

 

 

 

 

 

 

 

if available)

 

expiration date

 

 

 

 

 

 

 

 

 

 

 

 

The undersigned, in his or her individual capacity, hereby certifies, to the best of his or her knowledge, that the information set out in this certificate is true, complete and correct.

Date:

 

 

 

 

 

By:

 

 

Name:

 

 

Title:

 

 

Email:

 

 

Phone:

 

 


Exhibit 10.3

June 6, 2018

Patrick Patla

4201 Prince Andrew Lane

Austin, TX 78730

Dear Pat:

This letter sets forth the substance of the separation agreement (the “ Agreement ”) that Everspin Technologies, Inc. (the “ Company ”) is offering to you. 

S eparation .  Your last day of work with the Company and your employment termination date will be, June 30 th , 2018 (the “ Separation Date ”). 

A ccrued Salary .  On the Separation Date, the Company will pay you all accrued salary earned through the Separation Date, subject to standard payroll deductions and withholdings. 

S everance Benefits .  If you sign this Agreement, allow it to become effective, and remain in compliance with your legal and contractual obligations to the Company, then the Company will provide you with the following severance benefits in accordance with your Executive Employment Agreement with the Company dated January 9 th , 2017 (the “ Employment Agreement ”):

a.         Cash Severance.  The Company will pay you a total of $130,000.00, less applicable withholdings, which will be paid over the course of six (6) months from the Separation Date in accordance with the Company’s regular payroll schedule; provided, however, that no payments will be made to you before August 29, 2018 (the “Payment Start Date”). On the Payment Start Date, the Company will pay you a lump sum of $43,333.33 which is equivalent to the salary continuation payments that you would have received from the Separation Date until the Payment Start Date had the Company begun making payments under this paragraph on the Separation Date.

b.         Paid COBRA.  Provided that you timely elect continued coverage under COBRA, then the Company shall reimburse you for the COBRA premiums to continue your health insurance coverage (including coverage for eligible dependents, if applicable) through the period starting on the Separation Date and ending on the earliest to occur of: (i) June 30, 2019; (ii) the date you become eligible for group health insurance coverage through a new employer; or (iii) the date you cease to be eligible for COBRA coverage for any reason.  You must timely pay your premiums, and then provide the Company with proof of same, to obtain reimbursement for your COBRA premiums under this Section 3.b. 

c.          Accelerated Vesting.  During your employment, you were granted certain equity interests (the “ Awards ”).     The Company will accelerate the vesting of the Awards such


 

that, as of the Separation Date, you will be deemed vested in those Awards that would have vested in the six (6) months following the Separation Date had you remained employed

O ther Compensation or Benefits .  You acknowledge that, except as expressly provided in this Agreement, you will not receive any additional compensation, severance, or benefits after the Separation Date. You further expressly acknowledge and agree that the severance benefits being provided to you under this Agreement are in full satisfaction of any severance benefits you are eligible to receive under the Employment Agreement. 

E xpense Reimbursements .  You agree that, within ten (10) days after the Separation Date, you will submit your final documented expense reimbursement statement reflecting all business expenses you incurred through the Separation Date, if any, for which you seek reimbursement.  The Company will reimburse you for these expenses pursuant to its regular business practice. 

R eturn of Company Property .  By the Separation Date , you agree to return to the Company all Company documents (and all copies thereof) and other Company property within your possession, custody or control, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial information, specifications, computer-recorded information, tangible property (including, but not limited to), credit cards, entry cards, identification badges, and keys; and, any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof). 

P roprietary Information Obligations .  You acknowledge your continuing obligations under your Employee Proprietary Information and Inventions Assignment Agreement, a copy of which is attached hereto as Exhibit A .  

N ondisparagement .  You agree not to disparage the Company, its officers, directors, employees, shareholders, and agents, in any manner likely to be harmful to its or their business, business reputation or personal reputation; and the Company (through its officers and directors) agrees not to disparage you in any manner likely to be harmful to you or your business, business reputation or personal reputation; provided that you and the Company will respond accurately and fully to any question, inquiry or request for information when required by legal process. 

N o Admissions .   You understand and agree that the promises and payments in consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission.

R elease of Claims In exchange for the consideration under this Agreement to which you would not otherwise be entitled, you hereby generally and completely release the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date you sign this Agreement.  This general release includes, but is not limited to: (a) all claims arising out of or in any way related to your employment with the Company or the termination of that employment;


 

(b) all claims related to your compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (c) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (d) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act (“ ADEA ”) the Arizona Wage Act, the Arizona Employment Protection Act, the Arizona Civil Rights Act, the Arizona Revised Statutes, the Arizona Administrative Rules, the Texas Human Rights Act and the Texas Labor Code.  Notwithstanding the foregoing, you are not releasing the Company hereby from any obligation to indemnify you pursuant to the Articles and Bylaws of the Company, any valid fully executed indemnification agreement with the Company, applicable law, or applicable directors and officers’ liability insurance.  Also, excluded from this Agreement are any claims that cannot be waived by law. 

A DEA Release You acknowledge that you are knowingly and voluntarily waiving and releasing any rights you have under the ADEA, and that the consideration given for the waiver and releases you have given in this Agreement is in addition to anything of value to which you were already entitled.  You further acknowledge that you have been advised, as required by the ADEA, that:  (a) your waiver and release does not apply to any rights or claims that arise after the date you sign this Agreement; (b) you should consult with an attorney prior to signing this Agreement (although you may choose voluntarily not to do so); (c) you have twenty-one (21) days to consider this Agreement (although you may choose voluntarily to sign it sooner); (d) you have seven (7) days following the date you sign this Agreement to revoke this Agreement (in a written revocation sent to me); and (e) this Agreement will not be effective until the date upon which the revocation period has expired, which will be the eighth day after you sign this Agreement provided that you do not revoke it (the “ Effective Date ”).

P rotected Rights .   You understand that nothing in this Agreement limits your ability to file a charge or complaint with the Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission (“ Government Agencies ”).  You further understand this Agreement does not limit your ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  While this Agreement does not limit your right to receive an award for information provided to the Securities and Exchange Commission, you understand and agree that, to maximum extent permitted by law, you are otherwise waiving any and all rights you may have to individual relief based on any claims that you have released and any rights you have waived by signing this Agreement.

R epresentations .   You hereby represent that you have been paid all compensation owed and for all hours worked, have received all the leave and leave benefits and protections for which you are eligible pursuant to the Family and Medical Leave Act or otherwise, and have not suffered


 

any on-the-job injury for which you have not already filed a workers’ compensation claim.

M iscellaneous .   This Agreement, including Exhibit A , constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter.  It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations.  This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company.  This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns.  If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified so as to be rendered enforceable.  This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of Arizona without regard to conflict of laws principles.  Any ambiguity in this Agreement shall not be construed against either party as the drafter.  Any waiver of a breach of this Agreement shall be in writing and shall not be deemed to be a waiver of any successive breach.  This Agreement may be executed in counterparts and facsimile signatures will suffice as original signatures.

If this Agreement is acceptable to you, please sign below and return the original to me.  You have twenty-one (21) calendar days to decide whether you would like to accept this Agreement, and the Company’s offer contained herein will automatically expire if you do not sign and return it within this timeframe.

We wish you the best in your future endeavors.

Sincerely,

 

 

By:

/s/ Jim Everett

 

 

Jim Everett

 

 

Vice President of Human Resources

 

 

 Exhibit A – Employee Proprietary Information and Inventions Assignment Agreement


 

I   have read, understand and agree fully to the foregoing Agreement:

 

 

 

/s/ Patrick Patla

    

June 7, 2018

Patrick Patla

 

Date


 

E xhibit A

Employee Proprietary Information and Inventions Assignment Agreement

In consideration of my employment or continued employment by Everspin Technologies, Inc. (“ Company ”), and the compensation paid to me now and during my employment with the Company, I agree to the terms of this Agreement as follows:

Confidential Information Protections.

Nondisclosure; Recognition of Company’s Rights .  At all times during and after my employment, I will hold in confidence and will not disclose, use, lecture upon, or publish any of Company’s Confidential Information (defined below), except as may be required in connection with my work for Company, or as expressly authorized by the Chief Executive Officer (the “ CEO ”) of Company.  I will obtain the CEO’s written approval before publishing or submitting for publication any material (written, oral, or otherwise) that relates to my work at Company and/or incorporates any Confidential Information.  I hereby assign to Company any rights I may have or acquire in any and all Confidential Information and recognize that all Confidential Information shall be the sole and exclusive property of Company and its assigns.

Confidential Information.  The term “ Confidential Information ” shall mean any and all confidential knowledge, data or information related to Company’s business or its actual or demonstrably anticipated research or development, including without limitation (a) trade secrets, inventions, ideas, processes, computer source and object code, data, formulae, programs, other works of authorship, know-how, improvements, discoveries, developments, designs, and techniques; (b) information regarding products, services, plans for research and development, marketing and business plans, budgets, financial statements, contracts, prices, suppliers, and customers; (c) information regarding the skills and compensation of Company’s employees, contractors, and any other service providers of Company; and (d) the existence of any business discussions, negotiations, or agreements between Company and any third party.

Third Party Information.  I understand that Company has received and in the future will receive from third parties confidential or proprietary information ( “Third Party Information” ) subject to a duty on Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes.  During and after the term of my employment, I will hold Third Party Information in strict confidence and will not disclose to anyone (other than Company personnel who need to know such information in connection with their work for Company) or use, Third Party Information, except in connection with my work for Company or unless expressly authorized by an officer of Company in writing.

No Improper Use of Information of Prior Employers and Others.  I represent that my employment by Company does not and will not breach any agreement with any former employer, including any noncompete agreement or any agreement to keep in confidence or refrain from using information acquired by me prior to my employment by Company.  I further represent that I have not entered into, and will not enter into, any agreement, either written or oral, in conflict with my obligations under this Agreement.  During my employment by Company, I will not improperly make use of, or disclose, any information or trade secrets of any former employer or other third party, nor will I bring onto the premises of Company or use any unpublished documents or any property belonging to any former employer or other third party, in violation of any lawful agreements with that former employer or third party.  I will use in the performance of my duties only information that is generally known and used by persons with training and experience comparable to my own, is common knowledge in the industry or otherwise legally in the public domain, or is otherwise provided or developed by Company.


 

Inventions.

Inventions and Intellectual Property Rights.  As used in this Agreement, the term “Invention” means any ideas, concepts, information, materials, processes, data, programs, know-how, improvements, discoveries, developments, designs, artwork, formulae, copyrightable works, and techniques and all Intellectual Property Rights in any of the items listed above.  The term “Intellectual Property Rights” means all trade secrets, copyrights, trademarks, mask work rights, patents and other intellectual property rights recognized by the laws of any jurisdiction or country.

Prior Inventions.  I have disclosed on Exhibit A   a complete list of all Inventions that (a) I have, or I have caused to be, alone or jointly with others, conceived, developed, or reduced to practice prior to the commencement of my employment by Company; (b) in which I have an ownership interest or which I have a license to use; (c) and that I wish to have excluded from the scope of this Agreement (collectively referred to as “ Prior Inventions ”).  If no Prior Inventions are listed in Exhibit A , I warrant that there are no Prior Inventions.  I agree that I will not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions (defined below) without Company’s prior written consent. If, in the course of my employment with Company, I incorporate a Prior Invention into a Company process, machine or other work, I hereby grant Company a non-exclusive, perpetual, fully-paid and royalty-free, irrevocable and worldwide license, with rights to sublicense through multiple levels of sublicensees, to reproduce, make derivative works of, distribute, publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have made, use, sell, import, offer for sale, and exercise any and all   present or future rights in, such Prior Invention.

Assignment of Company Inventions.  Inventions assigned to the Company or to a third party as directed by the Company pursuant to the section titled “Government or Third Party” are referred to in this Agreement as “ Company Inventions .”  Subject to the section titled “Government or Third Party” and except for Inventions that I can prove qualify fully under the provisions of a Specific Inventions Law (as defined below) and I have set forth in Exhibit A , I

hereby assign and agree to assign in the future (when any such Inventions or Intellectual Property Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to Company all my right, title, and interest in and to (i) any and all Inventions (and all Intellectual Property Rights with respect thereto) made, conceived, reduced to practice, or learned by me, either alone or with others, during the period of my employment by Company and (ii) any and all priority rights corresponding to any patent applications of such Intellectual Property Rights, including the right to claim priority, provided by any International Convention, including the Paris Convention.  To the extent necessary, company accepts all such assignments.   

Specific Inventions Law.  I recognize that, in the event of a specifically applicable state law, regulation, rule or public policy (“ Specific Inventions Law ”), this Agreement will not be deemed to require assignment of any invention which qualifies fully for protection under a Specific Inventions Law by virtue of the fact that any such invention was, for example, developed entirely on my own time without using the company’s equipment, supplies, facilities, or trade secrets and neither related to the company’s actual or anticipated business, research or development, nor resulted from work performed by me for the Company.  Examples of Specific Inventions Laws include California Labor Code Section 2870 and the Revised Code of Washington Section 49.44.140. 

Obligation to Keep Company Informed.  While employed with the Company and for one (1) year after my employment ends, I will promptly and fully disclose to the Company in writing (a) all Inventions I author, conceive or reduce to practice, either alone or with others and including any that might be covered under a Specific Inventions Law, and (b) all patent applications I file or in which I am named as an inventor or co-inventor.

Government or Third Party .  I agree that, as directed by the Company, I will assign to a third party, including without limitation the United States, all my right, title, and interest in and to any particular Company Invention. 


 

Enforcement of Intellectual Property Rights and Assistance.  During and after the period of my employment, I will assist Company in every proper way to obtain and enforce United States and foreign Intellectual Property Rights relating to Company Inventions in all countries.  If the Company is unable to secure my signature on any document needed in connection with such purposes, I hereby irrevocably designate and appoint Company and its duly authorized officers and agents as my agent and attorney in fact, which appointment is coupled with an interest, to act on my behalf to execute and file any such documents and to do all other lawfully permitted acts to further such purposes with the same legal force and effect as if executed by me.

Incorporation of Software Code.  I agree that I will not incorporate into any Company software or otherwise deliver to Company any software code licensed under the GNU General Public License or Lesser General Public License or any other license that, by its terms, requires or conditions the use or distribution of such code on the disclosure, licensing, or distribution of any source code owned or licensed by Company.

Records .  I agree to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form that is required by the Company) of all Inventions made by me during the period of my employment by the Company, which records shall be available to, and remain the sole property of, the Company at all times.

Additional Activities . I agree that (a) during the term of my employment by Company, I will not, without Company’s express written consent, engage in any employment or business activity that is competitive with, or would otherwise conflict with my employment by, Company, and (b) for the period of my employment by Company and for one (l) year thereafter, I will not, either directly or indirectly, solicit or attempt to solicit any employee, independent contractor, or consultant of Company to terminate his, her or its relationship with Company in order to become an employee, consultant, or independent contractor to or for any other person or entity.

R eturn Of Company Property .   Upon termination of my employment or upon Company’s request at any other time, I will deliver to Company all   of Company’s property, equipment, and documents, together with all copies thereof, and any other material containing or disclosing any Inventions, Third Party Information or Confidential Information and certify in writing that I have fully complied with the foregoing obligation.  I agree that I will not copy, delete, or alter any information contained upon my Company computer or Company equipment before I return it to Company.  In addition, if I have used any personal computer, server, or e-mail system to receive, store, review, prepare or transmit any Company information, including but not limited to, Confidential Information, I agree to provide the Company with a computer-useable copy of all such Confidential  Information and then permanently delete and expunge such Confidential Information from those systems; and I agree to provide the Company access to my system as reasonably requested to verify that the necessary copying and/or deletion is completed.  I further agree that any property situated on Company’s premises and owned by Company is subject to inspection by Company’s personnel at any time with or without notice.  Prior to the termination of my employment or promptly after termination of my employment, I will cooperate with Company in attending an exit interview and certify in writing that I have complied with the requirements of this section.

N otification Of New Employer .  If I leave the employ of Company, I consent to the notification of my new employer of my rights and obligations under this Agreement, by Company providing a copy of this Agreement or otherwise.

G eneral Provisions.

Governing Law and Venue.  This Agreement and any action related thereto will be governed and interpreted by and under the laws of the State of Arizona, without giving effect to any conflicts of laws principles that require the application of the law of a different state.   I expressly consent to personal jurisdiction and venue in the state and federal courts for the county in which Company’s principal place of business is located for any lawsuit filed there against me by Company arising from or related to this Agreement.

Severability.    If any provision of this Agreement is, for any reason, held to be invalid or


 

unenforceable, the other provisions of this Agreement will remain enforceable and the invalid or unenforceable provision will be deemed modified so that it is valid and enforceable to the maximum extent permitted by law.

Survival.  This Agreement shall survive the termination of my employment and the assignment of this Agreement by Company to any successor or other assignee and be binding upon my heirs and legal representatives.

Employment .   I agree and understand that nothing in this Agreement shall give me any right to continued employment by Company, and it will not interfere in any way with my right or Company’s right to terminate my employment at any time, with or without cause and with or without advance notice.

Notices.  Each party must deliver all notices or other communications required or permitted under this Agreement in writing to the other party at the address listed on the signature page, by courier, by certified or registered mail (postage prepaid and return receipt requested), or by a nationally-recognized express mail service.  Notice will be effective upon receipt or refusal of delivery.  If delivered by certified or registered mail, notice will be considered to have been given five (5) business days after it was mailed, as evidenced by the postmark.  If delivered by courier or express mail service, notice will be considered to have been given on the delivery date reflected by the courier or express mail service receipt. Each party may change its address for receipt of notice by giving notice of the change to the other party.

Injunctive Relief .  I  acknowledge that, because my services are personal and unique and because I will have access to the Confidential Information of Company, any breach of this Agreement by me would cause irreparable injury to Company for which monetary damages would not be an adequate remedy and, therefore, will entitle Company to injunctive relief (including specific performance).  The rights and remedies provided to each party in this Agreement are cumulative and in addition to any other rights and remedies available to such party at law or in equity.

Waiver. Any waiver or failure to enforce any provision of this Agreement on one occasion will not be deemed a waiver of that provision or any other provision on any other occasion.

Export .  I agree not to export, directly or indirectly, any U.S. technical data acquired from Company or any products utilizing such data, to countries outside the United States, because such export could be in violation of the United States export laws or regulations.

Entire Agreement.  If no other agreement governs nondisclosure and assignment of inventions during any period in which I was previously employed or am in the future employed by Company as an independent contractor, the obligations pursuant to sections of this Agreement titled “Confidential Information Protections” and “Inventions” shall apply.  This Agreement is the final, complete and exclusive agreement of the parties with respect to the subject matter hereof and supersedes and merges all prior communications between us with respect to such matters.  No modification of or amendment to this Agreement, or any waiver of any rights under this Agreement, will be effective unless in writing and signed by me and the CEO of Company.  Any subsequent change or changes in my duties, salary or compensation will not affect the validity or scope of this Agreement.


 

 

This Employee Proprietary Information and Inventions Assignment Agreement shall be effective as of the first day of my employment with Company.

 

 

 

 

 

EMPLOYEE: 

    

COMPANY:  EVERSPIN TECHNOLOGIES, INC.

I HAVE READ, UNDERSTAND, AND ACCEPT THIS AGREEMENT AND HAVE BEEN GIVEN THE OPPORTUNITY TO REVIEW IT WITH INDEPENDENT LEGAL COUNSEL.

 

ACCEPTED AND AGREED:

 

 

 

 

 

 

/s/ Patrick M Patla

 

/s/ Jeff Winzeler

(Signature)

 

(Signature)

 

 

 

By

Patrick M Patla

 

By

Jeff Winzeler

 

 

 

Title:

SVP of Marketing

 

Title:

CFO

 

 

 

Date:

January 10, 2017

 

Date:

January 12, 2017

 

 

 

Address:

4201 Prince Andrew Lane, Austin, TX

 

Address:

1300 N Alma School


 

Exhibit A

INVENTIONS

1.         Prior Inventions Disclosure.  The following is a complete list of all Prior Inventions (as provided in Section 2.2 of the attached Employee Proprietary Information and Inventions Assignment Agreement, defined herein as the “ Agreement ”):

          None

          See immediately below:

_________________________________________________________________________________

_________________________________________________________________________________

2.         Limited Exclusion Notification. 

T his is to notify   you in accordance with any applicable Specific Inventions Law that the foregoing Agreement between you and Company does not require you to assign or offer to assign to Company any Invention that you develop entirely on your own time without using Company’s equipment, supplies, facilities or trade secret information, except for those Inventions that either:

a.          Relate at the time of conception or reduction to practice to Company’s business, or actual or demonstrably anticipated research or development; or

b.          Result from any work performed by you for Company.

To the extent a provision in the foregoing Agreement purports to require you to assign an Invention otherwise excluded from the preceding paragraph, the provision is against the public policy of this state and is unenforceable.

This limited exclusion does not apply to any patent or Invention covered by a contract between Company and the United States or any of its agencies requiring full title to such patent or Invention to be in the United States.


Exhibit 10.4

LEASE TERMINATION AGREEMENT

This Lease Termination Agreement (this " Agreement ") is made and entered into as of April 12, 2018 (the " Effective Date "), by and between JUTLAND 4141 INVESTMENTS, LTD., a California limited partnership (" Landlord "), and everspin technologies, inc., a Delaware corporation (" Tenant ").

RECITALS

Landlord and Tenant are parties to that certain Office Lease Agreement dated as of January 7, 2011 (the " Original Lease "), as amended by that certain First Amendment to Commercial Office Lease dated as of January [ undated ], 2015 (the " First Amendment " and, together with the Original Lease, the " Lease "), pursuant to which Landlord leases to Tenant, and Tenant leases from Landlord, certain premises containing approximately 11,837 rentable square feet and commonly known as Suites 200 and 220 (the " Premises "), in the office building located at 1347 N. Alma School Road, Chandler, Arizona (the " Building "), in the office project commonly known as Chandler Office Center (the " Project "), as more particularly described in the Lease.  The parties now desire to terminate the Lease in accordance with the terms and conditions of this Agreement.

AGREEMENT

NOW, THEREFORE, in consideration of the mutual covenants and upon the conditions contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows:

1.           Termination of Lease .  Effective as of April 13, 2018 (the " Termination Date "), the Lease shall be deemed terminated and Tenant shall surrender to Landlord all of Tenant's right, title and interest in and to the Premises, the Lease and any other rights of occupancy with respect to the Premises.  Subject to the terms of this Agreement, from and after the Termination Date, Tenant shall have no further rights whatsoever (occupancy or otherwise) to the Premises or under the Lease, and Landlord and Tenant shall have no further duties or obligations to one another in connection with the Lease, except for (i) Tenant's obligations to continue performance of all obligations under the Lease (including, without limitation, Tenant's obligation to pay rent and all other charges and amounts due under the Lease) until such time as Tenant has properly surrendered the Premises in accordance with the terms of the Lease; (ii) Tenant's obligations under this Agreement, and (iii) the obligations of Tenant under the Lease and/or at law which are specifically stated to survive the expiration or earlier termination of the Lease (collectively, the " Surviving Obligations "). Tenant hereby acknowledges and agrees that, notwithstanding anything to the contrary contained in the Lease or this Agreement, the Surviving Obligations shall include, without limitation, Tenant's indemnification obligations contained in the Lease.

2.           Agreement Contingency .  Notwithstanding anything to the contrary herein, Landlord and Tenant hereby acknowledge and agree that this Agreement (and the early termination of the Lease pursuant to the terms of this Agreement) is expressly conditioned upon the execution of a lease agreement (satisfactory to Landlord in its sole and absolute discretion), on or prior to, or concurrently with, the Effective Date, between Landlord and a third party tenant for the lease of the Premises (the " Third-Party Lease ").  The foregoing condition is for the sole benefit of Landlord and, accordingly, may be waived only by Landlord (in its sole and absolute discretion) in writing, and not by Tenant or any other party.  If the foregoing condition is not satisfied or waived in writing by Landlord, then the other terms and conditions of this Agreement shall be null and void and of no force or effect, unless otherwise designated by Landlord


 

within ten (10) business days after the Effective Date.

3.           Termination Fee .  In consideration of Landlord accepting the early termination of the Lease pursuant to this Agreement, on or before May 1, 2018 (the " Termination Fee Date "), Tenant shall pay to Landlord the amount of Forty-Two Thousand Five Hundred Forty-Five and 80/100 Dollars ($42,545.80) in immediately available funds (the " Termination Fee ").  The Termination Fee shall constitute separate consideration for Landlord's acceptance of the early termination of the Lease as described above and shall not be applied against any other amounts that may be due and payable by Tenant to Landlord on account of any Surviving Obligations.  In the event that this Agreement is terminated pursuant to Section 2 above after Tenant has paid the Termination Fee to Landlord, then Landlord shall return the Termination Fee to Tenant within ten (10) days following such termination of this Agreement.

4.           Security Deposit .  Landlord and Tenant hereby acknowledge and agree that Landlord is holding a Security Deposit in the amount of Twenty Thousand Three Hundred Eighty-Two and 00/100 Dollars ($20,382.00).  Within thirty (30) days following the full performance by Tenant of all of its obligations under the Lease and this Agreement (including, without limitation, the payment of the Termination Fee pursuant to Section 3 above), Landlord shall return any unapplied portion of such Security Deposit to Tenant.

5.           Condition of Premises . As of the Termination Date, Tenant has surrendered the Premises to Landlord in its currently existing "as is" condition , normal wear and tear excepted.  In consideration of Lessor's receipt of the Termination Fee as set forth above, and Tenant's execution of the Bill of Sale described in this Section 5 below, Landlord accepts the Premises in such "as is" condition and waives Tenant's obligations with respect to removal, surrender and restoration of the Premises, including Tenant's obligations under Section 2.03 of the Original Lease.  Concurrently with Tenant's execution and delivery of this Agreement, Tenant shall execute and deliver to Landlord a bill of sale in substantially the form of Exhibit A attached hereto (the " Bill of Sale "), relinquishing any rights of Tenant in and to any and all personal property, fixtures, furniture and equipment existing in the Premises as of the date of this Agreement. 

6.           Release by Tenant .  Effective on the Termination Date, Tenant, on behalf of itself and its predecessors, successors, affiliates and assigns, and all other persons, firms and corporations claiming through Tenant, and each of them (collectively, the " Tenant Releasing Parties "), do hereby release Landlord and its predecessors, successors, affiliates and assigns, and their respective partners, officers, shareholders, agents, contractors, representatives, members, employees and attorneys (collectively the " Landlord Released Parties "), of and from any and all claims, demands, disputes, damages, liabilities, obligations, controversies, debts, costs, expenses, lawsuits, actions, causes of action and other rights to relief, both legal and equitable, of every kind and nature, whether now known or unknown, suspected or unsuspected, past or present, contingent or fixed, which the Tenant Releasing Parties, or any of them, now have, had, or at any time hereafter may have, against the Landlord Released Parties, or any of them, arising out of or in connection with the Lease, the Premises, or any dealings between the Landlord Released Parties, or any of them, on the one hand, and the Tenant Releasing Parties, or any of them, on the other hand.  In connection therewith, Tenant hereby expressly waives all rights which it has, or may hereafter claim to have, that any claim, demand, obligation and/or cause of action has, through ignorance, oversight or error, been omitted from the terms of this Agreement.  In connection therewith, Tenant hereby expressly waives all rights which it has, or may hereafter claim to have, that any claim, demand, obligation and/or cause of action has, through ignorance, oversight or error, been omitted from the terms of this Agreement, and hereby expressly waives all rights it may have, or claim to have, under the provisions of California Civil Code Section 1542, or equivalent law of any jurisdiction, which provides:

"A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THE


 

CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR."

 

 

/s/ JW     

 

 

Tenant's Initials

 

 

7.           Representations and Warranties .  Tenant hereby makes the following representations and warranties to Landlord (all of which representations and warranties, together with all other representations and warranties made in this Agreement by Tenant, shall survive the mutual execution and delivery of this Agreement): (i) Tenant has the full power, authority and legal right to enter into and to perform and observe the provisions of this Agreement without the authorization or consent of any other party or entity; (ii) Tenant has not assigned, sublet, transferred or conveyed, and agrees not to assign, sublet, transfer or convey its interest in the Premises, the Lease or any claims or potential claims it may have against Landlord or any of the Landlord Released Parties; and (iii) Landlord is not in default under the Lease and Tenant does not have any defenses or offsets to the timely performance of Tenant's obligations under the Lease or this Agreement.  Tenant hereby agrees to indemnify, defend (by counsel reasonably satisfactory to Landlord) and hold Landlord and the Landlord Released Parties harmless from and against any claims, actions, causes of action, losses, liabilities, damages, costs and expenses (including, without limitation, attorneys' fees and costs) suffered or incurred by Landlord or the Landlord Released Parties as a result of any breach of Tenant's obligations under this Agreement including, without limitation, any breach of or inaccuracy in Tenant's representations and warranties contained in this Agreement.

8.           Invalidity of Provisions .  If any provision of this Agreement is found to be invalid or unenforceable by any court of competent jurisdiction, the invalidity or unenforceability of any such provision shall not affect the validity and enforceability of the remaining provisions hereof.

9.           Attorneys' Fees .  If either party hereto commences an action against the other to enforce any of the terms hereof, or to obtain damages for any alleged breach of any of the terms hereof, or for a declaration of rights hereunder, the losing party shall pay to the prevailing party the prevailing party's reasonable attorneys' fees and costs incurred in connection with the prosecution of such action, whether or not such action proceeds to trial or appeal.

10.         Brokers .  Tenant hereby warrants and represents that it has had no dealings with any real estate broker or agent who is or might be entitled to a commission, finder's fee or other like payment in connection with the negotiation of this Agreement.  Tenant hereby agrees to indemnify, defend and hold Landlord harmless from any and all claims, demands, losses, liabilities, lawsuits, judgments, costs and expenses (including without limitation reasonable attorneys' fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of any dealings with any real estate broker or agent occurring by, through, or under Tenant. 

11.         Further Assurances .  Each of the parties hereto agrees to execute and deliver all such further documents and to take all such further actions as may be reasonably requested by the other party hereto to effectuate fully the terms and provisions of this Agreement, provided such documents or actions do not limit, reduce or impair the rights of the party upon whom such request is made.

12.         Electronic Signatures; Counterparts .  Each party hereto shall be authorized to rely upon the signatures of all parties to this Agreement which are delivered by facsimile, email or other electronic means as constituting a duly authorized, irrevocable and actual delivery of this Agreement with original ink signatures.  This Agreement may be executed in two or more counterparts, each of which shall be deemed


 

an original, and all of which together shall constitute one and the same instrument.

13.         Binding Agreement .  This Agreement shall be binding upon and inure to the benefit of the heirs, successors and assigns of the parties hereto.

[ signatures follow on next page ]


 

IN WITNESS WHEREOF, Landlord and Tenant have entered into this Agreement as of the date first written above.

LANDLORD:

JUTLAND 4141 INVESTMENTS, LTD.,

a California limited partnership

 

 

 

By:

/s/ Danny Gabriel

 

Name:

Danny Gabriel

 

Its:

Authorized Representative

 

 

TENANT:

EVERSPIN TECHNOLOGIES, INC.,

a Delaware corporation

By:

/s/ Jeff Winzeler

 

Name:

Jeff Winzeler

 

Its:

Chief Financial Officer

 


 

EXHIBIT A

FORM OF BILL OF SALE

EVERSPIN TECHNOLOGIES, INC., a Delaware corporation (" Seller "), for and in consideration of the amount of Ten Dollars ($10.00) and other good and valuable consideration received, does hereby sell, assign, grant and convey to JUTLAND 4141 INVESTMENTS, LTD.,   a California limited partnership   (" Buyer "), all furniture, fixtures, equipment, appliances, tools, supplies and other personal property of every kind and character (the " Personal Property ") owned by Seller and attached to or located in that certain premises containing approximately 11,837 rentable square feet and commonly known as Suites 200 and 220, in the office building located at 1347 N. Alma School Road, Chandler, Arizona, in the office project commonly known as Chandler Office Center. 

The Personal Property is conveyed to Purchaser “AS IS, WHERE IS”.

IN WITNESS WHEREOF, Seller has caused this Bill of Sale to be executed effective as of the 12th day of April, 2018.

SELLER:

EVERSPIN TECHNOLOGIES, INC.,

a Delaware corporation

 

 

 

By:

/s/ Jeff Winzeler

 

Name:

Jeff Winzeler

 

Its:

Chief Financial Officer

 

 


Exhibit 31.1

 

Certification of the Principal Executive Officer

 

I, Kevin Conley, certify that:

 

1.

I have reviewed this Form 10-Q of Everspin Technologies, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: August 8, 2018

 

 

 

 

/s/ Kevin Conley

 

Kevin Conley

 

(Principal Executive Officer)

 


Exhibit 31.2

 

Certification of Principal Financial Officer

 

I, Jeffrey Winzeler, certify that:

 

1.

I have reviewed this Form 10-Q of Everspin Technologies, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: August 8, 2018

 

 

 

 

/s/ Jeffrey Winzeler

 

Jeffrey Winzeler

 

Principal Financial Officer

 


Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Kevin Conley, President and Chief Executive Officer of Everspin Technologies, Inc. (the “Company”), and Jeffrey Winzeler, Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

1. The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2018, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 8, 2018

 

 

 

 

/s/ Kevin Conley

 

Kevin Conley

 

(Principal Executive Officer)

 

 

 

/s/ Jeffrey Winzeler

 

Jeffrey Winzeler

 

(Principal Financial Officer)

 

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Everspin Technologies, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.